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The effect of probiotics on bacterial human skin pathogens 
 
 
Abstract 
Probiotic bacteria have been investigated in the prevention and treatment of 
various diseases and allergies. The current study was undertaken to 
determine the effect of eight probiotic Lactobacillus species against bacterial 
human skin pathogens using several techniques. Antimicrobial activity of 
lactobacilli  against Staphylococcus aureus, Staphylococcus epidermidis, 
Pseudomonas aeruginosa and Propionibacterium acnes was evaluated using 
lactobacilli broth cultures (BCB) and cell free supernatant (CFS). 
Antimicrobial activity was significantly greater with BCB compared with CFS 
especially for Lactobacillus plantarum and Lactobacillus acidophilus. 
Lactobacilli and pathogen aggregation, biofilm formation and adhesion to 
keratin were assessed. L. casei and L. plantarum were selected for further 
study as they showed the greatest co-aggregation (18.02 ± 1.34% with L. 
casei and 14.92 ± 1.45% with L. plantarum) with the pathogens (16.63 ± 1.65% 
with S. aureus 3761 and 14.58 ± 1.68% with P. aeruginosa) and prevention 
of biofilm formation by the pathogens. The antimicrobial activity of human 
beta defensin-2 (hBD-2) alone or with L. plantarum against pathogens was 
assessed. The results with hBD-2 showed that hBD-2 (10 μg / ml for 5 h) and 
L. plantarum together were significantly more inhibitory against S. aureus 
than hBD-2 alone. The presence of NaCl reduced the effectiveness of hBD-2 
alone and with L. plantarum. In the presence of L. plantarum, inactivation of 
mprF and dlt genes led to increased binding of hBD-2 by the bacterial cell 
wall, and then inhibition growth of bacterial cell wall. Studies investigated the 
effect of exposure of methicillin resistant Staphylococcus aureus (MRSA) to 
the supernatant of L. plantarum the susceptibility of MRSA to β-lactams. 
MRSA became sensitive to β-lactams when treated with culture supernatant 
of L. plantarum. Gene expression studies demonstrated that the mecR1-
mecI-mecA-PBP2 signalling pathway was impeded by exposure to culture 
supernatant of L. plantarum and β-lactams. The studies reported here 
demonstrate a possible alternative approach to dealing with skin pathogens, 
which may have clinical implications especially with regard to MRSA 
infections, and continued research is advised. 
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Chapter 1: General introduction and literature review 
1.1 Introduction 
The skin is a uniquely engineered organ that permits terrestrial life by 
regulating heat and water loss form the body whils t preventing the ingress of 
noxious chemicals or different microorganisms (Figure 1.1). It is also the 
largest organ of the human body, providing around 15% of the body mass of 
an average person, and it covers an average area of 1.5 - 2 m2 (Richardson, 
2002). The main role of the skin is to serve as a natural (physical) barrier, to 
protect from ultraviolet radiation, to restrict the inward and outward passage 
of water, and to protect bodies from potential attack by harmful 
microorganisms or dangerous substances (Zaidi and Lanigan, 2010). The 
skin is also an interface with the external environment and is colonized by 
several groups of microbes: bacteria, fungi, viruses and mites (Cogen et al., 
2008). The skin is the principal barrier against various microbial invasions; it 
continuously interacts with the external environment and is colonized with a 
large population of microorganisms. The vast majority of colonizing microflora 
consists of bacteria, whether Gram positive or Gram negative bacteria 
(Harder et al., 1997). Skin and soft tissue infections (SSTIs) are a prevalent 
problem confronted in clinical practice and range from mild infections, e.g. 
pyoderma, to serious life threatening ones such as necrotizing fasciitis. Many 
genera of bacteria infect the skin, such as Staphylococcus, Pseudomonas, 
Propionibacterium and others (Swartz, 2004; Hersh et al., 2008). 
Species of Staphylococcus bacteria are identified as one of the most 
important causes of acute disease in humans in many areas of the world. 
Staphylococcus aureus causes a wide range of infectious diseases, whether 
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localised to the skin or systemic diseases, in humans and animals (Vincze et 
al., 2013). These include atopic dermatitis (AD), also known as eczema, boils 
(furuncles), carbuncles, impetigo, folliculitis, endocarditis, osteomalitis, 
pneumonia, meningitis, food poisoning, mastitis and urinary tract infections 
(Ogston and Witte, 1984). 
Furthermore, Pseudomonas aeruginosa causes several diseases, such as 
cutaneous diseases, especially folliculitis and dermatitis. In addition, P. 
aeruginosa causes systemic diseases, for example cystic fibrosis, or is 
associated with acquired immune deficiency syndrome patients (Shanson, 
1990; Elkin and Geddes, 2003). In the past two decades, P. aeruginosa has 
emerged as a significant pathogen, which causes between 10 - 20% of 
infections in hospitals. P. aeruginosa causes numerous infectious diseases to 
humans and animals, e.g. septicaemia, leg ulcers and burn wound infections 
(Buivydas et al., 2013). 
As for the Propionibacterium species, Propionibacterium acnes is the primary 
cause of irritant dermatitis of the wall sebaceous follicles (Bek-Thomsen et al., 
2008). Liu and Huang (2012) observed that Pr. acnes play an important role 
in the development of inflammatory acne when Pr. acnes over-grows in 
pilosebaceous units.  
The spread of multiple drug resistant bacteria indicates a growing need for 
new antimicrobial agents. Researchers are attempting to find successful 
solutions to overcome microbial infections, such as methicillin resistant 
Staphylococcus aureus (MRSA), which is an example of a multiple drug 
resistant bacterial species. One potential area of investigation is the use of 
probiotics. Probiotics are beneficial microorganisms, such as some bacterial 
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genera, e.g. Bifidobacterium, Lactobacillus, Micrococcus, Propionibacterium, 
Pediococcus, Enterococcus, Bacillus and others, and some yeast species, 
such as Saccharomyces boulardii and Saccharomyces cerevisiae. Scientists 
have found a range of potentially useful medical applications, e.g. reducing 
inflammation (Reid et al., 2003), improving immune function and preventing 
infections (Cremonini et al., 2002; Reid et al., 2003), reducing the occurrence 
of colon cancer (Wollowski et al., 2001), lowering blood pressure, lowering 
cholesterol and  alleviating lactose intolerance (Sanders, 2000). 
 
Figure 1.1 Illustration of the human skin depicting three main layers; epidermis, 
dermis and subcutis. Each layer has its specific structures and functions, taken  
from McGrath et al. (2010). 
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Figure 1.2 Cell function and protective immunity to cutaneous microorganisms (A) 
Skin commensals control skin-resident T cell. Colonization of the skin with the 
commensal Staphylococcus epidermidis was shown to be required for the 
production of interleukin-17A (IL-17A) by skin-resident T cells136. (B) S. aureus 
induce mast cell degranulation and allergic skin inflammation. Colonization of the 
skin with S. aureus, a pathogenic bacterium that is often found on the skin of 
patients with atopic dermatitis, triggers local allergic responses, which directly 
induces degranulation of dermal mast cells, promoting innate and adaptive T helper 
2(TH2)-type responses, taken  from Pasparakis et al. (2014).  
 
   
1.2  Literature review  
 
1.2.1  Staphylococcus bacterium and taxonomy  
Staphylococcus is a genus of Gram positive bacteria of the 
Staphylococcaceae family (Table 1.1), which appears as cocci 
(approximately 1 - 1.5 µm in diameter) under a microscope and forms grape-
like clusters (Figure 1.3). Staphylococci are usually commensal with the 
host's body, whether human or animal, and cause superficial skin lesions and 
localized abscesses in other sites, and also cause deep-seated systemic 
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infections (Chiller et al., 2001; Sung et al., 2008). The most important 
pathogenic species are S. aureus and Staphylococcus epidermidis. Species 
of the Staphylococcus genus can be classified into two groups, coagulase 
positive Staphylococcus (CoPS) and coagulase negative Staphylococcus 
(CoNS) (Foster, 1996). 
 
 
Figure 1.3 SEM micrograph of S. aureus cells. Observe the grape-like gathering 
common to Staphylococcus species. 
 
 
Table 1.1 Scientific classification of Staphylococcus bacterium. 
  
 
 
Kingdom: Bacteria 
Phylum: Firmicutes 
Class: Bacilli 
Order: Bacillales 
Family: Staphylococcaceae 
Genus: Staphylococcus 
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1.2.1.1  Coagulase positive Staphylococcus 
 
 The Coagulase positive Staphylococcus (CoPS) includes seven species: S. 
intermedius, S. schleiferi subsp. coagulans, S. hyicus, S. lutrae, S. delphini, 
and S. pseudintermedius, and also S. aureus (Freney et al., 1999; Devriese 
et al., 2005), as outlined in Table 1.2. S. aureus is distinguished by round, 
golden-yellow colonies on nutrient agar, and beta-haemolysis on blood agar, 
and CoPS are most frequently connected with pathogenicity in the host. 
Clinical diseases caused by S. aureus range from minor and limited 
cutaneous infections to invasive and life-threatening diseases (Iwatsuki et al., 
2006). In addition, S. aureus, often referred to simply as ‘’staph’’, is an 
important species compared to others, and is commonly found on the skin of 
healthy people (Abudu et al., 2001). S. aureus causes many diseases in 
humans and animals, especially cutaneous diseases, such as wound 
infections, abscesses, furuncles, carbuncles, impetigo and others (Brown et 
al., 2003; Iwatsuki et al., 2006) and is a major cause of cellulitis. In addition, it 
causes other deep-seated infections, such as osteomyelitis, endocarditis, 
pneumonia, and septicaemia. Toxigenic bacterial strains can cause toxic 
shock syndrome-1 (TSS-1), staphylococcal scalded skin syndrome (SSSS) 
and staphylococcal food poisoning (Ogston and Witte, 1984; Projan and 
Novick, 1997). 
Table 1.2 The taxonomy of coagulase positive Staphylococcus (Co.P.S) using 
the 16S rRNA gene sequence analysis, adapted from Takahashi et al. (1999). 
 
Group CoPS 
S. aureus  S. aureus                              
S. hyicus-intermedius S. delphini, S. hyicus, S. intermedius, S. lutrae, S. 
pseudintermedius, S. schleiferi subsp. coagulans 
Chapter 1                                         General introduction and literature review                                                                                                           
8 
 
1.2.1.2  Coagulase negative Staphylococcus  
The Coagulase negative Staphylococcus (CoNS) includes S. epidermidis, S. 
saprophyticus and others (Table 1.3). CoNS is common in infections 
associated with hospitals (nosocomial infections) and can cause blood 
stream infections. These infections are often reported in infants, as well as in 
immune-compromised patients with diseases such as lymphoma and 
leukaemia. Furthermore, they are important in burns, indwelling intravascular 
devices, peritoneal catheters and ventricular shunts (Krediet et al., 2001). 
 
Table 1.3 The taxonomy of coagulase negative Staphylococcus (CoNS) using 
the 16S rRNA gene sequence analysis, adapted from Takahashi et al. (1999). 
 
Group  CoNS 
S. aureus S. simiae 
S. auricularis  S auricularis 
S. carnosus  S. carnosus S. carnosus, S. condimenti, S. massiliensis, 
S. piscifermentans, S. Simulans 
S. hyicus-intermedius S. chromogenes, S. felis, S. microti, S. muscae, S. rostri, 
S. epidermidis S. capitis, S. caprae, S. epidermidis, S. saccharolyticus 
S. haemolyticus S. devriesei, S. haemolyticus, S. hominis 
S. lugdunensis S. lugdunensis 
S. saprophyticus S. arlettae, S. cohnii, S. equorum, S. gallinarum, S. 
kloosii, S. leei, S. nepalensis, S. saprophyticus, S. 
succinus, S. xylosus 
S. sciuri S. fleurettii, S. lentus, S. sciuri, S. stepanovicii, S. vitulinus 
S. simulans S. simulans 
S. warneri S. pasteuri, S. warneri 
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1.2.3  Skin diseases caused by staphylococci 
 
1.2.3.1  Folliculitis  
Folliculitis is an inflammation of one or more hair follicles or an infection of 
the external part of the pilosebaceous unit. There are several causative 
agents, but S. aureus has become the main reason for infection, localizing on 
the skin and then spreading to several parts of the host’s body, such as the 
perineum, nares, vagina and axilla. The symptoms of folliculitis are eruptions 
on hair follicles, which is surrounded by erythema centred on the hair follicle 
(Wickboldt and Fenske, 1986; Sanford et al., 1994). 
 
1.2.3.2  Boils (furuncles) and carbuncles 
S. aureus is the most common cause of boils, carbuncles, and skin 
abscesses (Iwatsuki et al., 2006; McCaig et al., 2006). A boil or furuncle is an 
infection of the hair follicle, which is almost always caused by MRSA, 
resulting in a painful swollen region on the skin caused by an accumulation of 
purulent and necrotic tissue (Ibler and Kromann, 2014). Singular boils 
gathered to each other are named carbuncles. Carbuncles are an 
accumulation of infected hair follicles that produce broad, bloated, 
erythematous, deep, and painful masses that usually open and drain via 
multiple tracts (Stulberg et al., 2002). Signs and symptoms of boils include 
bumpy, red, purulent-filled masses around a hair follicle, which are fragile, 
warm, and very painful. A yellow or white point at the centre of the mass can 
be observed when the boil is ready to drain purulence. In a serious infection, 
an individual may experience fever, swollen lymph nodes and fatigue. 
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1.2.3.3  Impetigo 
Impetigo is a common superficial bacterial infection of the skin’s surface , 
characterized by an inflamed and infected epidermis. Usually, impetigo is 
caused by one of two bacteria: S. aureus, or sometimes Streptococcus 
pyogenes group A, or both (Dagan and Bar-David, 1992). Impetigo 
commonly infects children aged 2 - 5 years (Adams, 2002). The causative 
agent enters broken skin, such as scratches, which cause red bumps to form, 
mostly on the face, (mainly around the nose and mouth), and the legs, 
though these bumps may appear on other parts of the host’s body. 
 
1.2.3.4  Toxic shock syndrome-1  
Todd et al. (1978) were the first to describe toxic shock syndrome-1 (TSS-1), 
when they described the staphylococcal illness in three boys and four girls 
aged 8 - 17 years. Toxigenic staphylococci cause a severe illness called toxic 
shock syndrome, especially during menstruation and also in the postpartum 
period. The causative agent secretes many serotoxins , such as TSS-1 toxin 
(Kotzin et al., 1993). S. aureus can enter via cuts to the skin, surgery or 
burns. 
 
1.2.3.5  Staphylococcal scalded skin syndrome (SSSS) 
S. aureus secretes exofoliative toxins (ET), also known as epidermolytic 
toxins, which induce SSSS (Melish and Glasgow, 1970). This syndrome 
affects neonates, children and occasionally adults. Li et al. (2014) 
demonstrated that mortality in children with SSSS is approximately 4%. The 
site of infection depends on age. In infants, the lesion is often present on two 
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regions, either the perineum or periumbilicus, or both. SSSS consists of 
many stages, starting with erythema that soon rupture, leaving large regions 
of bare, infected skin (Melish, 1982; Cribier et al., 1994).  
 
1.2.4  Methicillin resistant Staphylococcus aureus  
Methicillin resistant Staphylococcus aureus (MRSA) is one of the most 
common etiological and opportunistic bacterial pathogens, and is responsible 
for healthcare-associated infections (Plata et al., 2009). 
 
1.2.4.1  History of antibiotic resistance 
MRSA has acquired the mecA gene giving resistance to methicillin and other 
β- lactam antibiotics. The emergence of S. aureus resistance to β-lactam 
antibiotics was first observed in the 1940s, particularly with penicillin. MRSA 
was first recognized in the early 1960s and became an increasingly important 
pathogen (Rolinson, 1961). However,  Barrett et al. (1968) reported the first 
documented outbreak of disorders in the United States, in Boston City 
Hospital. By the late 1970s and early 1980s, MRSA was responsible for 
outbreaks in several hospitals in the United States (File, 2008). Nowadays, 
diseases caused by MRSA have become a major epidemiological and clinical 
problem in health centres. In 2003, Naimi et al. (2003) proposed the term 
‘community-associated MRSA’ (CA-MRSA) in response to its appearance in 
the wider community.  
In the United Kingdom, resistance to methicillin among S. aureus isolates 
recovered from cerebrospinal fluid or blood, was stable at about 1.5% of 
isolates from 1989 - 1991, but increased afterwards to 13.2% in 1995 
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(Speller et al., 1997). Mayor (1999) demonstrated that in health centres in the 
UK, the predominance of MRSA has reached epidemic levels, has increased 
twelve fold since 1991 and was responsible for 37% of all S. aureus 
infections in 1999, in comparison to 3% in 1991. Furthermore, in the U.K., the 
proportion of S. aureus infections which were due to MRSA increased to 25 - 
50% between 2006 - 2009 (Stefani et al., 2012). A predominance of more 
than 25 - 30% was also observed in other European countries, e.g. Spain, 
France and Italy, as outlined in Figure 1.4 (Voss et al., 1994).   
 
 
Figure 1.4 Distribution of methicillin resistant Staphylococcus aureus in European 
countries, 2006 - 2009, adapted from Stefani et al. (2012). 
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1.2.4.2  Methicillin resistant Staphylococcus aureus cell wall structure 
and biosynthesis 
The Staphylococcus cell wall is a semi rigid structure, composed of three 
components: peptidoglycan (PG), teichoic acids (TAs), and surface proteins 
(Figure 1.5). PG is the major component of the bacterial cell wall, determining 
its shape and integrity (Labischinski, 1992). There are several steps in PG 
synthesis; the first step takes place in the cytoplasm, which leads to the 
synthesis of nucleotide sugar-linked precursors. The second stage occurs in 
the cytoplasmic membrane. In this step, MRSA produces lipid I and II 
(Scheffers and Pinho, 2005; Bouhss et al., 2007). The third stage takes place 
outside the cytoplasmic membrane and includes incorporation of the recently 
synthesized disaccharide peptide units into the PG. The fourth stage of PG 
biosynthesis is carried out by penicillin binding proteins (PBPs), which 
catalyse the trans-glycosylation and trans-peptidation reactions, e.g. 
formation of the glycosidic and peptide bonds, respectively (Barrett et al., 
2005). The second major component of the S. aureus cell wall are TAs, 
which are polymers of ribitol residues or polymers of glycerol phosphate , and 
account for up to half of the bacterial cell wall dry weight. Chatterjee (1969) 
observed that TA contributes to the negative charge present on the cell 
surface, which plays an important role in acquisition of ions. The third 
component of the S. aureus cell wall consists of surface proteins, including 
microbial surface components, recognizing adhesive molecules. There are 
several surface proteins, such as protein A, collagen binding protein, 
fibronectin binding protein and clumping factor A (Foster and Höök, 1998). 
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Figure 1.5 Illustration of the basic structure of MRSA cell wall, adapted from 
(http://www.cehs.siu.edu/fix/medmicro/genmicr.htm). 
 
1.2.4.3  Mechanism of β-lactam action and resistance 
Several antibiotics belong to β-lactams, including penicillins, cephalosporins, 
methicillin and oxacillin, which are considered bactericidal. The cell wall is the 
main target of β-lactams, especially the transpeptidation step of the PG 
synthesis, which is achieved by binding or inactivating the transpeptidase 
domain of PBPs in the bacterial cell wall. Moreover, β-lactams are structural 
analogs of the natural substrate of PBPs (D-alanyl-D-alanine) of the PG 
(Chambers, 2004). The reaction between the substrate of PBPs and β-
lactams begins with a non-covalent association between these two molecules. 
This intermediary can either dissociate or undergo an irreversible reaction of 
acylation process when the PBPs covalently bind with β-lactams at its active 
site, cleaving the cyclic amide bond in the β-lactams. In the case of 
resistance, the natural substrate for PBP, D-alanyl-D-alanine, undergoes a 
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rapid de-acylation by hydrolysis, which liberates the PBP for the next around 
of transpeptidation. Conversely, in the case of sensitivity, the de-acylation 
process is very slow and the PBPs are effectively inactivated. When the 
PBPs ceases to function, the cell wall synthesis is inhibited and death of the 
bacterial cell occurs (Chambers, 2003). 
 
1.2.4.4  Mechanism of resistance to methicillin  
Several β-lactam antibiotics, such as penicillins and cephalosporins, damage 
the bacterial cell wall by inactivating PBPs and enzymes, which are essential 
in the assembly of the bacterial cell wall. The cell wall becomes osmotically 
fragile and easily lysed when treated with antibiotics (Pinho et al., 2001; 
Weese et al., 2005).  
Resistant S. aureus has developed resistance to β-lactam antibiotics through 
acquisition of the mecA gene, which is carried on the staphylococcal cassette 
chromosome mec (SCCmec) elements (Berger-Bächi and Tschierske, 1998; 
Chambers, 2003). MecA encodes an alternative PBP2a, which has a low 
affinity to β-lactam antibiotics. Goffin and Ghuysen (1998) observed that 
PBP2a belongs to a group in the family of PBPs possessing a high molecular 
mass (78 kDa), and consists of a transpeptidase domain and a non-penicillin 
binding domain of unknown function. PBP2a possesses a low affinity for β-
lactam antibiotics, which allows MRSA to develop and grow in methicillin 
concentrations that inactivate all native types of PBPs (Gaisford and 
Reynolds, 1989). The serine in the active site of the transpeptidase domain in 
PBP2a is responsible for nucleophilic attack on both the β-lactam antibiotic 
ring and the D-alanyl-D-alanine substrate, and is located in an extended 
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narrow groove. The groove mediates non-covalent interactions with the β-
lactam that place the β-lactam in an un-favourable position for interaction 
with the serine in the active site. Consequently, the acylation between the β-
lactam antibiotic and the active site does not occur (Pinho et al., 2001). 
PBP2a successfully balances the critical transpeptidase activity with a 
decreased affinity toward β-lactams. Therefore, PBP2a is able to synthesize 
the bacterial cell wall at otherwise lethal concentrations of β-lactams (Lim 
and Strynadka, 2002).  
 
1.2.5  Pseudomonas bacterium 
The Pseudomonas bacteria are Gram negative rods. Nearly all strains are 
motile by means of a single polar flagellum, and are free-living bacteria. 
Generally, Pseudomonas is found in soil, water and other places which 
contain moisture. This bacterium is a member of the genus gamma 
proteobacteria belonging to the bacterial family pseudomonadaceae (Kreig et 
al., 1984). A Pseudomonas disease refers to a disease caused by one of the 
species of the Pseudomonas, which is considered to be an opportunistic 
microorganism (Christensen et al., 2013). 
 
1.2.5.1  Pseudomonas aeruginosa 
Pseudomonas aeruginosa is found throughout the environment and inhabits 
miscellaneous environments, including humans, animals, soil, water and 
plants (Green et al., 1974; Lyczak et al., 2000). It is a metabolically diverse 
microorganism which is tolerant of poor nutritional conditions and capable of 
tolerating miscellaneous hostile environmental conditions, for example, high 
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salt concentrations, as well as a wide range of temperatures (15 - 42 °C), in 
weak antiseptic solutions, and in the presence of several antimicrobial agents 
(Ernst et al., 2006). These features have contributed to the success of P. 
aeruginosa as an opportunistic pathogen to humans and animals (Bodey et 
al., 1983; Lyczak et al., 2000). Since P. aeruginosa is an opportunistic 
bacterium, it most commonly affects immune-compromised patients, such as 
those with cystic fibrosis, or AIDS patients (Elkin and Geddes, 2003).  
McGowan (2006) observed that Pseudomonas infections can affect several 
parts of the host’s body, especially the respiratory tract, particularly in cystic 
fibrosis sufferers. Moreover, P. aeruginosa is a major cause of skin diseases, 
particularly folliculitis and dermatitis, and such diseases may be spread either 
by direct contact or via contaminated water, with bacteria attaching to the 
skin and entering hair follicles. The clinical signs of such infections may 
manifest themselves as a red and itchy rash or resemble a burn (Levy et al., 
1998).  In addition, Christensen et al. (2013) observed that P. aeruginosa is 
able to form a biofilm in numerous conditions.  
 
 
Figure 1.6 SEM micrograph of P. aeruginosa cells, taken from Walker et al. (2003). 
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1.2.5.2  Pseudomonas and skin burn infections 
P. aeruginosa has emerged as a significant pathogen during the past two 
decades. It causes between 10 - 20% of infections in most hospitals. 
Pseudomonas disorders are particularly widespread among patients with 
burn wound infections (Bodey et al., 1983). This bacterium causes 
suppression of the immune system as a result of a break in the protective 
skin barrier by burn infection, after which it rapidly colonizes and infects the 
burn wound site (DeBoer and O'Connor, 2004). The denatured protein of the 
burn wound provides nutrition for microorganisms. Church et al. (2006) 
observed that rapid colonization of P. aeruginosa in burns, followed by 
distribution into distant organs via the bloodstream leads to bacteraemia, 
endotoxic shock and sepsis. Moreover, oral administration of antibiotics is 
usually ineffective against the most dangerous SSTIs by P. aeruginosa 
(McManus et al., 1985).  
 
1.2.6  Propionibacterium 
Propionibacterium species are Gram positive, non-motile, non-spore bearing 
bacilli, generally diphtheroid or club-shaped with one end rounded and the 
other end tapered. Bacterial cells may be coccoid, elongated or even 
branched. Ray and Kellum (1970) observed that the growth of 
Propionibacterium species are anaerobic or aero-tolerant, growing deep 
inside skin pores and hair follicles, where it feeds on the sebum that is 
produced by the sebaceous glands that surround the base of the hair shaft. 
The genus Propionibacterium contains eight species. Pr. acnes is a major 
member of the skin’s normal flora, and probably the predominant bacterium 
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of sebaceous areas. This bacterium inhabits the surface of the skin and is 
commonly non-pathogenic  Levy et al.,(2008). 
 
1.2.6.1  Propionibacterium acnes  
Propionibacterium acnes is a Gram positive anaerobic or aero-tolerant rod 
(Figure 1.7) and inhabits the human skin as flora in conjunctiva (Doyle et al., 
1995). Pr. acnes is associated with acne vulgaris, and believed usually to 
have a low pathogenicity (Eady and Ingham, 1994). Lee et al. (1978) 
observed that more than 40% of Pr. acnes infections are resistant to 
antibiotics. Kellum et al. (1970) revealed that the important role of Pr. acne in 
diseases is that it releases fatty acids by hydrolysis of triglycerides and these 
acids produce a primary irritant dermatitis of the wall of sebaceous follicles. 
 
 
 
Figure 1.7 SEM micrograph of Pr. acnes cells,  taken from Pan et al. (2009). 
Chapter 1                                         General introduction and literature review                                                                                                           
20 
 
1.2.7  Probiotics 
1.2.7.1  Introduction  
Probiotics are defined as live microorganism that, when administrated in 
sufficient amounts, confer a health benefit on the host (Salminen et al., 
1998); or a varied group of useful bacteria that are functionally defined by 
their capability to alleviate inflammation when introduced into the inflamed 
gastrointestinal tract (GIT) (Boirivant and Strober, 2007). The most frequently 
used probiotic genera in humans and terrestrial animals are Lactobacillus, 
Bifidobacterium and Enterococcus, which are normal residents in the GIT. 
There are some evidences to suggest that probiotics can prevent intestinal 
infection, which is caused by several microorganisms. Granto et al. (1999) 
tested 47 different strains of lactic acid bacteria (LAB) and found that they 
can discourage the growth of pathogenic bacteria, most frequently those from 
stool samples. The vast majority of these appear effective against S. aureus 
and Salmonella enterica serovar typhimurium (Simmering and Blaut, 2001). 
At the beginning of the 21st century, research indicated that the effect of 
probiotics was useful in improving the microbial balance in the intestine of the 
host, the final outcome being the prevention or inhibition causative agents of 
diseases involving the toxin-producing bacteria. The Russian researcher and 
Nobel laureate Metchnikoff was the first to propose and use alternative 
therapy (probiotics), especially LAB, for the treatment of bacterial infections. 
LAB have properties such as treatment of infections (Morelli, 2000; Mercenier 
et al., 2003). Several studies have used probiotics for the treatment of AD 
disease in infants and have observed significant improvement to the 
infections (Rosenfeldt et al., 2003; Weston et al., 2005). The spread of AD in 
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children could be reduced by giving probiotics to the mother before and after 
birth for six months (Kalliomäki et al., 2001). Probiotics are available to 
consumers, especially in the form of dietary supplements and food (Fuller, 
1989).  
Kopp-Hoolihan (2001) stated that the first clinical trials were done in the 
1930s on the beneficial effects of probiotic microorganisms on constipation. 
Research on probiotics has steadily increased since then, much of it taking 
place in Europe and Asia. Since then, there has been a rapid increase in the 
search for new formulations of probiotics, as well as in the consumption of 
probiotics in commercially available products. 
 
1.2.7.2  Historical perspectives on probiotics 
The potential benefits of probiotic microorganisms were first shown in the 
early 1900s. For example, Tissier (1907) demonstrated their potential 
benefits in the context of the relief of gastrointestinal diseases. Also in 1907,  
Nobel prize-winner Metchnikoff advocated that the consumption of 
Lactobacillus helps in controlling endogenous intoxication caused by an 
imbalance within the intestinal microflora. He noted the positive effect of LAB, 
which is present in fermented milk products, on longevity in humans. The 
works of Tissier and Metchnikoff were the first to make scientific suggestions 
about the use of bacteria in this way (Kopp-Hoolihan, 2001). Orrhage et al. 
(1994) reported that the first clinical experiments on the effect of probiotics 
microorganisms on constipation were performed in the 1930s. In the 1950s, 
probiotic microorganism products were authorized in the United States of 
America. Despite inconclusive evidence of the health effects of yogurt 
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bacteria, research interest intensified in subsequent years. Ferdinand Vergin 
(1954) was the first to introduce the term “probiotic,” mainly to differentiate it 
from antibiotics. Kollath (1954) used the term to designate “active substances 
that are essential for healthy development of life”. However, Lilly and Stillwell 
(1965) were the first to introduce the term “probiotic” to describe growth-
promoting factors produced by microorganisms. The word probiotic is derived 
from the Greek and means “pro”: for and “bio”: life (hence ‘for life’). This is 
the converse of “antibiotic” which means “against” life (Ghadban, 2002). 
Moreover, Parker (1974) defined probiotics as microorganisms or substances 
that contribute to intestinal microbial balance. Furthermore, Crawford (1979) 
defined a probiotic as a culture of specific living microorganisms, mainly 
Lactobacillus species, which is established in the host animal and ensures 
the rapid and effective establishment of a population of beneficial organisms 
in the intestines. Having considered the definition given by Parker (1974), 
Fuller (1989) narrowed the definition of “probiotics,” wanting to exclude 
antibiotic preparations, and re-defined “probiotic” as a live microbial feed 
supplement that has a beneficial effect on the host animal by improving its 
intestinal microbial balance. Vanbelle et al. (1990) mentioned that the 
majority of researchers considered probiotics as selected and concentrated 
viable counts of LAB. In 1995 Gunther broadened the term even more and 
defined probiotics as ‘organisms, live or dead, or as products of microbial 
fermentation, nucleotides and their metabolisable products, metabolites of 
the proteins and derived substances, organic acids, in addition to enzymes of 
a hydrolytic type, that beneficially affect the host’. However, Curbelo et al. 
(2005) observed that the majority of authors agree in defining probiotics as 
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feed additives, formed by live microbes that beneficially affect the health of 
the host (Schrezenmeir and de Vrese, 2001). 
 
1.2.7.3  Criteria for the selection of probiotics 
The criteria for probiotic selection are application-based and depends on the 
specific probiotic effects preferred and the site of action (Saarela et al., 
2000). Several criteria have been defined for the choice of probiotic strains. 
The most significant is that the chosen strains have to be safe for use in the 
host and for the environment, as briefly outlined in Figure 1.8. There is a wide 
range of requirements for applications of probiotics, e.g. the capacity of 
adhesion and colonization of the human body, immunomodulation, 
production of antimicrobial substances and competition with pathogens for 
nutrition and sites (Fooks and Gibson, 2002). Furthermore, there are other 
probiotic properties such as resistance to, and survival of natural human 
defence mechanisms during the GIT transit, prolonged residence period in 
the GIT (Lee, 2009). Safety aspects of probiotic bacteria include being of 
human origin and isolation from healthy human GIT. In addition, probiotics 
must be non-pathogenic, conferring clinically established physiological 
benefits and must maintain their activity. Moreover, probiotic strains must 
maintain viability throughout product processing and manufacture ; they must 
be able to survive during passage via the host’s upper GIT, and be able to 
tolerate the conditions predominant in the GIT, e.g. a high acidity level and 
the presence of bile acids, pancreatic and other digestive enzymes (Dunne et 
al., 1999; Ouwehand et al., 1999; Reid et al., 2003).  
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Figure1.8 The theoretical and necessary basic rules for choice of probiotic  
microorganisms include several characteristics, such as safety, functional and 
technological aspects, such as antimicrobial substances production, survival, 
adherence, colonisation immune stimulation, antigenotoxic activity , prevention of 
pathogens sensory properties stability, phage resistance and viability in processes, 
adapted from Saarela et al.(2000).  
 
 
1.2.7.4  Normal flora and the skin 
Limited numbers of particular species of microbes are present in the normal 
flora on the human skin. In general, two types of microbes exist on the skin, 
resident and transient. The resident organisms belong to a relatively stable 
group of microorganisms that are routinely found in the skin and that re-
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establish themselves after perturbation. Resident microbes are often 
considered to be commensal, meaning that these microbes are not harmful 
and may provide benefit to the host (Somerville and Noble, 1974). The 
transient organisms do not establish themselves permanently on the surface  
of skin, but rather arise from the environment and persist for hours to days. 
Transient and resident organisms are not pathogenic under normal 
circumstances if proper hygiene is maintained and if the normal resident 
flora, immune responses, and skin barrier function are intact. Nevertheless, if 
the skin barrier is disrupted in some way, resident and / or transient microbial 
communities can colonize, proliferate, and cause disease. For example, 
Staphylococcus epidermidis is a commensal skin associated species but can 
be an opportunistic pathogen in immune-compromised hosts (Otto, 2009). 
Adult skin comprises an average area of 1.7 m2, and microbial diversity 
varies across the various niches found on it (Zaidi and Lanigan, 2010). For 
instance, hairy, moist underarms lie a short distance from smooth dry 
forearms, but these two niches are ecologically distinct as are their resident 
microbial populations (Grice et al., 2009). Johnson et al. (2002) and Kong 
and Segre (2012) demonstrated that essential factors including age, 
genotype, and immune reactivity also influence the composition of cutaneous 
microorganism communities. Extrinsic factors, such as hygiene and 
environmental factors, such as climate may also have profound effects on 
microbial communities. Distinct habitats are characterized by differences in 
skin thickness and folds as well as the density of hair follicles and sweat 
glands. Cutaneous invaginations and appendages, including sebaceous 
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glands, sweat glands, and hair follicles, are likely to be associated with their 
own unique microbiota (Figure 1.9).  
Sebaceous glands secrete lipid-rich sebum, a hydrophobic coating that 
protects and lubricates hair and skin. Although sebum generally serves as an 
antimicrobial coating, Propionibacterium acnes hydrolyses tri-glycerides 
present in sebum, releases free fatty acids (FA) that promote bacterial 
adherence, and then colonizes sebaceous units (Marples, 1969). Several 
genera and species of bacteria live on the skin, such as Pr. acnes, 
Propionibacterium granulosum, S. epidermidis, Micrococcus species, 
Corynebacterium species and Acitobacter species (Grice et al., 2008). 
Propionibacterium species are important in certain medical conditions, such 
as acne and inflammation of the hair follicles (Leyden et al., 1998). However, 
sometimes these organisms may become dangerous to the host when the 
latter is exposed to shock, injury or a change in the immune defences, where 
they become opportunistic pathogens and may cause diseases. There are 
physical and chemical agents which determine the quality and quantity of 
bacterial species that reside on the skin (Leyden et al., 1987; Bojar and 
Holland, 2002). The physical factors involve the number and type of glands, 
gland functions, number and size of hair follicles, safety and functions of the 
skin barrier, osmotic pressure and pH of the skin. Chemical factors involve 
several compounds, e.g. fat, amino acids, vitamins and lactate. Moreover, 
biochemical molecules formed by microorganisms as a result of metabolic 
activity to the skin will be important for colonization on the skin (Leyden et al., 
1987).  
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Figure 1.9 Illustration of skin histology viewed in cross section with different 
microbial communities and skin appendages. Microbial communities (bacteria, 
viruses, fungi, and mites) cover the surface of the skin and reside deep within 
glands and hair follicles, adapted from  Kong and Segre (2012). 
 
 
 
1.2.7.5  Role of probiotics in skin diseases 
The studies investigating the role of probiotics in cosmetics and skin disease 
are very few compared to other studies dealing with the importance of 
probiotics in other locations. Currently, it is thought that probiotics can 
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positively affect the normal flora in a number of ways, for example by 
reducing the number of potential pathogens, in turn positi vely affecting GIT 
structure and function. It is now generally believed that probiotic 
microorganisms exert positive effects by improving the properties of the GIT’s 
normal flora (Ouwehand et al., 2002b). Kaila et al. (1992) and Saavedra et al. 
(1994), reported that probiotic LAB have been linked to  several effects 
involving improving rates of recovery from inflammation of the GIT and 
diarrhoea of bacterial and viral origins. Foolad et al. (2013) demonstrated that 
certain types of nutrient supplementation and the probiotic Lactobacillus 
rhamnosus GG are useful in preventing AD development and reducing its 
severity. Additionally, probiotic microorganisms administered prior and 
postpartum for 6 months may be able to reduce the incidence of eczema in 
children at high risk from atopic diseases as compared to placebo treatment 
(Kalliomäki et al., 2001). Moreover, Guéniche et al. (2006a) observed that 
nutritional supplementation of hairless mice with Lactobacillus johnsonii 
provided protection of the cutaneous immune system against ultraviolet B 
radiation Ouwehand et al. (2003) revealed the difficulty in recognizing 
advantageous bacteria in view of the severe environmental circumstances 
that may prevent colonization of cutaneous surfaces by probiotic strains. Two 
studies suggest that topical application of Vitreoscilla filiformis  exerts positive 
effects in patients with atopic eczema and seborrheic dermatitis (Guéniche et 
al., 2006b; Gueniche et al., 2008). In fact, the exact mechanisms through 
which cutaneous symptoms are improved in seborrheic and atopic dermatitis 
are not yet known. This hypothesis is supported by very recent research 
demonstrating that V. filiformis has a profound effect on the skin immune 
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system response, such as improving skin defence mechanisms, balancing 
cutaneous immune-homeostasis, and the direct  immunomodulation of the 
skin-associated immune response (Guéniche et al., 2006b; Gueniche et al., 
2008).  
 
1.2.7.6  Probiotics, the skin and Immune system  
The skin is an immunogenic organ that works as the first defence line and 
biologic sensor against pathogens. Contact with skin allergens can favour the 
beginning of allergic disorders, and atopic response can be secondary to the 
skin barrier disruption (Gallo and Nakatsuji, 2011). The keratinocytes secrete 
a large number of immune mediators: several interleukins (IL), such as 1, 3, 
6, 7, 8, 10, 12, 15 and 18, interferon (IFN) α, β and γ , tumour necrosis factor 
(TNF) α and β, granulocyte macrophage colony-stimulating factor, 
macrophage colony-stimulating factor, chemokines and growth factors 
(Pivarcsi and Homey, 2005; Strid and Strobel, 2005). Steinhoff et al. (2001) 
mentioned that a large numbers of cells in the dermal and perivascular 
regions play an important role in immune activities such as macrophages, 
mast cells, monocytes and T cells. Recently, Wollenberg et al. (2002) 
reported that epidermal dendritic cells were found in infected cutaneous, e.g. 
Langerhans cells, and identified populations of inflammatory dendritic 
epidermal cells. Cutaneous dendritic cells serve as a main part within the 
infiltrated portion of AD. As antigen-presenting cells, they are capable of 
adjusting the amount and property of T lymphocyte responses, and thus they 
probably play an important role in the pathogenesis of T lymphocyte skin 
disorders like AD (Strid et al., 2004; Strid and Strobel, 2005). Strid and 
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Strobel (2005) observed that lymph node cells are activated with notable 
secretion of IL-4, restricted IFN-γ secretion, a large amount of production of B 
cells, immunoglobulin (Ig) E and G1.  
 
1.2.7.7  Mechanism action of probiotics  
Probiotics are considered helpful and play an important role in the health of 
the host (Tuohy et al., 2003). There are numerous studies on the subject of 
how probiotic microorganisms work. Therefore, several mechanisms from 
these studies attempt to describe how probiotics could protect the host from 
disease (Table 1.4). The precise way in which probiotic microorganisms 
achieve their effects is not fully understood. Nevertheless, some mechanisms 
of the action of probiotics have been observed, such as competition for 
adhesion receptors, competition for nutrients, immune clearance and others 
(Fooks and Gibson, 2002). The mechanism of action for probiotics can be 
divided, based on specific effects of probiotics on the microbial environment, 
epithelium, immune system response e.g. epithelial cells, dendritic cells, 
natural killer cells and others (Neurath, 2007; Zhang et al., 2007). Several 
mechanisms of the action of probiotics are briefly listed below.  
 
1.2.7.7.1  Competition of adhesion (blocking of adhesion sites)  
Alaner et al. (1997) mentioned that binding to the epithelium is one of the 
determinants in establishing the ability of a probiotic, whereby probiotic 
bacteria compete with pathogens for a limited number of receptors present 
on the surface of the epithelium. There are several examples, such as L. 
rhamnosus GG and L. plantarum, which competitively impede the attachment 
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of entero-haemorrhagic Escherichia coli (Mack et al., 1999). Moreover, 
certain strains of probiotic Lactobacillus species are able to block receptor 
sites, preventing the invasion of pathogens (Bernet et al., 1994). In addition, 
adhesion and growth of pathogenic bacteria in the host is inhibited by 
lowering pH, producing lactic acid (LA) with other bactericidal metabolites 
(De Keersmaecker et al., 2006). 
 
1.2.7.7.2  Release of antimicrobial substances 
The production of antimicrobial substances, such as organic acids, hydrogen 
peroxide (H2O2) and bacteriocins are inhibitory to both Gram positive and 
Gram negative bacteria (Silva et al., 1987; Meurman et al., 1995). 
Furthermore, antimicrobial substances may induce an antagonistic action to 
pathogens (Balcázar et al., 2007). Moreover, the accumulation of such 
metabolites, e.g. short chain fatty acids (SCFA), can reduce the pH of the 
surrounding environment, which may directly impede the growth of 
pathogens. LAB also release other antimicrobial factors, for example 
bacteriocins and reuterin (Vandenbergh, 1993; O'Hara et al., 2007). 
 
1.2.7.7.3  Competition for nutrients 
Wilson and Perini (1988) observed that probiotics may also compete for 
nutrients otherwise consumed by pathogens. Consumption of 
monosaccharides by probiotics may reduce the growth of Clostridium difficile, 
which is dependent on monosaccharides for growth. 
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1.2.7.7.4  Modify toxin receptors 
Probiotics may also modify toxin receptors and block toxin mediated 
pathology via an enzymatic mechanism, which has been seen with 
Saccharomyces boulardii via its effect on the Clostridium difficile toxin A 
receptor (Pothoulakis et al., 1993). Cebra (1999) observed that the effect of 
Saccharomyces boulardii on Clostridium difficile toxins was supposed when 
investigators witnessed clinical improvement without a change in the 
concentration of Clostridium difficile in the stools. 
 
1.2.7.7.5  Modification of microflora 
Probiotics modulate the composition of the human GIT microbiota. The useful 
impacts may result from inhibition of pathogens or stimulation of organisms, 
which contribute in a positive way to the nutrition and health of the host 
(Fuller and Gibson, 1997). Several studies propose the ingestion of certain 
probiotic Lactobacillus and Bifidobacterium species. These probiotics 
decrease the faecal concentrations of Escherichia coli, Clostridium and 
Bacteroides and increase the endogenous levels of Lactobacillus and 
Bifidobacterium, and in addition significantly affect the metabolic activities of 
microflora by reducing the production of cancer-causing materials such as 
nitroreductase, faecal azoreductase and β-glucoronidase (Cebra, 1999). 
 
1.2.7.7.6  Stimulation of immune response 
Many probiotics, such as some Lactobacillus spp., produce substances that 
have detrimental effects on pathogens. When probiotic agents are ingested 
by the host, antimicrobial substances can be secreted by the bacteria 
Chapter 1                                         General introduction and literature review                                                                                                           
33 
 
themselves at the site of the infected region in the target organ (Steidler et al., 
2000). In addition, the maturation the immune system may be stimulated by 
probiotics (Viljanen et al., 2005).  
The immune system response to particular pathogens must induce a suitable 
set of effector functions that can eradicate the disease cause or its toxic 
products from the host. The Th-1 subgroup is responsible for several cell-
mediated functions and the secretion of IgA, IgG, IgM and IgE. Some 
interleukins, for example IL-4, are necessary for the increase of a Th-2 
response. IL-12, IL-18 and IFN-γ are essential to the physiological 
development of Th-1 lymphocytes. In addition, IFN-γ is generated by 
stimulation of T lymphocytes from the activation of natural killer (NK) cells. 
IFN-γ induces the up-regulation of IL-12 receptors on activated T 
lymphocytes. Moreover, Th-2 cells produce a profile of interleukins, such as 
IL-10 and IL-13, that synthesize of IgE and promote eosinophil activation. 
Probiotics exert immune-enhancing effects by increasing both specific and 
non-specific immune system responses (Ouwehand et al., 2002b; Rook and 
Brunet, 2005). Lymphocytes can be stimulated by probiotics to produce some 
cytokine, like IFN-γ, and stimulate nonspecific lymphocytic and phagocytic 
activity. Moreover, introduction of antigens via the oral route induces 
secretion of Immunoglobulins like IgA and IgM (Maassen et al., 2000; Rook 
and Brunet, 2005). Haller et al. (2000) explained that probiotics have also 
been found to improve defective immune system function through stimulating 
the cytokines IL-10, IL-12, IFN-γ, all of which have a supposed suppressive 
effect on antigen specific immune system responses. Some probiotic 
Lactobacillus species, like the L. casei and L. johnsonii have been reported 
Chapter 1                                         General introduction and literature review                                                                                                           
34 
 
as stimulating some cytokines like IL-10 and IFN-γ secretion (Miettinen et al., 
1996). There is research demonstrating that oral administration of L. casei to 
laboratory-bred strain of the  house mice leads to improvement of the innate 
immune system response and reduces dermatitis (Sheil et al., 2004; 
Galdeano and Perdigon, 2006). Intra-peritoneal injection of L. casei induced 
an IL-12 response in the transgenic mice serum. Dieleman et al. (2003) 
observed the effectiveness of L. rhamnosus GG in the prevention of colon 
inflammation by reducing IL-1 and TNF-α levels and increasing cecal IL-10 
content. Galdeano and Perdigon (2006) reported that both subcutaneous and 
oral administration of probiotic microorganisms promotes this effect. The 
effectiveness of probiotic Lactobacillus through the subcutaneous route 
protects not only against colon inflammation, but also against collagen joints 
inflammation. 
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Table 1.4 Mechanisms of action of probiotic, adapted from Ng et al. (2009). 
 
Immunomodulation Antimicrobial activity  Enhancement of the barrier function 
-Effects on epithelial cells (recognition 
molecules or TLR-2 and TLR - 4). 
-Decrease luminal pH -Increase mucus production 
-Effect on dendritic cells (regulatory T 
cells and IgA-producing B cells through 
production of cytokines, such as IL - 10).  
-Secrete antimicrobial peptides -Enhance barrier integrity 
-Effects on monocytes / macrophages 
(promoted the production of IFNγ, IL - 12 
and IL - 18). 
-Inhibit bacterial invasion -Improve mucus quality 
-Effects on lymphocytes : -Block bacterial adhesion to epithelial cells  
 B lymphocytes (antibody 
production, such as IgG, IgA and 
IgM). 
  
 Natural killer cells (increased 
production of IL - 10). 
  
 T cells (induced IL - 2, IL - 4 and 
IL - 10). 
  
 T cells redistribution (improving 
the competence of lymphatic 
cells to trap T lymphocytes) 
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1.2.8  Types of probiotic microorganisms 
Numerous genera of microorganisms are considered as probiotic, both LAB 
and non-LAB. LAB includes Lactobacillus species, Bifidobacterium species 
and others. There are other LAB for example, Enterococcus faecium, 
Lactococcus lactis, Leuconstoc mesenteroides, Pediococcus acidilactici and 
Streptococcus thermophilus (Klein et al., 1998). Moreover, there are non-LAB 
such as Bacillus subtilis (Spano and Massa, 2006), E. coli strain Nissle 1917 
(Altenhoefer et al., 2004), Saccharomyces boulardii (Czerucka et al., 2007) 
and Saccharomyces  cerevisiae (Shetty and Jespersen, 2006).  
Lactobacillus bacterium is a Gram-positive, facultative anaerobes, non-spore 
forming, non-flagellated and rod or coccobacilli. So far, there are more than 
56 species of Lactobacillus probiotics (Gupta and Garg, 2009). Lactobacillus 
is a normal resident of the human GIT and vagina, and significant for public 
health. The various beneficial of Lactobacillus include: reducing GIT 
permeability and maintain of the mucosal barrier (Rohde et al., 2007; Grice et 
al., 2008); inhibiting the growth of pathogens by producing antimicrobial 
substances, e.g. organic acids, H2O2 and others (Bezkorovainy, 2001); 
modulation of immunity, such as by effect on the function of immune 
response (Tahmourespour and Kermanshahi, 2011); and inhibiting some 
species of harmful yeast e.g. Candida albicans (Lehrer et al., 1993). There 
are several important lactobacilli  species which are probiotic, such as L. 
casei, L. plantarum, L. salivarius and L. acidophilus. L. casei is one of the 
many species of bacteria belonging in the genus Lactobacillus. L. casei is a 
mesophilic that is Gram positive, non-motile, rod shaped and non-sporing 
(Holzapfel et al., 2001). Cai et al. (2007) demonstrated that L. casei can be 
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found in different environments, such as raw and fermented dairy products, 
intestinal tracts, reproductive systems of humans and animals, fresh and 
fermented plant products. Moreover, L. casei can produce LA via 
fermentation and reduce cholesterol levels, enhance immune response, 
control diarrhoea, alleviate lactose intolerance, inhibit intestinal pathogens 
and serve as a probiotic (Mishra and Prasad, 2005). Furthermore, L. casei 
has demonstrated effectiveness in raising immunoglobulin, especially IgA in 
new-borns infected with rotavirus, and in shortening the duration of diarrhoea 
(Ouwehand et al., 2002a). Moreover, L. casei has induced production of IL-
10 and IL-12 from human blood mononuclear cells, or monocytes (Hessle et 
al., 1999).  
With regards to L. plantarum, this is the most prevalent species in most 
naturally fermented foods and has the capacity to block receptors for Gram 
negative bacteria, as well as having an important antimicrobial effect. 
Furthermore, this bacterium is very resistant to harsh conditions involving 
high temperature, ethanol and acidic pH (Zarazaga et al., 2004). As for L. 
salivarius, it is considered non-pathogenic and is exploited as a probiotic. L. 
salivarius produces large amounts of antimicrobial substances such as LA, 
which inhibit the growth of pathogenic bacteria. Bacteriocin was the first 
natural substance which was isolated from L. salivarius (Flynn et al., 2002). L. 
salivarius possesses several features, e.g. it is a moderately heat tolerant 
microorganism and loses viability after storage under non-refrigerated 
temperatures. With reference to L. acidophilus, this bacterium stimulates the 
immune system, increasing levels of cytokines, especially IL-1 α and TNF-α, 
which suppresses cancerous tumour growth, and produces biosurfactant 
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(Rangavajhyala et al., 1997). L. acidophilus possesses a range of health 
benefits which include: providing immune system support, reducing diarrhoea 
in humans, lowering cholesterol and improving the symptoms of lactose 
intolerance (Tahmourespour et al., 2011).  
 
1.2.9  Metabolic products of lactic acid bacteria 
The most important role of LAB is the fermentation of products and 
production of antimicrobial substances. Antimicrobial substances have an 
important role in disrupting the growth of harmful bacteria (Lasagno et al., 
2002). Ennahar et al. (2000) and Lasagno et al. (2002) demonstrated that 
inhibition may be due to the production of metabolites, such as organic acids, 
H2O2, diacetyl, carbon dioxide (CO2) and bacteriocins. Antimicrobial 
substances produced by LAB can be divided into two major groups: high 
molecular mass substances (> 1000 Da) e.g. bacteriocins, and low molecular 
mass substances (< 1000 Da), such as phenyllactic acid. All non-bacteriocin 
antimicrobial substances from LAB are of low molecular mass (Collins et al., 
2009). These metabolites are discussed in more detail in subsequent 
sections. 
 
1.2.9.1  Organic acids  
The majority of products of LAB are organic acids, which are significant and 
the best antimicrobial products. These acids, produced through fermentation, 
affect the consequent microbial activity in fermented substances. Acetic acid 
(AA) is considered to have the most antagonistic effect against fungi, 
especially yeasts, compared to other organic acids, such as lactic acid (LA) 
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(Daeschel et al., 1987). The types and levels of organic acids are dependent 
on the probiotic species and growth conditions. Homo-fermentative LAB use 
the glycolytic pathway to produce 2 pyruvates, which are further converted to 
lactate. In addition, to the pH effect, the un-dissociated acid collapses the 
electrochemical proton gradient, causing bacteriostasis, followed by the 
death of pathogens. Furthermore, LA has been observed to permeabilize the 
external membrane of Gram negative bacteria by releasing of 
lipopolysaccharides (LPS), leading to loss of viability (Alakomi et al., 2000). 
Caplice and Fitzgerald (1999) demonstrated that the action of LA may help 
the action of other antimicrobial substances. The effect of AA and LA against 
different pathogenic bacteria, moulds and yeasts is well documented. 
 
1.2.9.2  Hydrogen peroxide  
The antimicrobial activity of hydrogen peroxide (H2O2) is due to its strong 
oxidising effect on the microbial cells, and damage to the basic molecular 
structures of cell proteins (Lindgren and Dobrogosz, 1990). Reid (2008) 
mentioned that production of H2O2 has been considered as the chief 
metabolite of LAB that could protect against urogenital tract (UGT) disorders. 
 
1.2.9.3  Bacteriocins  
Bacteriocins are small antimicrobial substances produced by several bacteria 
(Hassan et al., 2012), and are proteinaceous materials with bactericidal 
activity. Bacteriocins are produced by LAB (Table 1.5), and are small 
antimicrobial peptides or proteins that have activity closely related to Gram 
positive bacteria (Klaenhammer, 1988; Chen and Hoover, 2003). Hassan et 
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al. (2012) observed that the mechanism of action of bacteriocins are 
represented in the destruction of target cells by pore formation (efflux of cell 
substances) and / or inhibition of cell wall synthesis. Numerous researches 
have revealed that bacteriocins display a large potential in the medical sector 
as bacteriocinogenic probiotics, and in the clinic as therapeutic agents (De 
Vuyst and Leroy, 2007). Meanwhile, Kirkup (2006) observed that numerous 
types of bacteriocins have been proposed for application in GIT microbiology, 
and reduce dental caries.  
 
Table 1.5 Major bacteriocins produced by probiotic LAB, adapted from Soomro 
et al. (2002) and Zacharof and Lovitt (2012).  
 
Bacteriocin Producer microorganism 
Lactacin F Lactobacillus johnsonii 
Lactocin 705 Lactobacillus casei 
Lactoccin G  Lactobacillus lactis 
Lactococcin MN  Lactococcus lactis 
Nisin, Lacticin (3147 and 481)  Lactococcus lactis subsp. lactis 
Leucocin H.  Leuconostoc spp. 
Plantaricin EF Lactobacillus plantarum 
Plantaricin W Lactobacillus plantarum 
Plantaricin JK Lactobacillus plantarum 
Plantaricin S Lactobacillus plantarum 
Leucocin Leuconostoc gelidum UAL 187 
Helveticin J Lactobacillus helveticus 
Carnobacteriocin Carnobacterium piscicola LV17 
Pediocin A, and  AcH Pediococcus pentosaceus FBB61 
Enterocin A Enterococcus species 
Carnocin U149 and Piscicolin 126 Carnobacterium species 
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1.2.9.4  Carbon dioxide  
Carbon dioxide (CO2) is significant as an antimicrobial agent, and has an 
influence on product preservation. CO2 is mainly produced from hetero-lactic 
fermentation and is directly generated in anaerobic conditions. In addition, 
CO2 is toxic to certain aerobic microorganisms through its action on the 
membranes of bacterial cells (Šušković et al., 2010). The antimicrobial action 
of the CO2 molecule is thought to be because of the inhibition of enzymatic 
de-carboxylation and the accumulation of CO2 in the membrane lipid bi-layers 
causing defective function in membrane permeability (Lindgren and 
Dobrogosz, 1990).  
 
1.2.9.5  Diacetyl, acetaldehyde and acetoin 
Decarboxylation of pyruvate is a process that produces active acetaldehyde 
by hetero-fermentative LAB, after which this product condenses together with 
pyruvate, making a-acetolactate, and is then converted to diacetyl by a-
acetolactate synthases. Acetoin is considered the product of decarboxylation 
of acetolactate and reduction of diacetyl (Jyoti et al., 2003). These 
metabolites are very important as a preservative of food from harmful 
bacteria, and are considered essential for the inhibition of pathogens and 
also very important for controlling the growth of pathogens in collaboration 
with other antimicrobial metabolites (Vandenbergh, 1993). 
 
1.2.9.6  Low molecular mass antimicrobials 
There are several low molecular mass compounds that have antimicrobial 
activity against pathogens. These antimicrobials include antifungal cyclic 
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dipeptides, 4-hydroxyphenyllactic 3-hydroxy fatty acids and phenyllactic acid 
(Strom et al., 2002; Valerio et al., 2004). Moreover, there are new types of 
antimicrobial compounds created by L. plantarum like benzoic acid, which 
are effective against fungi and some Gram-negative bacteria (Niku Paavola 
et al., 1999). 
  
1.2.10  Antimicrobial peptides  
 Antimicrobial peptides (AMPs) are an abundant and diverse group of small 
cationic polypeptides (less than 100 amino acids) that are produced by 
several tissues and cell types in a variety of invertebrate, plant and animal 
species (Brogden, 2005). 
 
1.2.10.1  Antimicrobial peptides in the skin; biological and clinical 
relevance 
AMPs were first observed in mammalian skin tissues when cathelicidins were 
discovered in porcine wound fluid (Gallo et al., 1994). In the early 1980s, 
Steiner et al. (1981) reported that investigators injected pupae of the cecropia 
moth with Escherichia coli and several other Gram negative bacteria, and 
later purified a newly synthesized 37 amino acid cationic peptide from the 
hemolymph. The induced cecropin peptides demonstrated potent 
antibacterial activity against multiple Gram negative bacteria including , E. coli 
and P. aeruginosa. AMPs are considered bacteriocidal against Gram positive 
and Gram negative bacteria, fungi and some envelope viruses (Lehrer et al., 
1985). Moreover, β-defensins are abundant in psoriatic scale (Harder et al., 
1997). In human skin, there is a wide range of peptides, including enzyme 
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inhibitors and some enzymes and neuropeptides, which possess inherent 
antimicrobial activity (Izadpanah and Gallo, 2005). The cathelicidine and 
defensins were the first to be discovered and possess the ability to kill 
pathogens (Cole and Ganz, 2000). A cathelicidin could function in the skin to 
kill both Gram positive and Gram negative bacteria and to aid wound healing 
(Agerberth et al., 1991; Storici and Zanetti, 1993). In humans, cathelicidin 
was initially detected directly in the human skin keratinocyte only at the site of 
inflammation (Izadpanah and Gallo, 2005). Frohm et al. (1997) reported that 
the LL-37 (two leucine residues and is 37 amino acids long) is the first 
cathelicidin and peptide isolated from humans. The mature LL-37 peptide has 
a different spectrum of antimicrobial activity against different pathogens, and 
can also directly modify the host’s immune system response (Murakami et al., 
2002). In the skin, the LL-37 is made by several cells e.g. mast cells, 
neutrophils and keratinocytes, and activated by inflammatory processes 
(Zanetti et al., 1991).  
Moreover, defensins are a broadly dispersed family of AMPs, which are 
expressed by keratinocytes and mucosal epithelial cells such as the GIT, 
UGT and pulmonary epithelia (Raj and Dentino, 2002). Ganz (2003) 
demonstrated that defensins contain 6 - 8 cystine residues that form 
characteristic disulphide bridges, which are divided into three distinct 
subfamilies, α-defensin, β-defensin and θ-defensin. Defensins display high 
levels of activity against Gram positive and Gram negative bacteria, fungi and 
certain enveloped viruses. Defensins are isolated from immune cells, such as 
neutrophils, macrophages and some epithelial cells in GIT (Kagan et al., 
1994). α-defensins contains 1 - 6 types. Human neutrophils express 4 distinct 
Chapter 1                                         General introduction and literature review                                                                                                           
44 
 
α-defensins (1 - 4) that are also referred to as human neutrophil peptides- 1 - 
4 (White et al., 1995). Other human defensins (5 and 6) are expressed in 
Paneth cells of GIT and in epithelial cells of the female UGT (Jones and 
Bevins, 1993).  
In addition, human beta-defensins (hBD) contain four types (1 - 4). HBD-1 
contains 36 amino acids, which is constitutively produced by epithelial tissue 
in the respiratory system and UGT. Moreover, hBD 2 - 4 have been isolated 
from extracts of lesional scales of psoriatic cutaneous tissues (Harder et al. 
1997). Furthermore, hBD-2 (41 amino acid) and hBD-3 (45 amino acid) 
expression is inducible by several agents such as IFN-1β, IFN-γ, TNF-α, 
Gram negative and Gram positive bacteria (Yang et al., 2001).  
Concerning hBD-2, a study was conducted by Schröder and Harder (1999), 
who observed that hBD-2 is a cysteine rich cationic peptide of the innate 
immune system and has a low molecular weight. hBD-2 was first discovered 
in the human skin in 1997. Butmarc et al. (2004) showed that expression of 
hBD-2 is widely observed in epithelial cells of the skin tissue. The induction of 
hBD-2 is by mean of a probiotic cocktail; four Lactobacillus species 
(L. acidophilus, L. paracasei , L. delbrueckii ssp. bulgaricus and L. plantarum), 
three Bifidobacterium species (B. longum, B. infantis and B. breve) and 
Streptococcus salivarius ssp. thermophilus (Schlee et al., 2008). Moreover, 
pathogen-associated molecular patterns (PAMPS), for example bacterial 
flagella antigen, LPS, PG, and DNA are capable of inducing hBD-2 
expression in epithelial cells (Takahashi, 2001, Platz et al. 2004). 
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 1.2.10.2  Mechanism of action of AMPs 
The activity of AMPs against microorganisms is related to their positive 
charge and their structure. The positive charge allows AMPs to be attracted 
to negative components on the surface lipid membranes of different 
microorganisms, such as bacteria, fungi, viruses and protozoa (Kagan et al., 
1994). This amphipathic structure then drives entry or penetration of the 
AMPs via the cell membrane, and disruption of the cell membrane can occur 
by several mechanisms, including pore formation or a detergent-like 
solubilisation. Because of this change in membrane permeability, ion 
gradients and energy are dissipated, leading to cell lysis (Gutsmann et al., 
2001). The bacterial cell is exposed to AMPs and protein synthesis 
decreases before cell lysis. It appears that these AMPs penetrate the cell 
membrane to enter the target cell, with subsequent disruption of protein 
synthesis (Boman et al., 1993; Chan and Gallo, 1998). In fact, several 
observations suggest that translocated AMPs can change cytoplasmic 
membrane septum formation, for example by inhibiting cell wall synthesis, 
inhibiting protein synthesis, inhibiting nucleic acid synthesis, and / or 
inhibiting enzymatic activity (Brodgen, 2005). 
In S. aureus, there are several pathways to regulate the mechanism of action 
of AMPs. Essentially, the mechanism of action against AMPs depends on 
regulation of multiple peptide resistant factor (mprF) and D-alanyl-lipoteichoic 
acid (dlt) genes. White and Frerman (1967) demonstrated that S. aureus 
cells have three major phospholipids; phosphatidylglycerol,  
lysylphosphotidylglycerol (LPG) and cardiolipin.  Generally, the mprF gene in 
S. aureus encodes LPG synthesis (Oku et al., 2004). MprF encodes LPG 
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synthase which transfers positively charged L-lysine molecules from lysyl-
tRNA and adds them to negatively charged phosphatidylglycerol within the S. 
aureus cell membrane.   
S. aureus achieves AMPs resistance by modifying negatively charged 
phosphatidylglycerel with positively charged L-lysine, resulting in repulsion of 
the AMPs (Staubitz et al., 2004). This unusual lipid is identiﬁed not only in 
Staphylococcus, but also in other important bacteria, e.g. Enterococcus 
faecalis (Houtsmuller and Deenen, 1965) and P. aeruginosa (Kenward et al., 
1979). Lately, Peschel et al. (2001) and Krisian et al. (2003) reported that an 
S. aureus mprF gene mutant, in which LPG is absent, and is sensitive to 
cationic AMPs of the innate immune system. Interestingly, Ruzin et al. (2003) 
observed that mprF gene mutation also sensitized the S. aureus cells to 
some antibiotics, such as vancomycin, bacitracin and β-lactams, and 
suggesting that LPG has an important role in the multi-drug resistance in a 
series of MRSA strains. 
As for dlt, staphylococcal species, such as S. aureus and S. xylosus, which 
tolerate high concentrations of several AMPs, were mutagenized to identify 
genes responsible for this insensitivity. Several mutants with increased 
sensitivity were obtained, which displayed an altered structure of TAs, major 
components of the Gram positive cell wall. The mutant TAs lacked positively 
charged D-alanine, as a result of which the cells carried an increased 
negative surface charge (Peschel et al., 1999). The mutated genes shared 
sequence similarity with the dlt genes involved in the transfer of positively 
charged D-alanine into negatively charged techoic acids from other Gram 
positive bacteria. Wild type bacterial strains bearing additional copies of 
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the dlt operon produced TAs with higher amounts of D-alanine esters and  
increase net positive surface charge by covalently attaching D-alanine to cell 
wall TA, bound positively charged proteins less effectively and were less 
sensitive to AMPs (Weidenmaier et al., 2005).  
Since both the mprF gene and dlt operon participate in maintaining overall 
staphylococcal surface cationic charge (Peschel et al., 2001; Oku et al., 
2004; Staubitz et al., 2004). 
 
1.2.11  Advantages and disadvantages of probiotics 
There are certain strains of probiotics that have been observed to usefully 
affect the structure and / or metabolic vitality of endogenous microbiota, as 
outlined in Figure 1.10. Some of these have also been observed to reduce 
the growth of a wide range of enteropathogenic bacteria and create 
antimicrobial metabolites (Coconnier et al., 1998). There are several 
advantages, including lactose production, alleviation of symptoms of lactose 
intolerance and malabsorption, lowering serum cholesterol concentration and 
reducing blood pressure in hypertension (Sanders, 2000), and prevention 
and reduction of certain colon cancers (Wollowski et al., 2001). Moreover, 
probiotics have effects on the immune system, e.g. improving immune 
function and prevention of infections, inhibition of pathogen growth, 
stimulation of GIT immunity, reduced chance of infection from common 
pathogens (Hooper and Gordon, 2001) and reducing inflammation (Braat et 
al., 2004). In addition, probiotics promote recovery from diarrhoea, decrease 
constipation, treat colitis (Whorwell et al., 2006) and improve UGT health 
(Reid, 2001). 
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Regarding the disadvantages of probiotics, in some specific cases, 
particularly in persons infected with dangerous diseases, it has been shown 
that administration of a combination of probiotic bacteria may be harmful 
(Reyed, 2007). Moreover, an increased mortality rate was observed in 
patients with predicted severe acute pancreatitis who had received a 
probiotic prophylactic treatment, in comparison to patients receiving a  
placebo, whilst no reduction in infectious complications was observed in 
either group (Besselink et al., 2008). Uchida et al. (2011) reported that 
administration of probiotic bacteria such as Lactococcus lactis may cause 
septicaemia in neonates, which is a potentially dangerous disease, especially 
when the patient has a lowered immune system. 
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Figure 1.10 Prophylactic properties and beneficial effects of probiotics on human 
health, adapted from Parvez et al. (2006). 
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1.2.12  Summary 
Some Staphylococcus spp., Pseudomonas spp. and Propionibacterium spp. 
are important bacteria in skin infections. Some strains of S. aureus are 
resistant to antibiotics, and are called MRSA, whilst P. aeruginosa is very 
important in burn infections. For this reason, conventional treatments are 
becoming less effective, and therefore researchers have to find alternative 
ways to treat diseases, including skin diseases, such as employing probiotics 
and AMPs. Probiotics have selective criteria, including antimicrobial 
substances, modulation of immune response and others. Probiotics were first 
used in veterinary medicine to treat digestive diseases, especially diarrhoea, 
and then more recently applied to other diseases. Probiotic treatment has 
already made its way into the treatment of a number of conditions. However, 
before bringing probiotics into routine usage, proper assessment of these 
products is necessary. The important point is careful selection of the probiotic 
agent, its dose standardization, and a thorough knowledge of its beneficial 
effects over and above the toxic effects, so that this conventional treatment 
proves to be an effective tool for medical treatment. 
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1.2.13  Aims and objectives 
The current study aimed to investigate the role of selective probiotics on 
some bacterial human skin pathogens. 
The specific objectives of this study were to: 
1. Study and evaluate the antimicrobial activity of selected Lactobacillus 
species against some human bacterial skin pathogens. 
2. Investigate the aggregation, biofilm formation, and adhesion to keratin 
between selected probiotic Lactobacillus species and some human 
bacterial skin pathogens. 
3. Evaluate and determine the antimicrobial activity of the probiotic L. 
plantarum, both alone and in synergy with the recombinant hBD-2, 
against human bacterial skin pathogens.  
4. Appraise the antimicrobial activity of some probiotic Lactobacillus species 
against pathogenic human skin MRSA strains, as well as to investigate 
the possible role of probiotics in the modulation of methicillin resistance 
in MRSA, using culture supernatants derived from selected Lactobacillus 
species. 
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Chapter 2 
Evaluation of antimicrobial activity of 
probiotic Lactobacillus species against 
bacterial human skin pathogens 
 
The results from this chapter have been presented at the XVth International 
Congress on Animal Hygiene 2011, 3th - 7th July 2011, Vienna, Austria 
Congress and the abstract published in the conference proceedings. In 
addition, the results have also been presented at the Plymouth University 
Postgraduate Society Conference Series, Wednesday 29th June 2011 and 
the abstract published in the conference proceedings.  
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Chapter 2: Evaluation of antimicrobial activity of probiotic Lactobacillus 
species against bacterial human skin pathogens 
 
2.1  Introduction 
Probiotics are living microorganisms which, upon ingestion in certain 
numbers, exert useful health effects beyond inherent general nutrition 
(Guarner and Schaafsma, 1998). LAB have an important role in the inhibition 
of pathogenic microorganisms with antimicrobial substances, including: 
organic acids (lactic, acetic and propionic acids), H2O2, polypeptides and 
others (Cálix-Lara et al., 2014). Ouwehand et al. (2002b) reported that 
probiotics have been widely used for the treatment / prevention of GIT 
diseases, but a growing number of clinical studies have reported that 
probiotic strategies induce systemic effects which extend beyond the GIT and 
may even affect selected functions of the skin (Gatesoupe, 1999; Bodera and 
Chcialowski, 2009; Gueniche et al., 2010). In addition, Kalliomäki et al. (2001) 
and Guéniche et al. (2006a) demonstrated that modulation of the GIT’s 
microflora, via probiotics, appears to cause beneficial effects in healthy as 
well as diseased human skin. Modulation via GIT is probably due to 
interaction with the immune system, but also systematically and the latter 
property may be of importance for human skin (Link-Amster et al., 1994). 
Most probiotics are included in food supplements and are limited at 
functioning in the GIT (Simmering and Blaut, 2001). Reid (1999) reported that 
non-GIT application of probiotics are few and focus on the UGT. The skin 
also has its own normal microflora, albeit less complex than the GIT 
microbiota. However, the probiotic principle is likely to be applicable to any 
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environment where a normal microbiota exists. The normal microflora of the 
skin is likely to be involved in competitive exclusion of pathogens, a function 
that could possibly be developed with the use of probiotics (Ouwehand et al., 
2003). Because the skin is a very different environment from the GIT, some 
different selection criteria for probiotics in this environment would apply. Bile 
and acid resistance are main selection criteria for GIT probiotics, obviously 
these are not relevant for application to the skin. Nevertheless, the ability of 
probiotics to adhere at the required site (be it the GIT or the skin) remains an 
important characteristic, in order to facilitate their colonization, be it 
temporary or permanent, and subsequent beneficial effects against harmful 
pathogens. Therefore, adhesion to and inhibition of pathogen adhesion to 
human keratin were assessed. In addition, the production of antimicrobial 
substances is important for an application on the skin, together with inhibition 
of pathogen adhesion (Ouwehand et al., 2003). Several methods of 
measuring antimicrobial activity were used, namely the agar well diffusion 
and agar spot assay. The agar well diffusion method has long been used for 
testing antimicrobial activity, especially for biologically derived compounds. 
Fleming first used it in 1924 and includes; agar well diffusion and spot 
methods. The results with these tests are generally semi-quantitative (Parish 
and Davidson, 1993). The method requires that the indicator organisms must 
grow rapidly, uniformly, and aerobically. Since highly hydrophobic 
antimicrobial compounds cannot diffuse in agar, they are not appropriate for 
testing by this method (Piddock, 1990). The assay used for the determination 
of the antimicrobial activity of different species of LAB was slightly different 
with respect to the sizes of the well and the samples, and the incubation 
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conditions were dependent on the indicator organisms used. Several 
modified procedures based on the agar well diffusion method have also been 
used to test the antimicrobial activity of LAB, including the agar spot test 
(Daeschel and Klaenhammer, 1985). Christiansen et al. (2005) used the agar 
well diffusion assay to evaluate the antimicrobial activity of L. paracasei 
strains against each other and against other Lactobacillus species.  
Probiotic lactobacilli can be grown in a broad range of temperatures 
(facultative bacterium) and different conditions (Anas et al., 2008). In addition, 
lactobacilli  can be grown in modified and unmodified MRS, but this bacterium 
has a great potential in unmodified MRS to produce antimicrobial substances 
that inhibit and control pathogens. Unmodified de Man Rogosa and Sharpe 
(MRS) is important as it contains a large amount of glucose (2%) which acts 
as a precursor for organic acid production (Soleimani et al., 2010). 
The objective of the current study was the evaluation of the antimicrobial 
activity of Lactobacillus species against some bacterial human skin 
pathogens and to determine the antimicrobial activity of Lactobacillus species 
as a probiotic.  
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2.2  Material and methods 
2.2.1  Reagents and media 
Unless otherwise stated, all laboratory materials, chemicals and reagents 
were purchased from Fisher Scientific Ltd. (Loughborough, Leicestershire, 
UK), Qiagen (West Sussex, UK) or Oxoid, UK. Different media and 
equipment requiring sterilization were sterilized by autoclaving (121 °C, 15 
minutes, pressure 15 lbs / in2). Cultures were mixed with sterile glycerol (30% 
v / v), and stored at - 20 °C. Agar cultures were stored at 4 °C and sub-
cultured every 3 - 4 weeks. 
 
2.2.2  Preparation of standard calibration curve for estimation of 
probiotic Lactobacillus and pathogen species numbers 
Based on a specific absorbance or optical density (OD) reading, a standard 
calibration curve of OD versus CFU numbers was produced for probiotic and 
pathogen species. 
Sterile de Man Rogosa and Sharpe broth (MRSB) and nutrient broth (NB) 
broths were placed in five sterile 2 ml Eppendorf tubes (one ml in each tube). 
One ml of exponentially growing bacteria broth culture was then added to the 
first tube and mixed well. From the first tube, one ml was then added to a 
second tube and so on to obtain a twofold dilution series down to 1/32. The 
spectrophotometer (Unicam, UK) was blanked using sterile MRSB and NB. 
One ml from each dilution and the undiluted stock was placed in a cuvette 
and OD taken at wavelength of 595 nanometres (nm) using the 
spectrophotometer. In addition, tenfold serial di lution series (10-1 to 10-7) of 
exponentially growing bacteria (lactobacilli and pathogen species) were 
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prepared using sterile phosphate buffered saline (PBS). From each dilution, 
100 µl was inoculated onto MRS and nutrient agars, and then incubated at 
37 ºC for 24 h in triplicate. The mean number of CFUs was counted, and 
expressed as CFU ml-1 (Morris and Nicholls, 1978; Koch, 1994; Sutton, 
2011).  
 
2.2.3  Microorganisms 
All microorganisms used in this study were categorized 1 or 2 according to 
the Advisory Committee on Dangerous Pathogens (ACDP). A total of 13 
microbial species were used in this experiment, these are listed in Table 2.1. 
Microorganisms were obtained from the School of Biological Sciences, 
Plymouth University culture collection which were stored in liquid nitrogen. All 
microorganisms were grown according to the optimum oxygen requirement, 
temperature and incubation time for each species. 
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Table 2.1 Bacterial strains used in this study and their optimum growth conditions. 
 
Bacteria O2 requirement Grow th temperature (°C) Grow th medium Isolated 
from 
Probiotics     
Lactobacillus casei  
Lactobacillus rhamnosus NCTC 10302  
Microaerophlic 
Microaerophlic 
37 
37 
de Man Rogosa Sharpe medium (MRS) broth and agar 
" 
PUCC* 
" 
Lactobacillus plantarum NCIMB 41605  Microaerophlic 37 " Not 
disclosed  
Lactobacillus reuteri DSMZ 20016  Microaerophlic 37 " Intestine 
Lactobacillus salivarius DSMZ 20492  Microaerophlic 37 " Saliva 
Lactobacillus vaginalis DSMZ 5837  Microaerophlic 37 " Vagina 
Lactobacillus jensenii DSMZ 20557 Microaerophlic 37 " " 
Lactobacillus acidophilus DSMZ 20079 Microaerophlic 37 " Human 
Pathogens and opportunistic pathogens     
Staphylococcus aureus NCO 3750  Aerobic 37 Nutrient (N) broth and agar, Staph 110 Skin 
Staphylococcus aureus NCO 3761  Aerobic 37 " " 
Staphylococcus aureus NCO 4137  Aerobic 37 " " 
Staphylococcus epidermidis NCO 6513  Aerobic 37 " " 
Staphylococcus epidermidis NCO 11047  Aerobic 37 " " 
Pseudomonas aeruginosa NCIB 8626  Aerobic 37 Nutrient and Pseudomonas isolation agar (PIA) " 
Propionibacterium acnes NCTC 737  Anaerobic 37 Brain and Heart Infusion (BHI) broth and agar Hair follicle 
Methicillin resistant S. aureus ATCC 33591 (MRSA 33591) Aerobic 37 Mueller Hinton broth (MHB) and N Lung 
Methicillin resistant S. aureus NCTC 12493 (MRSA 12493) Aerobic 37 MHB and N Skin 
abscess 
Methicillin resistant S. aureus DSMZ 25691 (MRSA 25691) Aerobic 37 " Skin 
        * Probiotic strains / species were obtained from the Plymouth University Culture Collection. 
        NCO: National Collection Office, Inc. Horsham, PA, UK. 
        DSMZ: Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH, Germany. 
        NCTC: National Collection of Type Cultures. 
        NCIMB: National Collection of Industrial, Marine, and Food Bacteria. 
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2.2.4  Agar well diffusion method 
2.2.4.1  Preparation of broth culture bacteria (BCB) 
The antimicrobial activity of probiotic Lactobacillus species and S. 
epidermidis as a probiotic against S. aureus was assessed. Several species 
were used in this experiment: L. casei, L. rhamnosus, L. jensenii, L. reuteri, 
L. salivarius, L. vaginalis, L. acidophilus, L. plantarum S. epidermidis 6513 
and S. epidermidis 11047 were tested as the probiotics. The bacterial human 
skin pathogens used in this experiment were S. aureus 3750, S. aureus 3761 
and S. aureus 4137. Each probiotic Lactobacillus species was cultured in 
MRSB (107 CFU / ml) at 37 °C with 5% CO2 for 18 - 20 h, and was used as 
the broth culture bacteria (BCB). In addition, Staphylococcus strains were 
grown on NB and incubated at 37 °C for 18 - 20 h. 
 
2.2.4.2  Preparation of CFS  
Cell free supernatant (CFS) for each probiotic Lactobacillus species were 
produced using MRSB (107 CFU / ml) incubated for 18 - 20 h at 37 °C and 5% 
CO2. CFS was obtained by centrifuging the culture at 2772 × g (Harrier 18 / 
80, MSE, UK) for 10 minutes, followed by fi ltration of the supernatant through 
a 0.22 μm pore size filter (MILLEX-HA MF Millipore MCE Member, 
Corrighwohill, Co. Cork, Ireland), according to Nowroozi et al. (2004). CFS 
was neutralised to pH 7.0 ± 0.2 by adding 1M NaOH, and afterwards filtered, 
as described previously. 
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2.2.4.3  Procedure for agar well diffusion method 
Petri dishes containing 20 ml of nutrient agar were prepared, and inoculated 
with 100 µl of 20 h broth culture of S. aureus strains (107 CFU / ml) using the 
spread plating method, and left for 1 h at room temperature. Then four wells 
were cut into the agar of each plate. Each well was filled with 50 μl of: BCB, 
non-neutralised and neutralised CFS according to Kalalou et al. (2004). 
Aliquots of fresh NB and MRSB were used as controls for S. epidermidis and 
Lactobacillus species respectively, according to Anas et al. (2008). Agar 
plates were incubated at 37 °C for 24 h. After incubation, the diameter of the 
inhibition zone was measured (in mm) with Vernier callipers (Figure 2.1). All 
tests were replicated three times under the same identical experimental 
conditions. 
 
Figure 2.1 Procedure for agar well diffusion method, which shows the antimicrobial 
activity of probiotic Lactobacillus species against bacterial human skin pathogens. 
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2.2.5  Agar spot method 
To confirm the results with the agar well diffusion method, an agar spot 
method was used. In this method, the Lactobacillus species were tested 
against S. aureus and S. epidermidis. Strains were those that demonstrated 
significantly greater inhibition zones than the other species of Lactobacillus in 
the agar well diffusion method. The materials used were according to the 
previous assay (agar well diffusion method). The method was a modification 
of that described by Schillinger  and Lücke (1989), and four probiotic 
Lactobacillus species (L. casei, L. salivarius, L. acidophilus and L. plantarum) 
were used. Three µl of each test probiotic (107 CFU / ml) were spotted on the 
surface of modified MRS and unmodified MRS agar. Modified MRS and 
unmodified MRS agar, containing 0.2% and 2% glucose respectively, to 
observe the importance of the role of organic acids, which are produced from 
fermented glucose, against pathogens. Plates were incubated anaerobically 
at 37 °C with 5% CO2 (GasPak system; BBL Microbiology Systems,
 
Cockeysville, Md.) for 24 h, and aerobically at 37 °C and 30 °C for 24 h to 
develop the colony spots. Sterile MRSB was used as a negative control on 
each plate. After the probiotic had grown, a 100 µl volume of an overnight 
broth culture of each Staphylococcus broth (18 - 20 h), was mixed with 10 ml 
of soft nutrient agar (0.7% w / v bacteriological agar in nutrient broth). Then 
the mixture was poured over the plate with the probiotic spotted onto the 
surface, and left for 1 h to solidify. The plates were incubated aerobically at 
37 °C for 24 h. After incubation, the diameter of the inhibition zone was 
measured in mm with Vernier callipers (Figure 2.2). A clear zone of more 
than 1 mm around a spot was considered as an indicator of antimicrobial 
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effect (Tahara et al., 1996). All tests were replicated three times under the 
same identical experimental conditions. 
 
 
Figure 2.2 Procedure for agar spot method (modified and unmodified MRS), which 
is show the antimicrobial activity of probiotic Lactobacillus species against bacterial 
human skin pathogens. 
 
2.2.6  Statistical analysis 
Data were subjected to balance analysis of variance (ANOVA) followed by 
Tukeys’ HSD multiple range post hoc testing by using Minitab v.16. Data are 
shown as mean ± SD, and P < 0.05 was considered as significant. 
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2.3  Results 
2.3.1  Agar well diffusion method  
For the results with BCB, only five species of Lactobacillus demonstrated a 
significant inhibition zone with staphylococci species. Overall, the results with 
probiotic Lactobacillus species displayed the greatest inhibition (P < 0.05) 
against S. aureus strains. The results were as follows: L. plantarum with S. 
aureus 3761 (10.83 ± 0.28 mm) and S. aureus 4137 (7.50 ± 0.5 mm) and L. 
acidophilus with S. aureus 3750 (9.83 ± 0.28 mm) respectively, as outlined in 
Table 2.2. 
For the results with CFS, the overall main antimicrobial activities of the 
probiotics were as follows: L. plantarum with S. aureus 3761 (6.83 ± 0.28 
mm), S. aureus 3750 (6.16 ± 0.28), S. aureus 4137 (3.50 ± 0.5 mm) and L. 
acidophilus with S. aureus 3750 (6.16 ± 0.28) respectively, as outlined in 
Table 2.2. These results displayed highly significant differences (P  < 0.05) 
against S. aureus strains respectively, while pH 7.0 CFS and controls were 
negative and there were no significant differences (P > 0.05).  
The statistical analyses observed high significant differences (P < 0.05) with 
pathogens, probiotics, and treatments (BCB and CFS). 
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Table 2.2 Zones of inhibition (mm; mean ± SD) for S. aureus strains with a broth culture (BCB) and cell free supernatant (CFS) of 
probiotic Lactobacillus species. 
 
Probiotics              S. aureus 3750           S. aureus 3761           S. aureus 4137 
 BCB CFS BCB CFS BCB CFS 
L. casei 7.00 ± 1.00c, 1, 2 3.83 ± 0.28b, 2 7.66 ± 0.57b, c, 1 4.83 ± 0.28b, c, 1 6.00 ± 0.86b, 2 3.33 ± 0.57a, b, 2 
L. rhamnosus   6.33 ± 0.57c, d, 1, 2   3.83 ± 0.28b, 1, 2 7.00 ± 1.00c, d, 1 4.16 ± 0.76c, d, 2 5.83 ± 0.28b, 2 3.50 ± 0.50a, b, 2 
L. jensenii   6.00 ± 1.00c, d, 1, 2   3.50 ± 0.50b, 1, 2 6.66 ± 0.57c, d, 1  3.83 ± 0.76d, 1   5.33 ± 0.57b, c, 2      2.66 ± 0.57b, 2 
L. reuteri 3.33 ± 1.15e, 1, 2 1.66 ± 0.57c, 1  3.66 ± 0.57e, 1  1.66 ± 0.57e, 1    2.50 ± 0.50e, 2      1.33 ± 0.57c, 1 
L. salivarius   9.00 ± 1.00b, 1 5.83 ± 0.28a, 1  8.66 ± 0.57b, 1  5.66 ± 0.57b, 1    5.83 ± 0.28b, 2 3.83 ± 0.76a, 2 
L. vaginalis   5.66 ± 0.57d, 1 3.33 ± 0.57b, 1  6.33 ± 0.57d, 1  3.66 ± 0.57d, 1    4.50 ± 0.50c, 2   3.00 ± 1.00a, b, 1 
L. acidophilus 10.50 ± 0.50a, 1 6.16 ± 0.28a, 1 10.83 ± 0.28a, 1  6.50 ± 0.86a, b, 1    6.16 ± 0.28b, 2   3.50 ± 0.50a, b, 2 
L. plantarum 9.83 ± 0.28a, b, 1 6.16 ± 0.28a, 1 10.50 ± 0.50a, 1   6.83 ± 0.28a, 1    7.50 ± 0.50a, 2   3.33 ± 0.57a, b, 2 
 
Values with the same superscript letters in each column are not significantly different, while mean values with the same superscript 
numbers in each row are not significantly different.   
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In addition, S. epidermidis strains were tested as probiotics against S. aureus 
strains. The results were negative (no inhibition zone) with all tests, whether 
BCB, filtered neutralised and non-neutralised CFS.  
Species of Lactobacillus were also tested for antimicrobial activity as 
probiotics against S. epidermidis strains. The results were similar to the 
results for S. aureus strains, with some minor differences in inhibition zone 
widths. 
The overall mean zone widths with BCB were as follows: L. plantarum (10.00 
± 1 mm) and S. epidermidis 11047 (8.66 ± 1.15 mm) respectively (Table 2.3).  
Furthermore, the important results of S. epidermidis with non-neutralised 
CFS were as follows: L. plantarum with S. epidermidis 6513 (6.16 ± 0.28 
mm) and S. epidermidis 11047 (4.33 ± 0.57 mm) respectively (Table 2.3).  
The statistical analyses found highly significant differences (P < 0.05) with 
pathogens, probiotics and treatments (BCB and CFS). 
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Table 2.3 Zones of inhibition (mm; mean ± SD) for S. epidermidis strains with a broth culture and cell free supernatant of probiotic 
Lactobacillus species. 
 
Probiotics S. epidermidis 6513 S. epidermidis 11047 
 BCB CFS BCB CFS 
L. casei 7.66 ± 0.57b, 1 3.66 ± 0.57c, 1 7.00 ± 1.00b, 1 3.33 ± 0.57b, c, 1 
L. rhamnosus   6.33 ± 0.57b, c, 1 3.50 ± 0.50c, 1 5.50 ± 0.50c, 1        2.83 ± 0.28c, 1 
L. jensenii   5.66 ± 0.57c, d, 1   3.33 ± 0.57c, d, 1   4.83 ± 0.28c, d, 1 2.50 ± 0.50c, d, 1 
L. reuteri 3.66 ± 0.66e, 1 1.66 ± 0.57e, 1 3.16 ± 0.28e, 1        1.33 ± 0.57e, 1 
L. salivarius              10.00 ± 1.00 a, 1 4.83 ± 0.28b, 1   7.66 ± 0.57a, b, 2    3.60 ± 1.15a, b, c, 2 
L. vaginalis   4.33 ± 0.57d, e, 1   2.50 ± 0.50d, e, 1   3.66 ± 0.57d, e, 1 1.83 ± 0.28d, e, 1 
L. acidophilus 9.33 ± 1.52a, 1 6.16 ± 0.28a, 1   8.33 ± 0.57a, b, 1 4.33 ± 0.57a, 2 
L. plantarum 10.00 ± 1.00a, 1 5.83 ± 0.57a, 1 8.66 ± 1.15a, 2    4.16 ± 0.28a, b, 2 
 
Values with the same superscript letters in each column are not significantly different, while mean values with the same superscript 
numbers in each row is not significantly different. 
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2.3.2  Agar spot method 
The results with the agar spot method were different compared with the agar 
well diffusion method. In addition, there were also differences between 
modified and unmodified MRS results.  
The factorial analysis showed that in modified MRS, the most inhibitory  
probiotic species was L. plantarum with an overall mean inhibition zone of 
0.99 ± 0.23 mm. 
The mean of the inhibition zones in modified MRS were as follows: L. 
plantarum (0.99 ± 0.23 mm) with 30 °C incubation, L. acidophilus (1.09 ± 
0.25 mm) with aerobic 37 °C incubation and L. plantarum (1.26 ± 0.22 mm) 
with anaerobic 37 °C incubation respectively (Tables 2.4 - 2.6). The inhibition 
zones ranged between 0.33 - 1.33 mm.  
The inhibition zones produced in the case of pathogens varied according to 
incubation temperatures: there were specific significant differences between 
certain individual pathogen species and certain individual probiotic species (P 
< 0.05) for example at 30 ºC, a significant difference was observed between 
inhibition zones of S. aureus 4137 and S. epidermidis 6513 in the presence 
of L. acidophilus. However, as a general rule, there were no overall 
significant differences between probiotics and pathogens at 30 °C, aerobic 
37 °C, and anaerobic 37 °C, respectively.  
Inhibition zones were as follows: S. epidermidis 6513 (0.99 ± 0.3 mm) with 30 
°C incubation, S. aureus 3761 (1.03 ± 0.28 mm) and S. epidermidis 6513 
(1.03 ± 0.15 mm) with aerobic 37 °C incubation and S. aureus 3761 (1.07 ± 
0.16 mm) with anaerobic 37 °C incubation, respectively (Tables 2.4 - 2.6). 
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Table 2.4 Zones of inhibition (mm; mean ± SD) on modified MRS 0.2% glucose for Staphylococcus species with broth culture of 
probiotic Lactobacillus species incubated at 30 °C aerobic for 24 h. 
 
Staphylococcus spp. L. casei  L. salivarius L. acidophilus L. plantarum 
S. aureus 3750 0.50 ± 0.50a, 2 0.66 ± 0.28a, 2 0.83 ± 0.28a, b, 1, 2 1.33 ± 0.57a, 1 
S. aureus 3761 0.83 ± 0.28a, 1 0.66 ± 0.28a, 1 0.83 ± 0.28a, b, 1 0.83 ± 0.28a, 1 
S. aureus 4137 0.33 ± 0.28a, 1 0.33 ± 0.28 a, 1 0.66 ± 0.28b, 1 0.83 ± 0.28a, 1 
S. epidermidis 6513 0.66 ± 0.57a, 2 0.83 ± 0.28a, 1, 2 1.33 ± 0.57 a, 1 1.16 ± 0.28a, 1, 2 
S. epidermidis 11047 0.50 ± 0.50a, 1 0.66 ± 0.28a, 1 1.00 ± 0.5a, b,1 0.83 ± 0.28a, 1 
 
Values with the same superscript letters in each column are not significantly different, while mean values with the same superscript 
numbers in each row are not significantly different.  
 
 
 
Table 2.5 Zones of inhibition (mm; mean ± SD) on modified MRS 0.2% glucose for Staphylococcus species with broth culture of 
probiotic Lactobacillus species incubated at 37 °C aerobic for 24 h. 
 
Staphylococcus spp. L. casei  L. salivarius L. acidophilus L. plantarum 
S. aureus 3750 0.50 ± 0.5a, 2 0.66 ± 0.28a, b, 1, 2 0.83 ± 0.28a, 1, 2 1.16 ± 0.28a, 1 
S. aureus 3761 0.66 ± 0.28a, 2 1.16 ± 0.28a, 1, 2 1.33 ± 0.57a, 1 1.00 ± 0.50a, 1, 2 
S. aureus 4137 0.33 ± 0.28a, 1 0.33 ± 0.28b, 1 0.83 ± 0.28a, 1 0.83 ± 0.28a, 1 
S. epidermidis 6513 0.83 ± 0.28a, 1 1.16 ± 0.28a, 1 1.16 ± 0.28a, 1 1.00 ± 0.50a, 1 
S. epidermidis 11047 0.50 ± 0.50a, 2 0.83 ± 0.28a, b, 1, 2 1.33 ± 0.57a, 1 1.33 ± 0.28a, 1 
 
Values with the same superscript letters in each column are not significantly different, while mean values with the same superscript 
numbers in each row are not significantly different.  
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Table 2.6 Zones of inhibition (mm; mean ± SD) on modified MRS 0.2% glucose for Staphylococcus species with broth culture of 
probiotic Lactobacillus species incubated at 37 °C anaerobic for 24 h. 
Staphylococcus spp. L. casei  L. salivarius L. acidophilus L. plantarum 
S. aureus 3750 0.66 ± 0.28a, 3 0.83 ± 0.28a, b, 2, 3 1.33 ± 0.57a, 1, 2 1.66 ± 0.57a, 1 
S. aureus 3761 0.83 ± 0.28a, 1 1.16 ± 0.28a, 1 1.16 ± 0.28a, 1 1.16 ± 0.28 a, 1 
S. aureus 4137 0.33 ± 0.28a, 3 0.33 ± 0.28b, 2, 3 1.00 ± 0.50a, 1 1.16 ± 0.28 a, 1 
S. epidermidis 6513 0.83 ± 0.28a, 1 0.83 ± 0.28a, b, 1 1.33 ± 0.57a, 1 1.16 ± 0.28a, 1 
S. epidermidis 11047 0.50 ± 0.50a, 2 0.66 ± 0.28b, 1, 2 0.83 ± 0.28a, 1, 2 1.16 ± 0.28 a, 1 
 
Values with the same superscript letters in each column are not significantly different, while mean values with the same superscript 
numbers in each row are not significantly different.  
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For the unmodified MRS agar (2% glucose), inhibition zones were large 
compared to modified MRS agar. In the case of unmodified MRS agar, 
different results were revealed, but there was a significantly large inhibition 
zone with L. plantarum for all tests (Tables 2.7 - 2.9), ranging between 15.33 
- 27.66 mm.  
The results were as follows: L. plantarum (25.06 ± 2.68 mm) with 30 °C 
incubation, (25.33 ± 3.74 mm) with aerobic 37 °C incubation and (25.33 ± 1.2 
mm) with anaerobic 37 °C incubation.  
As for pathogens, the results were higher significant on the following, 
according to temperatures: S. epidermidis 6513 (23.58 ± 4.34 mm) with 30 
°C incubation, S. aureus 3750 (23.75 ± 3.63 mm) with aerobic 37 °C 
incubation and S. aureus 3750 also (23.50 ± 3.31 mm) with anaerobic 37 °C 
incubation (Tables 2.7 - 2.9). 
Overall, no significant differences were observed between probiotics and 
pathogens at 30 °C and 37 °C, as well as at 37 °C under anaerobic 
conditions (P > 0.05, Tables 2.7 - 2.9). However, some significant differences 
were observed. For example, generally speaking, S. aureus 4137 was in 
many cases significantly less susceptible to probiotics than the other 
pathogens used. 
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Table 2.7 Zones of inhibition (mm; mean ± SD) on unmodified MRS (2% glucose) for Staphylococcus species with probiotic 
Lactobacillus species incubated at 30 °C aerobic for 24 h. 
 
Staphylococcus spp. L. casei L. salivarius L. acidophilus 
S. aureus 3750 20.00 ± 1.00a, 2, 3 18.33 ± 3.51a, 3 23.33 ± 1.15b, 1, 2 
S. aureus 3761 20.33 ± 0.57a, 2, 3 18.60 ± 2.08a, 3 22.60 ± 2.51b, 1, 2 
S. aureus 4137 16.00 ± 2.00b, 2, 3 15.66 ± 3.51b, 3 19.33 ± 1.15c, 1, 2 
S. epidermidis 6513 20.00 ± 2.00a, 2 19.66 ± 2.88a, 2 27.00 ± 2.64a, 1 
S. epidermidis 11047 21.00 ± 1.00a, 2 18.00 ± 2.64a , 2 27.33 ± 0.57a, 1 
 
Values with the same superscript in each column are not significantly different, while mean values with the same superscript numbers 
in each row are not significantly different.  
 
 
 
 
Table 2.8 Zones of inhibition (mm; mean ± SD) on unmodified MRS (2% glucose) for Staphylococcus species with probiotic 
Lactobacillus species incubated at 37 °C aerobic for 24 h. 
 
Staphylococcus spp. L. casei L. salivarius L. acidophilus L. plantarum 
S. aureus 3750 21.00 ± 1.73a, 2 20.33 ± 1.52a, 2 26.00 ± 1.00a, 1 27.66 ± 0.57a, 1 
S. aureus 3761 20.33 ± 0.57a, b, 2 18.00 ± 2.00a, b, 2 25.66 ± 1.15a, 1 27.00 ± 1.00a, 1 
S. aureus 4137 16.00 ± 2.64d, 2 18.00 ± 1.00b, 1, 2 19.66 ± 0.57c, 1 18.66 ± 1.52b, 1 
S. epidermidis 6513 18.33 ± 1.52b, c, 3 17.66 ± 1.15b, 3 22.00 ± 1.00b, 2 26.66 ± 1.50a, 1 
S. epidermidis 11047 18.00 ± 2.00c, d, 3 19.66 ± 0.57a, b, 3 23.00 ± 1.00b, 2 26.66 ±0.57a, 1 
 
Values with the same superscript in each column are not significantly different, while mean values with the same superscript numbers 
in each row are not significantly different.  
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Table 2.9 Zones of inhibition (mm; mean ± SD) on unmodified MRS (2% glucose) for Staphylococcus species with probiotic 
Lactobacillus species incubated at 37 °C anaerobic for 24 h. 
 
Staphylococcus spp. L. casei L. salivarius L. acidophilus L. plantarum 
S. aureus 3750 20.66 ± 1.15a, 3 20.66 ± 2.08a, 3 25.66 ± 0.57a, 2 27.00 ± 1.00a, 1 
S. aureus 3761 20.00 ± 1.00a, 4 18.00 ± 2.00b, c, 3 23.33 ± 1.52b, 2 26.66 ± 0.57a, 1 
S. aureus 4137 17.00 ± 1.73b, 3 18.33 ± 1.15b, c, 2 20.00 ± 1.00c, 1 20.66 ± 2.08b, 1 
S. epidermidis 6513 15.00 ± 1.00b, 4 17.00 ± 2.00c, 3 24.33 ± 2.10a, b, 2 25.33 ± 1.15a, 1 
S. epidermidis 11047 17.00 ± 1.73b, 4 19.66 ± 0.57a, b, 3 23.66 ± 0.57a, b, 2 27.00 ± 1.00a, 1 
 
Values with the same superscript in each column are not significantly different, while mean values with the same superscript numbers 
in each row are not significantly different.  
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There were major differences between inhibition zones in the two assays, 
depending on whether modified or unmodified MRS agar were used. With 
respect to the modified MRS assay, several of the Lactobacillus species 
showed weak inhibition (L. plantarum and L. acidophilus) or no inhibition on 
some skin pathogenic strains. By contrast, the unmodified MRS assay 
demonstrated significant differences in the inhibition zone and a large 
inhibition zones around different bacterial skin colonies were observed. 
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2.4  Discussion 
Based on susceptibility tests the effectiveness of Lactobacillus species 
isolates against bacterial human skin pathogens was observed. The majority 
of S. aureus strains appeared sensitive to Lactobacillus species. Five 
probiotic Lactobacillus species indicated significantly greater (P < 0.05) 
inhibition zones against S. aureus strains compared with other species. 
These results may be explained by the antimicrobial activity of different 
Lactobacillus species via production of numerous antibacterial substances, 
such as organic acids, bacteriocins, CO2, H2O2 or other substances (Vallor et 
al., 2001; Noordiana et al., 2013). Pathogenic bacteria were found to be 
sensitive to most Lactobacillus species, especially to non-neutralised CFS, 
but with a lesser inhibition zone compared to BCB results. This may be due 
to presence of greater levels of inhibitory substances in the BCB, such as 
those associated with whole bacteria and antimicrobial substances. In 
contrast, CFS was likely to only contain antimicrobial substances without 
whole bacteria. Lactobacillus species possess a high ability to inhibit 
Staphylococcus species growth and proliferation via competition with other 
pathogenic microorganisms for nutritional requirements (Vallor et al., 2001; 
Cadieux et al., 2002), and have been observed to have stronger antimicrobial 
properties against Gram positive bacteria such as S. aureus  (Gilliland and 
Speck, 1977). 
The role of S. epidermidis as a probiotic is not clear from the current study. 
All strains of S. aureus showed strong resistance (no inhibition zone) to S. 
epidermidis and neutralised CFS. The reason may be due to the lack of 
production of organic acids or other products that can impede or inhibit 
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growth of S. aureus strains. These factors may be the main reason for the 
effectiveness of competition for nutrition as well as competition for adhesion 
sites (Malago and Koninkx, 2011). 
The application of probiotic bacteria to the cutaneous region has up to now 
not been well studied. Nevertheless, the probiotic principle may be supposed 
to function there as well. Verschuere (2000) observed that some probiotic 
bacteria can be applied to diseased skin. It was shown that the Lactobacillus 
species were strong and effective probiotics and produced a range of 
antimicrobial agents. According to Ryan et al. (1999), using non antibiotic 
(probiotic) formulations to prevent udder disorders can reduce the need for 
the use of antibiotics in treatment of these disorders. Therefore, the problems 
of the emergence of antibiotic resistance in bacterial pathogens can be 
reduced. 
The results of the current study are compatible with other studies, for 
example a study conducted by Tejero-Sarinena et al. (2012), used an agar 
spot method to show that most of the selected strains of probiotic 
Lactobacillus, Bifidobacterium, Lactococcus, Streptococcus and Bacillus gen-
era were able to produce active compounds against pathogens such as S. 
aureus. Wang et al. (2012) showed that several Lactobacillus species, such 
as L. crispatus and L. jensenii demonstrated the ability to inhibit S. aureus 
growth and block S. aureus adherence to HeLa cells in vitro. 
In unmodified MRS, all tested probiotic Lactobacillus strains were found to 
disrupt the growth of pathogen strains in the agar spot assay, but in modified 
MRS, the effect on pathogens by probiotic Lactobacillus species was slight. 
The reason may be due to amount of glucose in MRS agar. In general, the 
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largest zones of inhibition of pathogens was found in L. plantarum, whether in 
modified or unmodified MRS. The current study found that there were no 
significant differences between different temperatures, because these 
bacteria (Lactobacillus species) can be grown in a broad range of 
temperatures and different conditions. These results were in agreement with 
the finding of Anas et al. (2008), who revealed that probiotics have a proteinic 
nature causing the growth inhibition of S. aureus. In the current study, the 
results observed were that the inhibitory effect of the unmodified MRS was 
stronger than the modified MRS, which may be due to the amount of glucose 
(a precursor for organic acid production). On the contrary, in unmodified MRS, 
the results demonstrated a large inhibition zone. This signifies that the action 
is due to organic acids and / or other substances. This study agrees with the 
findings of Soleimani et al. (2010), who observed that probiotic Lactobacillus 
species have a great potential to produce antimicrobial substances that 
inhibit and control pathogens such as S. aureus, with some differences as to 
conditions and bacterial regions. Generally, the agar spot method was a very 
effective method compared to agar well diffusion method. L. plantarum was 
the most effective of the Lactobacillus species studied. 
 
 
 
 
 
 
 
Chapter 2                                     Evaluation of antimicrobial activity of probiotic 
77 
 
2.5  Conclusions 
The results of the current study revealed that Lactobacillus species were able 
to inhibit growth of Staphylococcus species. Moreover, BCB were more 
effective in inhibiting the growth of Staphylococcus species in comparison 
with CFS. The results demonstrated that there was no antimicrobial activity of 
S. epidermidis isolates against S. aureus strains. In addition,   the results with 
unmodified MRS agar spot assay were more effective compared to modified 
MRS agar spot and agar well diffusion assays. This suggests the 
antimicrobial activity of the Lactobacillus was due to LA production and / or 
other substances. 
Generally, probiotic Lactobacillus species can be applied as successful 
solutions to bacterial antibiotic resistance. What is very interesting, as 
observed by the current study, is that one can select mixtures of different 
probiotic microorganisms to better adapt their common action and obtain 
remarkable results. 
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Chapter 3 
Assessment of aggregation, biofilm 
formation, and adhesion to keratin in 
probiotics and human skin pathogens 
 
The results from this chapter have been presented at NEMO Keele 
Conference, Keele University, Keele, UK, "Prebiotics and Probiotics in 
Medicine, Veterinary Sciences and Aquaculture” 9 th - 11th September 2012, 
and the abstract published in the conference proceedings . In addition, the 
results have also been presented in Annual Conference, in the Centre for 
Agricultural and Rural Sustainability, 19th June 2013, Plymouth, UK and the 
abstract published in the conference proceedings. 
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Chapter 3: Assessment of probiotic aggregation, biofilm formation, and 
adhesion to keratin in probiotics and human skin pathogens 
 
3.1  Introduction 
Adhesion to epithelial tissue is a prerequisite for temporary colonization of 
probiotic species. Several bacterial components, such as carbohydrates, cell 
wall proteins and lipo-teichoic acid (LTA) play an important role in the 
adhesion of bacteria to epithelial tissue (Gusils et al., 2002). Collado et al. 
(2008) observed that co-aggregation is a process by which genetically 
distinct bacteria become attached to one another via specific lectin-like 
adhesions and receptor molecules. A relationship between auto -aggregation 
and adhesion ability has been reported for some Bifidobacterium species 
(Vlková et al., 2008). In addition, connection between adhesive ability and 
hydrophobicity has been observed in certain lactobacilli  (Del Re et al., 2000). 
Furthermore, Collado et al. (2007), indicated that co-aggregation of a 
bacteriocin producing LAB with harmful bacteria may represent an important 
host defence mechanism. 
Biofilms are structured microbial populations attached to a surface. Individual 
microorganisms in biofilms are implanted inside a matrix of often slimy 
extracellular polymers (Douglas, 2003). There are three main stages to the 
formation of a biofilm: (1) the reversible and irreversible attachment stage, (2)  
the micro-colony stage and (3) the detachment stage. In the first stage, 
Postollec et al. (2006) showed that the bacteria surface and interface are 
important in biofilm formation due to facilitation of the acquisition of nutrients. 
There is always an initial attachment of a forerunner bacterium on the 
surface. Wolcott et al. (2008) observed that there are two types of attachment 
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during biofilm formation, the reversible and the irreversible. In the second 
stage, the matrix assists the microorganism to self-attach to the surface and 
protects the colony of microorganisms from harsh ecological and host stress. 
Stoodley et al. (2002) observed that at the third stage a micro-colony attains 
a high density of microbial population. Several studies have shown that 
microorganisms living in biofilm have a high resistance to antibiotics 
compared to planktonic cells (Stewart and William Costerton, 2001). Several 
mechanisms of drug resistance have been suggested: (a) penetration of 
drugs is restricted through the biofilm substance, (b) restriction of nutrients, 
decreased growth rate for microorganisms and altered microenvironment (c) 
adaptive responses and (d) genetic modification to persister cells (Mah and 
O'Toole, 2001). 
With regard to adhesion to keratin, Reid (1999) indicated that other regions 
for application of probiotic bacteria are few compared to the GIT, and 
especially when compared with the UGT. The main purpose of this 
experiment was therefore to research the likelihood of applying probiotic 
Lactobacillus species to the skin. Ouwehand et al. (2003) showed that 
because the human skin is a very different environment from the GIT, and 
therefore different selection measures for probiotic Lactobacillus would apply 
in this environment. In addition, adhesion is important for the skin as well, to 
improve temporary settlement and colonization resistance towards latent 
harmful bacteria. Therefore, inhibition of adhesion of bacterial human skin 
pathogens was assessed in the current study. Several antimicrobial 
substances can be produced by probiotic LAB, such as Propionibacterium 
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freudenreichii subsp. freudenreichii and L. rhamnosus, for application to the 
skin (Fuller, 1989; Ouwehand et al., 2003). 
The aims of this study were to investigate aggregation (auto-aggregation and 
co-aggregation), biofilm formation, and adhesion to keratin between 
probiotics and human skin pathogens. 
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3.2  Materials and methods 
3.2.1  Aggregation assay 
The auto-aggregation assay was achieved according to Del Re et al. (2000), 
and is represented in Figure 3.1. Some modification was applied to these 
methods. L. casei, L. salivarius, L. acidophilus and L. plantarum were 
selected in this study as they showed the greatest antimicrobial activity 
against selected bacterial human skin pathogens, as reported in Chapter 2. 
Probiotic bacteria L. casei, L. salivarius, L. acidophilus and L. plantarum 
(Table 2.1) were grown for 18 - 20 h at 37 °C in MRSB. Pathogen strains, e.g. 
S. aureus strains and P. aeruginosa (Table 2.1) were grown in NB for 18 h at 
37 °C, as outlined in Figure 3.1 (1). The bacterial cells (probiotics and 
pathogens) were harvested by centrifugation at 4300 ᵡ g (Harrier 18 / 80, 
MSE, UK) at 4 °C for 15 minutes (2). Bacterial pellets were washed with PBS 
three times (3). Then pellets were re-suspended in the same buffer to give an 
OD of 0.5 (OD600 nm) (4). Five ml (10
7 CFU / ml) of each bacterial suspension 
in PBS were centrifuged at 4300 ᵡ g at 4 °C for 15 minutes (5). The pellets 
were re-suspended in 4 ml of their own fi ltered (0.22 µm) sterilized culture 
supernatant fluid, mixed for 10 seconds, then the absorbance at 600nm was 
measured (OD1, 6), and incubated for 4 h at room temperature. The auto-
aggregation was determined by taking 1 ml of the upper suspension into a 
cuvette and measuring absorbance at 600nm (OD2, 7). The equation used to 
calculate the percentage auto-aggregation was: 
Auto-aggregation (%) = [(OD1 - OD2) / (OD1) ᵡ 100] (8) (Vandevoorde et al., 
1992). 
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Where OD1 and OD2 represent first optical density and second optical 
density after 4 h, respectively. 
All tests were replicated three times under identical experimental conditions. 
 
 
Figure 3.1 Procedure of aggregation (auto-aggregation and co-aggregation) method 
with some probiotic Lactobacillus species and bacterial human skin pathogens. 
 
 
Co-aggregation of pathogens with probiotic strains, as described in Figure 
3.1. Steps 1 - 6 were the same in the auto-aggregation. Equal volumes of 
cells (2 ml) for both probiotic and pathogens were mixed and incubated at 
room temperature at 5 h without agitation. The absorbance on an OD600 nm of 
the suspensions was measured after mixing and after 5  h of incubation at 
room temperature (OD3) (7). The equation used to calculate the percentage 
co-aggregation was: 
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Co-aggregation (%) = [(OD1 + OD2) - 2 (OD3) / (OD1 + OD2) ᵡ 100] (8) 
(Vandevoorde et al., 1992). 
Where; OD1: optical density of Lactobacillus strain, OD2: optical density of 
pathogen strain and OD3: optical density of mixture bacteria after 5 h. 
All tests were replicated three times under identical experimental conditions. 
 
3.2.2  Preparing aggregation samples for SEM examination 
Scanning electron microscopy (SEM) was used to visualize bacteria (auto-
aggregation) and their interaction with each other (co-aggregation). Ten µl of 
each suspension was placed on a slide, then left to air dry. Samples were 
then fixed with one ml 2.5% glutaraldehyde ( w / v in 0.2 M sodium cacodylate 
buffer; 1:1 vol., pH 7.2, Sigma, Chemical Company, St. Louis, MO, USA) for 
2 h at 25 °C. Fixative removal from samples was carried out by rinsing 3 
times with 0.1 M sodium cacodylate buffer for 15 minutes at pH 7. The 
samples were dehydrated via a graded series of acetone and ethanol 
mixtures, and samples were critical point drier (EMITECH K850, Ashford, 
Kent, UK) to remove all ethanol (at 35 °C and 1250 psi for 15 minutes). Dried 
samples are then mounted on aluminium stubs and sputter coated 
(EMITECH / K550, UK) with gold, and examined with a Jeol JSM 5600 LV 
electron microscope at 15 kV accelerating voltage (Jeol, Tokyo, Japan).  
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3.2.3  Crystal violet assay for assessment of biofilm formation  
In this study, several strains of human skin pathogens and probiotic 
Lactobacillus species were tested: pathogen S. aureus (3750, 3761 and 
4137), S. epidermidis (6513 and 11047), P. aeruginosa, Pr. acnes and 
probiotic Lactobacillus species (L. casei and L. plantarum) (Table 2.1). All 
pathogens were cultured in 10 ml nutrient broth at 37 °C aerobically for 24 h, 
except Pr. acnes which was incubated in strict anaerobic condition at 37 °C 
for 3 - 5 days (GasPak Anaerobic System, OXOID Ltd. Company, UK). 
Lactobacillus species were cultivated in 10 ml unmodified MRS 2% (20 g / l) 
glucose or modified MRS 0.2% (2 g / l) glucose, which were incubated in 5% 
CO2 at 37 °C aerobe for 24 h. The OD (570 nm) were determined by a Versa 
Max Plate Reader (Versa Max Plate Reader [Molecular devices, UK] Ltd., UK 
South). 
For individual bacteria strains (pathogen or probiotic bacteria), microtitre 
plates were inoculated with 250 μl broth culture per well (107 CFU / ml). 
Sterile nutrient and MRS broth were inoculated as controls . Plates were 
covered and incubated at 37 °C for 24 h. After incubation, the bacterial 
culture broth (BCB) was removed from each well, each well was washed 
three times with 300 µl sterile PBS to remove bacteria that were not adhered 
to the wells and vigorously shaken. Biofilms adhering to the wells were fixed 
with 250 µl of 96% ethanol per well for 15 minutes. The ethanol was then 
removed and the plate was left to dry. Each well was stained with 0.2 ml 
crystal violet solution (2% w / v) for five minutes, and excess removed by 
washing with molecular grade water. The quantitative examination of biofilm 
production was achieved by adding 200 μl of 33% glacial acetic acid (v / v) 
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per well, incubating for 15 minutes, and measuring absorbance at 570nm 
using a Versa Max Plate Reader, as described previously by Christensen et 
al. (1985). All tests were replicated three times under the same experimental 
conditions, as according to the method of Tahmourespour and Kermanshahi 
(2011). The strains were classified as follows, according to Christensen et al. 
(1985): 
If the optical densities were less than or equal to 0.120, the microorganism 
was classified as non-adherent. 
-If the optical densities were more than 0.120 and less than 0.240 they were 
classified as weakly adherent.  
-If the optical densities in either medium exceeded 0.240, the strain was 
classified as strongly adherent. 
For the mixed strains (probiotic and pathogen), to evaluate the effectiveness 
of probiotics Lactobacillus species on biofilm formation, the pathogenic 
strains and Lactobacillus species were grown in nutrient broth and MRSB, 
respectively for 18 - 20 h at 37 °C aerobically. 
There were two procedures used to evaluate the effects of probiotic 
Lactobacillus species on biofilm formation in human pathogenic strains.  
(1), Lactobacillus species (0.125 ml) were incubated at the same time as 
pathogens (0.125 ml), (2) incubation of Lactobacillus species (0.125 ml) for 
30 minutes prior to addition of pathogens (0.125 ml). The control wells 
contained PBS instead of broth, as mentioned above. Staining with crystal 
violet was done, as described previously. The absorbance was determined 
by using a Versa Max Plate Reader, as described formerly by Christensen et 
al. (1985). All tests were replicated three times under the same conditions. 
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3.2.4  Detection of bacterial adhesion to keratin with the crystal violet 
assay 
In this technique, human skin pathogenic strains (S. aureus 3750, P. 
aeruginosa, Pr. acnes), two probiotic Lactobacillus species; L. casei and L. 
plantarum (107 CFU / ml) were used (Table 2.1). Keratin from human hair 
[Meta-Keratins surface coating I (K1), II (K2), III (K3) and IV (K4)] (KeraFAST 
Company, Winston-Salem City, NC state, USA) were used. A Versa Max 
Plate Reader was used to determine optical density and the absorbance 
values were 570 nm (Versa Max Plate Reader [Molecular devices, UK] Ltd., 
UK South). 
The method consisted of preparing the keratin surface coating on the day of 
the experiment. A stock solution of keratin was prepared with steri le water at 
the concentration of 1 mg / ml. The vial was incubated for thirty minutes at 37 
°C to dissolve the keratin completely. This stock solution was diluted 1:4 to a 
working solution by using sterile water, according to the manufacturing 
company’s instructions. The working solution (0.15 ml) was added to each 
well of a 96 well microtitre plate, and then the microtitre plates were 
incubated for 2 h at 37 °C. After that, the working solution was carefully 
aspirated from each well. Broth cultures of bacteria for pathogens and 
Lactobacillus species (107 CFU / ml) were added to wells and incubated at 37 
°C for 1 h, and then the wells were washed with PBS three times. NB and 
MRSB were used as a control for pathogens and Lactobacillus species, 
respectively. 
The crystal violet assay was modified after Vesterlund et al. (2005). In short, 
bacterial broths were added as a volume of 0.1 ml from each bacterium into 
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96 microtitre plate wells coated with 0.15 ml of working solution. A large 
volume of working solution compared to the volume of added bacteria was 
used to reduce contact of the crystal violet stain with the wall of the plate. 
The plates were incubated for 1 h at 37 °C. Non-adherent bacterial cells were 
removed by washing three times with 0.25 ml of PBS. The adherent bacterial 
cells were fixed at 60 °C for 20 minutes, and then stained with 0.1 ml (0.1% 
solution) crystal violet for 45 minutes at room temperature. The wells were 
washed five times with PBS to remove excess crystal violet stain. The crystal 
violet stain bound to the bacterial cell was released by adding 0.1 ml of 
citrate buffer (pH 4.3) for 45 minutes at room temperature. The absorbance 
was determined by using a Versa Max Plate Reader (Molecular devices, UK. 
Ltd.). Stained Meta-keratin without added bacteria cells was used as a 
control. All tests were replicated three times under the same identical 
experimental conditions. 
 
3.2.5  Statistical analysis 
Data (mean ± SD OD) were subjected to balanced ANOVA using Minitab 
v.16 and least significant differences (LSD) post cost testing. A P  value of 
less than 0.05 was used to indicate a significant difference. 
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3.3  Results 
3.3.1  Aggregation assay 
The results of OD for aggregation (auto-aggregation and co-aggregation) 
methods at 600 nm are seen in Tables 3.1 - 3.2. The auto-aggregation for 
different probiotic Lactobacillus species was measured after 4 h. The results 
showed that L. casei displayed a stronger auto-aggregation (mean ± SD 
OD600nm) (11.48 ± 1.15%) than other Lactobacillus species, while the results 
with other species were as follows: L. salivarius (7.47 ± 1.2%), L. plantarum 
(7.4 ± 0.36%) and L. acidophilus (6.52 ± 0.94%) respectively, as outlined in 
Table 3.1. 
 
Table 3.1 The optical density (600nm) percentages ([(OD1 - OD2) / (OD1) ᵡ 
100]) of auto-aggregated Lactobacillus and pathogen species. 
 
 
Values with the same superscript letters in each column are not significantly 
different. 
 
 
 
 
 
Lactobacillus and pathogen spp. Mean of auto-aggregation (%) 
L. casei  11.48 ± 1.15b 
L. salivarius   7.47 ± 1.20d 
L. acidophilus   6.52 ± 0.94
d
 
L. plantarum   7.40 ± 0.36d 
S. aureus 4137 14.40 ± 0.14a 
P. aeruginosa 8626 12.60 ± 0.65b 
S. aureus 3761 10.07 ± 0.02c 
S. aureus 3750   9.48 ± 1.38c 
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The results with auto-aggregation for pathogen strains (mean ± SD OD600nm), 
showed that S. aureus 4137 demonstrated significantly higher auto-
aggregation (14.4 ± 0.14%) compared with other strains of pathogen, P. 
aeruginosa (12.6 ± 0.65%) or S. aureus 3761 (10.07 ± 0.02%) and S. aureus 
3750 (9.48 ± 1.38%), respectively (Table 3.1). 
The results for the co-aggregation assay varied among bacterial species. The 
results were expressed as the percentage reduction after 5 h in the 
absorbance after 5 h of a mixed suspension compared with the individual 
suspension. All experiments displayed co-aggregation characteristics in 
different degrees (Table 3.2). The majority of bacterial strains demonstrated 
weak co-aggregation abilities in comparison with auto-aggregation, but this 
depended on specific strains and the duration of incubation. The results were 
analysed as a factorial design with the factors being the pathogens and the 
probiotics. In the factorial analysis, the highest effective probiotic was L. 
casei (11.48 ± 1.15%). The most susceptible pathogen was S. aureus 3761 
(19.03 ± 0.71%). In the current experiment, L. casei demonstrated the 
greatest co-aggregation with all pathogen strains, and the results (mean ± 
SD OD600nm) were as follows: S. aureus 3761 (19.03 ± 0.71%), S. aureus 
4137 (18.58 ± 0.46%), S. aureus 3750 (18.45 ± 0.93%) and (16.04 ± 0.98%) 
with P. aeruginosa respectively (Table 3.2). S. aureus 3761 was greatest 
overall. 
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Table 3.2 The optical density (600nm) percentages ([(OD1 + OD2) - 2 (OD3) / (OD1 + OD2) ᵡ 100]) of co-aggregated 
Lactobacillus species and bacterial human skin pathogens. 
 
Pathogens L. casei  L. salivarius  L. acidophilus  L. plantarum  
S. aureus 3761 19.03 ± 0.71a, 1 15.84 ± 0.84a, 2 15.29 ± 0.25a, 2 16.36 ± 0.11a, 2 
S. aureus 4137 18.58 ± 0.46a, 1 12.75 ± 0.84b, 3 11.85 ± 0.52b, 3 14.69 ± 1.61b, 2 
S. aureus 3750 18.45 ± 0.93a, 1 10.07 ± 0.59c, 3 13.17 ± 0.05b, 2 12.88 ± 0.19c, 2 
P. aeruginosa 8626  16.04 ± 0.98b, 1 12.38 ± 1.21b, 3 14.13 ± 0.19a, 2 15.75 ± 1.20a, b, 1 
 
Values with the same superscript letters in each column are not significantly different, while mean values with the same superscript 
numbers in each row are not significantly different. 
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In cases where auto-aggregation did not display significant differences, 
scanning electron microscope examination was conducted to determine the 
susceptibility of strains to auto-aggregation (Figures 3.2 - 3.3). 
 
 
Figure 3.2 Auto-aggregation reactions for some Lactobacillus species under SEM, 
(A) L. casei, (B) L. acidophilus, (C) L. salivarius and (D) L. plantarum. 
 
       
 
Figure 3.3 Auto-aggregation reactions for some bacterial human skin pathogens 
under SEM, (A) P. aeruginosa and (B) S. aureus 3750. 
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In the majority of co-aggregates, the scanning electron micrograph 
demonstrated the presence of large contact regions between probiotic 
lactobacilli and bacterial human skin pathogens (Figure 3.4). 
 
 
Figure 3.4 Co-aggregation reactions for Lactobacillus species and bacterial human 
skin pathogens under SEM, (A) L. plantarum and P. aeruginosa 8626, (B) L. casei 
and S. aureus 4137 and (C) L. salivarius and S. aureus 3750. 
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3.3.2  Crystal violet assay for assessment of biofilm formation 
For individual bacteria, the ability of bacterial species (Lactobacillus and 
pathogens) to form a biofilm varied. The results indicated biofilm production 
by all tested pathogen strains. The pathogenic strains showed strong and 
significant differences by increase of OD570nm from 0.2 - 1.5 (Table 3.3). P. 
aeruginosa produced the highest OD570nm (1.45 ± 0.03). 
 
Table 3.3 Biofilm formation (expressed as OD570nm mean ± SD) of bacterial 
human skin pathogens.  
 
 
 
 
 
 
 
 
 
 
Values with the same superscript letters in each column are not significantly 
different, BF: biofilm formation, S: strong, W: weak and NA: no adherence. 
 
 
 
 
 
 
 
 
 
Pathogens  OD570nm BF 
P. aeruginosa 8626 1.45 ± 0.00a  S 
Pr. acnes 737 1.34 ± 0.00b  S 
S. aureus 4137 0.89 ± 0.01c  S 
S. epidermidis 11047 0.67 ± 0.00d  S 
S. aureus 3750 0.44 ± 0.01e  S 
S. aureus 3761 0.24 ± 0.01f   W 
S. epidermidis 6513 0.23 ± 0.03g  W 
Control (N.B) 0.00 ± 0.00h  NA 
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In addition, the results showed no adherence or no significant differences 
between Lactobacillus species in unmodified and modified MRS (Table 3.4). 
 
Table 3.4 Biofilm formation (expressed as OD570nm mean ± SD) of Lactobacillus 
species in unmodified MRS (2% glucose) and modified MRS (0.2% glucose).  
 
Probiotics unmodified (OD) modified (OD) BF 
L. plantarum 0.08 ± 0.00a, 1 0.07 ± 0.00a, 2 NA 
L. casei 0.07 ± 0.01a, 1 0.07 ± 0.00a, 1 NA 
Control (MRS) 0.00 ± 0.00b, 1 0.00 ± 0.00b, 1 NA 
 
Values with the same superscript letters in each column are not significantly 
different, while mean values with the same superscript numbers in each row are not 
significantly different, BF: biofilm formation, NA: no adherence. 
 
 
For results with mixed bacteria, all results demonstrated a large significant 
reduction in adherence the presence of probiotic species, whether in 
unmodified or modified MRS (Tables 3.5 - 3.8). The results demonstrated 
highly significant differences (P < 0.05), but no significant differences 
between unmodified and modified MRS assays, except for changes in the 
rates of the scores between them. 
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Table 3.5 Biofilm formation (expressed as OD570nm mean ± SD) of Lactobacillus species with bacterial human skin pathogens 
(unmodified MRS glucose; probiotics added at the same time with pathogens). 
 
Pathogens Individual pathogen       L. casei     L. plantarum BF 
P. aeruginosa 8626 1.45 ± 0.00a 0.14 ± 0.01a, 1    0.13 ± 0.00a, b, 2 W 
Pr. acnes 737 1.34 ± 0.04b 0.13 ± 0.01a, 1 0.13 ± 0.00a, 1 W 
S. aureus 4137 0.89 ± 0.01c  0.11 ± 0.01b, 2 0.12 ± 0.00b, 1 NA 
S. epidermidis 11047 0.67 ± 0.00d  0.09 ± 0.01c, 2 0.12 ± 0.00b, 1 NA 
S. epidermidis 6513 0.44 ± 0.01e    0.08 ± 0.00c, d, 1 0.08 ± 0.00c, 1 NA 
S. aureus 3750 0.24 ± 0.01g  0.08 ± 0.00d, 1 0.08 ± 0.00c, 1 NA 
S. aureus 3761 0.23 ± 0.00f   0.08 ± 0.01d, 1 0.08 ± 0.01c, 1 NA 
Control (PBS) 0.00 ± 0.00h  0.00 ± 0.00e, 1 0.00 ± 0.00d, 1 NA 
 
Values with the same superscript letters in each column are not significantly different, while mean values with the same superscript 
numbers in each row are not significantly different, BF: biofilm formation, NA: no adherence, W: weak and S: strong. 
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Table 3.6 Biofilm formation (expressed as OD570nm mean ± SD) of Lactobacillus species with bacterial human skin pathogens 
(unmodified MRS glucose; probiotics added 30 minutes before pathogens). 
 
Pathogens Individual pathogen      L. casei     L. plantarum BF 
P. aeruginosa 8626 1.45 ± 0.03a 0.14 ± 0.01a, 1 0.13 ± 0.01a, 1 W 
Pr. acnes 737 1.34 ± 0.04b 0.13 ± 0.01a, 1 0.14 ± 0.01a, 1 W 
S. aureus 4137 0.89 ± 0.05c 0.12 ± 0.00b, 1 0.13 ± 0.01a, 1 W 
S. epidermidis 11047 0.67 ± 0.00d 0.12 ± 0.01b, 2 0.13 ± 0.01a, 1 W 
S. epidermidis 6513 0.44 ± 0.01e 0.09 ± 0.01c, 1 0.08 ± 0.00b, 1 NA 
S. aureus 3750 0.24 ± 0.01g   0.08 ± 0.00c, d, 1 0.09 ± 0.00b, 1 NA 
S. aureus 3761 0.23 ± 0.03f  0.08 ± 0.00d, 1 0.08 ± 0.00b, 1 NA 
Control (PBS) 0.00 ± 0.00h 0.00 ± 0.00e, 1 0.00 ± 0.00c, 1 NA 
 
Values with the same superscript letters in each column are not significantly different, while mean values with the same superscript 
numbers in each row are not significantly different, BF: biofilm formation, NA: no adherence, W: weak and S: strong. 
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Table 3.7 Biofilm formation (expressed as OD570nm mean ± SD) of Lactobacillus species with bacterial human skin pathogens 
(modified MRS 0.2%; added at the same time). 
 
Pathogens Individual pathogen      L. casei     L. plantarum BF 
P. aeruginosa 8626 1.45 ± 0.03a 0.13 ± 0.00a, 1 0.13 ± 0.00a, 1 W 
Pr. acnes 737 1.34 ± 0.04b 0.13 ± 0.00a, 1 0.13 ± 0.00a, 1 W 
S. aureus 4137 0.89 ± 0.01c 0.12 ± 0.00b, 1 0.12 ± 0.00b, 1 W 
S. epidermidis 11047 0.67 ± 0.00d 0.12 ± 0.00b, 1 0.12 ± 0.00b, 1 NA 
S. epidermidis 6513 0.44 ± 0.01e 0.09 ± 0.01c, 1 0.09 ± 0.00c, 1 NA 
S. aureus 3750 0.24 ± 0.01g 0.08 ± 0.00d, 2   0.09 ± 0.00c, d, 1 NA 
S. aureus 3761 0.23 ± 0.03f  0.08 ± 0.00d, 2 0.09 ± 0.00d, 1 NA 
Control (PBS) 0.00 ± 0.00h 0.00 ± 0.00e, 1 0.00 ± 0.00e, 1 NA 
 
Values with the same superscript letters in each column are not significantly different, while mean values with the same superscript 
numbers in each row are not significantly different, BF: biofilm formation, NA: no adherence, W: weak and S: strong. 
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Table 3.8 Biofilm formation (expressed as OD570nm mean ± SD) of Lactobacillus species with bacterial human skin pathogens 
(modified MRS 0.2%; probiotics added 30 minutes before pathogens). 
 
Pathogens Individual pathogen L. casei L. plantarum BF 
Pr. acnes 737 1.45 ± 0.03a 0.14 ± 0.00a, 1 0.13 ± 0.00a, 1 W 
P. aeruginosa 8626 1.34 ± 0.04b 0.13 ± 0.00a, 1 0.13 ± 0.01a, 1 W 
S. aureus 4137 0.89 ± 0.05c 0.13 ± 0.00b, 2 0.13 ± 0.00b, 1 W 
S. epidermidis 11047 0.67 ± 0.00d 0.12 ± 0.01c, 1 0.12 ± 0.00c, 1 NA 
S. epidermidis 6513 0.44 ± 0.01e 0.09 ± 0.00d, 1 0.09 ± 0.00d, 1 NA 
S. aureus 3750 0.24 ± 0.01g 0.08 ± 0.01e, 1 0.09 ± 0.01d, 1 NA 
S. aureus 3761 0.23 ± 0.03f  0.08 ± 0.01e, 1 0.09 ± 0.00d, 1 NA 
Control (PBS)  0.00 ± 0.00h 0.00 ± 0.00f , 1 0.00 ± 0.00e, 1 NA 
 
Values with the same superscript letters in each column are not significantly different, while mean values with the same superscript 
numbers in each row are not significantly different, BF: biofilm formation, NA: no adherence, W: weak and S: strong. 
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3.3.3  Adhesion to keratin 
The bacterial human skin pathogens were found to adhere to keratin and 
Lactobacillus species, and to adhere to keratin from 0.055 - 0.113 OD570nm. 
The results with different keratin (mean ± SD OD570nm) were as follows: 
keratin III (0.085 ± 0.029), keratin IV (0.083 ± 0.038), keratin II (0.061 ± 0.014) 
and keratin I (0.059 ± 0.021), respectively (Table 3.9). All results with 
pathogens exhibited adhesion to keratin, but in different degrees. There were 
no significant differences (P > 0.05) between them. P. aeruginosa (0.113 ± 
0.029) had shown significant differences (P < 0.05) with other strains. 
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Table 3.9 Adhesion ability (expressed as OD570nm mean ± SD) between probiotics, bacterial human skin pathogens and four types 
of keratin. 
 
Bacteria          Keratin 1          Keratin 2         Keratin 3         Keratin 4 
P. aeruginosa 8626 0.09 ± 0.01a, 1 0.08 ± 0.00a, 1    0.13 ± 0.02a, 1    0.15 ± 0.02a, 1 
Pr. acnes 737    0.07 ± 0.01a, b, 1 0.07 ± 0.08a, 1 0.10 ± 0.08a, b, 1 0.09 ± 0.01a, b, 1 
S. aureus 3750    0.06 ± 0.00a, b, 1 0.07 ± 0.01a, 1 0.09 ± 0.00a, b, 1 0.10 ± 0.02a, b, 1 
L. casei  0.01 ± 0.00b, 1 0.05 ± 0.01a, 1 0.07 ± 0.01a, b, 1    0.06 ± 0.00b, 2 
L. plantarum 0.04 ± 0.00b, 1 0.07 ± 0.01a, 1 0.07 ± 0.01a, b, 1    0.07 ± 0.02b, 1 
Control (PBS)      0.00 ± 0.00c,1 0.00 ± 0.00b, 1    0.00 ± 0.00c,1    0.00 ± 0.00c, 1 
 
Values with the same superscript letters in each column are not significantly different, while mean values with the same superscript 
numbers in each row are not significantly different. 
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3.4  Discussion 
In this study, the highest auto-aggregation was shown with L. casei after 
incubation at 25 °C for 4 h. Boris et al. (1997) showed that most of the auto-
aggregation was attributable to adherence properties. The observed auto-
aggregation of the potential probiotic strain L. casei could be related to cell 
surface components, because it was not lost after washing and suspension 
of the cells in PBS. The current study was compatible with the findings of Kos 
et al. (2003), and Woo and Ahn (2013), which showed the ability of some 
Lactobacillus strains, e.g. L. acidophilus, L. casei, L. paracasei and L. 
plantarum to adhere and aggregate with some pathogenic bacteria, such as 
Enterococcus faecium (19.46%), E. coli (15.7%) and Salmonella typhimurium 
(15.11%) respectively. On the other hand, the current study was incompatible 
with the findings of Zakaria Gomaa (2013), which observed the high ability of 
some probiotic Lactobacillus species, e.g. L. casei, L. paracasei, L. 
plantarum and others to adhere and aggregate with some pathogenic 
microorganisms, such as S. aureus (22.10 - 48.88%), Proteus vulgaris (22.19 
- 45.76%) and Candida albicans (27.55 - 59.37%), respectively. 
Several surface proteins, such as S-layer proteins, are found in Lactobacillus 
species. These 45 KDa have been shown to encourage binding to ecological 
surfaces, such as the surface of other bacteria, and play an important role in 
aggregation (Pouwels et al., 1998; Sara and Sleytr, 2000). This structure 
forms a crystalline layer around many bacterial species, reaching 15 - 20% of 
the total cellular protein content, with apparent molecular weights of 40 - 200 
kDa. These structures are believed to play an important role in cell protection, 
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surface recognition, and potential mediators in the initial steps included in 
adhesion. 
In addition, carbohydrate and basic protein material on the cell surface are 
responsible for adhesion (Greene and Klaenhammer, 1994). The ability to 
adhere to epithelial cells and mucous surfaces has been proposed as a 
significant characteristic of several bacterial isolates used as probiotics. 
Many studies have indicated that structures, forces and composition of 
interaction are correlated with the ability of bacteria to adhere to epithelial 
cells (Del Re et al., 2000) and mucus (Collado et al., 2005). Tareb et al. 
(2013) observed that bacterial aggregation and / or adhesion are generally 
key factors for colonization of the target environment and the ability of 
probiotic strains to exclude pathogens. 
The results of the co-aggregation assay in the current study observed 
overlap between probiotic Lactobacillus species and bacterial human skin 
pathogens. Lactobacillus species exerted some co-aggregation than 
individual strains alone. In the present study, the majority of probiotic 
Lactobacillus species showed some co-aggregation with S. aureus strains or 
P. aeruginosa. The reason may be due to conditions of study, such as 
temperature, osmolality, acidic conditions, adhesion factors, type of strain, 
source of strain, growth of culture, technique and / or others. 
The current study was incompatible with the findings of Zakaria Gomaa 
(2013), which observed the highest ability of some probiotic Lactobacillus 
species, e.g. L. casei, L. paracasei, L. plantarum and others to adhere and 
aggregate with some pathogenic microorganisms, such as S. aureus (22.10 - 
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48.88%), Proteus vulgaris (22.19 - 45.76%) and Candida albicans (27.55 - 
59.37%), respectively. 
In addition, the current study examined the ability of probiotic Lactobacillus 
species to inhibit adherence of human skin pathogens in vitro. LAB produce 
several substances, e.g. organic acids, bacteriocins, diacetyl and H2O2 
(Millette et al., 2008; Lengkey and Adriani, 2009). Modified MRS limits acid or 
other bio-products production of these products by LAB. Therefore, the 
reduction of adherence of pathogens by probiotics in modified MRS is 
probably due to interaction between the bacteria rather than the effect of the 
LA. S. epidermidis and S. aureus have the ability to produce polysaccharide 
intracellular adhesion (PSIA) molecules on the surfaces (StepanoviI  et al., 
2007), which allowed them to form biofilms. This structure is very important in 
contributing to the virulence of Staphylococcus (Satorius et al., 2013). 
Moreover, P. aeruginosa also demonstrated strong adherence and biofilm 
formation compared to other bacteria. P. aeruginosa produces a mucoid 
exopolysaccharide matrix with alginate, as well as other structures , such as 
lipopolysaccharide (LPS) (Gupta et al., 1994), and filament surface 
appendages, pili and flagella (Drake and Montie, 1988). These surface-
associated structures play an important role in their adherence, and are 
called adhesion factors. Gupta and Garg (2009) reported that probiotic 
Lactobacillus species can produce low molecular weight antimicrobial agents, 
adhesion inhibitors, such as bio-surfactants and, as well as several 
antimicrobial substances, e.g. organic acids, bacteriocins, H2O2, CO2, 
diacetyl. Many bio-surfactants, e.g. surlactin, have a glycoproteonaceous 
character (Gołek et al., 2007). Van Hoogmoed et al. (2004) revealed that bio-
                                                                                                                      
Chapter 3                      Probiotic aggregation, biofilm and adhesion to keratin 
 
105 
 
surfactants are very important because they decrease the colonisation sites 
of pathogens and overlap with the microbial adhesion. Bio-surfactants play 
an important role in the regulation of the adhesion of probiotic lactobacilli  to 
host cells. Bio-surfactants are important in reducing adhesion and biofilm 
formation by Staphylococcus strains (Walencka et al., 2008). Moreover, 
Pascual et al. (2008) demonstrated that some probiotic Lactobacillus species 
play this protective role by producing antimicrobial substances, such as 
H2O2, bacteriocins, and organic acid (LA and AA), and bio-surfactants, which 
inhibit the growth of pathogens. 
With regard to Pr. acnes, Burkhart and Burkhart (2003) elucidated that Pr. 
acnes live in a population of various bacteria that coat themselves inside an 
extracellular polysaccharide lining, which they secrete after adherence to the 
surface. This layer (glycocalyx polymer) acts as a protective exo -skeleton 
and helps as a natural barrier and in addition, it limits effective antimicrobial 
concentrations in the biofilm micro-environment. In the current study, Pr. 
acnes exhibited high biofilm formation. The reason may be due to the 
presence of a glycocalyx polymer layer. 
In the case of biofilm formation with mixed cultures of bacterial strains, 
inoculation of probiotic Lactobacillus species at the same time as bacterial 
human skin pathogen strains had more effect on adherence reduction, but 
without any significant differences (P > 0.05) compared to inoculation of 
probiotic Lactobacillus species with pathogens thirty minutes before. Comelli 
et al. (2002) and Tahmourespour et al. (2011) demonstrated that the 
reduction of adherence may be due to interaction of bacteria and the 
colonisation of the adhesion site with probiotic Lactobacillus species. 
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Furthermore, Lactobacillus species were able to modify the proportion of 
pathogens within the biofilm. Comelli et al. (2002) indicated that the reduction 
of pathogens can be due either to competition for adhesion sites or to other 
growth factors. In another study, Meurman et al. (1995) observed the 
inhibitory activity of some Lactobacillus species against pathogens in low pH. 
Finally, results with modified MRS were generally the same as the results 
with unmodified MRS, although there were some minor differences in the 
rates of results. 
As regards adhesion to keratin, P. aeruginosa displayed significant 
differences (P < 0.05) in comparison with other bacterial strains, such as S. 
aureus, Pr. acnes, L. casei and L. plantarum. The reason may be the nature 
of these bacterial cells or other determinants. The cell wall structure of P. 
aeruginosa contains several components, e.g. flagella and pili, which play an 
important role in the adhesion (Drake and Montie, 1988). These factors are 
very important for the pathogenesis of bacteria in adhering to and damaging 
mucosal epithelia, traumatized tissue and burn infections (Johanson Jr et al., 
1980). Some Staphylococcus strains demonstrated adherence with keratin 
because these strains contain many substances, such as PSIA and 
proteinaceous factors, which allowed them to form biofilms (StepanoviI et al., 
2007). These substances are very important for Staphylococcus adherence 
in human skin (Fitzpatrick et al., 2005; Toledo-Arana et al., 2005). In addition, 
O’Brien et al. (2002) showed that Staphylococcus, especially S. aureus, has 
a surface-expressed protein, clumping factor B (CLFB), which promotes 
adherence to immobilized epidermal cyto-keratins in vitro. These factors are 
                                                                                                                      
Chapter 3                      Probiotic aggregation, biofilm and adhesion to keratin 
 
107 
 
very important for the severity and pathogenicity of bacteria in the incidence 
of infections (Gotz, 2004). 
Pr. acnes revealed adherence with keratin because this bacterium contains 
an important structure, the so-called glycocalyx polymer (glue). Burkhart and 
Burkhart (2007) indicated that Pr. acnes contained a glue which allows 
adherence to follicular walls. This glue is secreted by Pr. acnes and presents 
a sebum composition. 
In confirmation, Tareb et al. (2013) mentioned that the adhesive capacities of 
probiotic Lactobacillus species were also displayed at significant levels in GIT 
cells, mucin and extra-cellular matrix material (in vivo). 
 
3.5  Conclusions 
There was significant auto-aggregation among all bacterial groups. L. casei 
was exhibited the weakest co-aggregation with all of the human bacterial skin 
pathogens tested. Species of different bacteria were more adherent alone 
than when mixed with other species, suggesting that they form a more robust 
biofilm. When mixing probiotic Lactobacillus species with pathogens biofilm 
formation and adhesion of pathogenic bacteria were reduced.  Strains that are 
adherent to human keratin, the main protein component found in skin, can be 
readily identified, but this does not necessarily mean that they can be 
classified as a successful probiotic. Therefore, further studies are needed 
which focus on the identification and assessment of strains that exhibit 
activity against potential skin pathogens, and will also persist on the skin in 
vivo and be active there. 
Chapter 4          Antimicrobial activity of probiotic L. plantarum and hBD-2 
108 
 
 
Chapter 4 
Antimicrobial activity of probiotic 
Lactobacillus plantarum and human beta-
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The results have been presented at SFAM conference, 1st - 4th July, Cardiff, 
UK and the abstract published in the conference proceedings. In addition, the 
results have also been presented at V International Conference on 
Environmental, Industrial, and Applied Microbiology, Medicine College, 
Madrid University, Madrid, Spain, 2nd - 4th October 2013 and and the abstract 
published in the conference proceedings.  
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Chapter 4: Antimicrobial activity of probiotic Lactobacillus plantarum 
and human β-defensin-2 (hBD-2) against bacterial human skin 
pathogens 
 
4.1  Introduction 
L. plantarum is the most prevalent species in most naturally fermented foods 
and has the ability to block receptors for Gram negative bacteria, as well as 
having an important antimicrobial effect (Zarazaga et al., 2004). Antimicrobial 
peptides (AMPs) are a group of predominantly small cationic polypeptides 
(less than 100 amino acids) that are classified together because of their 
ability to impede the growth of microorganisms. AMPs have been known for 
more than twenty years (Ganz, 2003; Bardan et al., 2004). AMPs, especially 
defensins, have a broad range of antimicrobial activity against different 
bacteria, fungi and viruses (Lehrer et al., 1993). Defensins and cathelicidins 
are the two major groups of epidermal AMPs that possess inherent 
antimicrobial activity (Zaiou et al., 2003). AMPs were the first observed in 
mammalian cutaneous tissues when cathelicidins were discovered in porcine 
wound fluid (Gallo et al., 1994). Defensins are small cationic, cysteine-rich 
peptides with a wide range of antimicrobial activities. Defensins are divided 
into α-, β- and θ- subfamilies (Ganz, 2003) and exhibit a high level of activity 
against both Gram positive and Gram negative bacteria, fungi and certain 
enveloped viruses, as well as immune cells, such as neutrophils, 
macrophages and some epithelial cells in the small intestine (Kagan et al., 
1994). Jones and Bevins (1992) observed that six α-defensins have been 
identified. Human α-defensins 1 - 4 are known as human neutrophil peptides, 
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and are associated with human neutrophils. Human α-defensins 5 and 6 are 
expressed in Paneth cells of the GIT and epithelial cells of the female UGT. 
HBD have been identified in numerous cells, including neutrophils and 
epithelial cells (Liu et al., 2002). Valore et al. (1998) clarified that hBD 1 - 4 
have been identified in humans. HBD-1 (36 amino acid) is constitutively 
produced by epithelial tissue in the respiratory system and UGT. HBD 2 - 4 
have been isolated from lesional scales of psoriatic cutaneous tissues 
(Harder et al., 1997). Yand et al. (2001) reported that hBD-2 (41 amino acid ) 
and hBD-3 (45 amino acid) expression is inducible (stimuli) by external 
agents, e.g. IFN-1β, IFN-γ, TNF-α, Gram negative and Gram positive 
bacteria. 
HBD-2 is a cysteine-rich cationic peptide of the innate immune system that 
serves as an AMP. HBD-2 contains forty one amino acids with low molecular 
weight, and was first discovered in human skin in the 1990s (Schröder and 
Harder, 1999). The expression of hBD-2 is prevalently observed in epithelial 
cells of cutaneous tissue (Butmarc et al., 2004), the GIT (Wagner, 2000) and 
respiratory system (Bals et al., 1998). Wehkamp et al. (2004) mentioned that 
there are specific probiotic bacteria, such as E. coli Nissle strain 17 which 
potentiate and up regulate expression of hBD-2 in Caco-2 cells. Moreover, 
Schlee et al. (2008) showed that the induction of hBD-2 by a probiotic 
cocktail of four Lactobacillus species (L. acidophilus, L. paracasei , 
L. delbrueckii spp. bulgaricus and L. plantarum), three Bifidobacterium 
species (B. longum, B. infantis and B. breve) and one Streptococcus 
salivarius subsp. thermophilus. In addition, pathogen-associated molecular 
patterns (PAMPS) molecules, e.g. bacterial flagella antigens, LPS, PG and 
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DNA are capable of inducing hBD-2 expression in epithelial cells (Takahashi 
et al., 2001; Platz et al., 2004; Vora et al., 2004). 
Pathogens (Gram positive and Gram negative) contain several genes, such 
as mprF, dlt, pmr, pagp and others to protect themselves from hBD-2 and 
other host defense peptides (Nizet, 2006). Dlt types catalyse the introduction 
of D-alanine into TA, staphylococcal cell wall polymers, whereas the mprF 
gene is involved in modification of membrane phosphatidylglycerol with L-
lysine (Peschel et al., 1999; Peschel et al., 2001). Furthermore, Peschel et al. 
(1999) and Peschel et al. (2001) demonstrated that esterification of cell 
envelope components with amino acids leads to a decrease in the net 
negative surface charge of the bacteria, and consequently to the repulsion of 
positively charged AMPs.  
Interestingly, sodium chloride (NaCl) may be responsible for the decrease in 
mucosal defenses. NaCl reduces killing of bacteria by a number of defensins, 
including hBD (Bals et al., 1998; Singh et al., 1998). Interestingly, 
Krishnakumari et al. (2006) reported that the inhibitory effect on the activity of 
hBD depends on the concentration of NaCl and the concentration of the 
peptide. The antimicrobial activity of most hBD-2 are decreased in the 
presence of NaCl concentrations (Bals et al., 1998). Therefore, hBD2 may 
exhibit antimicrobial activity at physiological salt concentrations if its 
concentration is sufficiently high.  
The aims of the current study were to determine the antimicrobial activity of 
probiotic L. plantarum, the effectiveness of a mixture of probiotic L. plantarum 
with hBD-2 and different concentrations NaCl, and synergism between the 
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probiotic L. plantarum and hBD‐2 against pathogens, such as S. aureus, 
MRSA and P. aeruginosa strains. 
 
4.2  Materials and methods 
4.2.1  Materials  
L. plantarum was selected in the current experiment as it showed the 
greatest antimicrobial activity, aggregation and biofilm formation against 
bacterial human skin pathogens, as reported in Chapters 2 and 3 . 
Recombinant hBD-2 (100 µg / ml) was supplied by Pepro Tech, (Pepro Tech 
Inc., UK) and tested against different bacteria, such as P. aeruginosa, S. 
aureus strains (3761 and 4137), MRSA 12493 strain and L. plantarum 41605 
(Table 2.1).  
Staph 110, nutrient agar and broth (NA and NB), Pseudomonas isolation 
agar (PIA), MRS agar and broth, sodium phosphate buffer (SPB; 8.2 mM 
Na2HPO4, 1.8 mM KH2PO4, pH 7.4) and 2 M NaCl, Oxoid (Oxoid, UK) were 
used. In addition, Lysostaphin (1 mg / ml) was supplied by Sigma Aldrich, 
(UK). Molecular grade water was used (Fisher Scientific, UK Ltd.). 
 
4.2.2  Methods  
Recombinant hBD-2 was dissolved in molecular biology grade water at a 
concentration 100 µg / ml and stored at - 20 °C. A single colony of MRSA, P. 
aeruginosa and S. aureus strains was used to inoculate 5 ml of NB. In 
addition, a single colony of L. plantarum was used individually to inoculate 5 
ml of MRS broth. After that, broth cultures were incubated at 37 °C for 18 - 20 
h. Broths were centrifuged at 4300 × g (Harrier 18 / 80, MSE, UK.) at 4 °C for 
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10 minutes. The bacterial cell pellet was re-suspended in SPB. This 
procedure was modified, as is described previously by Huang et al. (2007). In 
short, the optical density of the suspension was adjusted to 0.2 at 620 nm 
(107 CFU / ml) by adding an appropriate volume of SPB. Reaction mixtures 
(a total volume 20 µl) from overnight broth culture bacteria from each 
bacteria and hBD-2 (2.5, 5, 10, 20 and 30 µg / ml) were incubated at 37 °C 
for 2 and 5 h. Following incubation, the samples were diluted 5000-fold in 
SPB, and 10 µl of this dilution was plated onto both NA and Staph 110 agar 
(for MRSA and S. aureus strains), NA and PIA (for P. aeruginosa), and MRS 
agar (for L. plantarum). After incubation overnight at 37 °C, colonies were 
counted. Using the same method and procedure as above, hBD-2 and L. 
plantarum were used together (synergistically) against pathogens. In addition, 
hBD-2 (5 µg / ml) was mixed with different NaCl concentrations (0, 25, 50, 
100 and 150 mM), and applied on: P. aeruginosa and S. aureus 4137, using 
the same procedure as above. After incubation 18 - 20 h at 37 °C, the 
microbial colonies were counted. HBD-2 and L. plantarum were also used, 
and mixed with different NaCl concentrations, as described above. All tests 
were replicated three times under the same identical experimental conditions. 
The percentage viability following exposure to hBD-2 and/ or L. plantarum 
was calculated as follows: 
[(mean number of colonies observed on treated plates/ number of  colonies 
observed on non-treated control plates) x 100]. 
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4.2.3  Effect of L. plantarum and hBD-2 on mprF and dlt genes 
mediating hBD-2 resistance in MRSA 33591 
hBD-2 and L. plantarum were used to measure the effect of hBD-2 and L. 
plantarum on mprF and dlt gene expression because when used together in 
a culture-based study, MRSA viability was reduced to 71% of control levels, 
as reported in section 4.3.1 (Figure 4.3, A). 
 
4.2.4  Modulation of mprF gene by hBD-2 and L. plantarum 
4.2.4.1  RNA extraction from bacterial cells 
MRSA 33591 cells (107 CFU / ml) were cultured at 37 °C for 18 - 20 h in 20 
ml nutrient broth. Cells were harvested by centrifuging at 2772 × g (Harrier 
18 / 80, MSE, UK) for 10 minutes, and washed twice using SPB. Pellets were 
re-suspended in 1 ml SPB. Recombinant hBD-2 (10 µg / ml) was mixed with 
a suspension of MRSA 33591 (1 ml a total volume), and incubated at 37 °C 
for 2 h. Total RNA was extracted using the Rneasy Protect Bacteria Mini Kit 
(Qiagen, UK). A control set was prepared and incubated at 37 °C for 2 h. The 
cells were centrifuged at 13000 ᵡ g (Heraeus Fresco 21 Microcentrifuge, USA) 
for 3 minutes, and washed twice using SPB. Cells were lysed by the addition 
of 1 mg / ml lysostaphin (30 µl), and incubation at 37 °C for 15 minutes. RNA 
was extracted and purified according to the manufacturer’s recommendations 
for bacteria RNA isolation protocol, using the optional step of using the 
RNase-free DNase Kits (Qiagen, UK), as outlined in Figure 4.1. 
Finally, RNA concentration and quality were evaluated using a NanoDrop 
spectrophotometer, as presented in Appendix 2 (Figure 2.1). RNA samples 
with low purity were discarded, and the extractions were repeated if required. 
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Four microliters of each RNA sample was electrophoresed in a 1 g / 50 ml 
agarose gel to appraise RNA integrity. Aliquots of RNA were stored in sterile 
1.5 ml micro-centrifuge tubes at - 80 °C until further analysis. L. plantarum 
and hBD-2 were also used against MRSA, according to the same procedure 
as described above. 
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Figure 4.1 Protocol for the extraction of total RNA from bacterial human skin 
pathogens, according to the manufacturer’s Rneasy Protect Bacteria Mini Kit 
(Qiagen, UK) recommendations. 
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4.2.4.2  Agarose gel electrophoresis  
In order to determine the quality of RNA, agarose gel electrophoresis was 
used. The gel was prepared by dissolving 1 g agarose into 50 ml Tris-acetate 
ethylene diamine tetraacetic acid (EDTA) buffer (1 ᵡ TAE) in a conical flask 
using a microwave oven on medium power for 2 - 3 minutes, until the 
agarose was completely dissolved. The molten agarose was poured into 
casting tray with a comb inserted. RNA samples (4 µl) were prepared by 
mixing them with RNA loading buffer (4 µl). The comb was removed when 
the gel was left to set. Hyper Ladder IV (3µl; Bioline, UK) was used. The 
ladder and samples were loaded into the gel’s wells. The gel was run at 90 V 
for 1 h. The RNA bands were visualized in a gel documentation system 
(Chemi Doc HR, UVP, UK) using ethidium bromide and UV light and images 
were captured. 
 
4.2.4.3  Reverse transcription and cDNA synthesis  
Reverse transcription (RTs) was performed to create a complementary 
deoxyribonucleic acid (cDNA). This was carried out using a High Capacity 
RNA-to-cDNA 50 ᵡ Kit (Fisher Scientific, UK Ltd.), according to the 
manufacturer’s instructions. The cDNA was prepared in 0.2 ml RNase- / 
DNase-free micro-centrifuge tubes The RNA (1 µg) was mixed with 1 μl RT 
(200 U / μl) and 10 μl of mixed deoxynucleotide triphosphates (dNTPs). 
Molecular grade water was added to a final volume of 20 μl. The contents 
were mixed gently and briefly centrifuged at 13000 ᵡ g for 30 seconds and 
tubes put in a Thermal Cycler System (Applied Biosystem, UK) at 37 °C for 1 
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h, followed immediately by 85 °C for 5 minutes. The reaction mixture was 
then stored at - 20 °C until use for qPCR. 
 
 4.2.4.4  Quantitative RT - PCR (qRT - PCR) 
qPCR was carried out to semi-quantitatively to analyse gene expression 
levels in the experiment relative to the reference gene (the control). PCR 
amplification was performed with primers, with pyruvate kinase (Pyk) as a 
housekeeping gene, and multiple peptide resistance factor (mprF) and D-
alanyl-lipoteichoic acid (dlt) as target genes (Table 4.2). As stated previously, 
these genes were targeted as they are responsible for bacterial resistance to 
hBD-2, and specific gene-targeting primers were designed using the mRNA 
sequences, which were obtained from a primer blast in the NCBI (National 
Centre for Biotechnology Information). The criteria for primer selection 
included the GC ratio, temperature and product length 
(http://ecom.mwgdna.com/services/home.tcl). Primers were obtained from 
Eurofins MWG Operon (MWG, Germany). The reaction mixture consisted of 
5 μl cDNA, 12.5 μl SYBR® green master mix (Qiagen, UK), 0.3 μl reference 
dye, 0.8 μl primer mix (10 pmol) and 6.4 μl molecular grade water to give a 
final volume of 25 μl for each reaction. Reactions were run in triplicate in 
three independent experiments. The geometric mean of the housekeeping 
gene was used as an internal control to normalize the variability in 
expression levels. PCR reactions were carried out using the following 
conditions: denaturant at 95 °C for 10 minutes, followed by 40 cycles, single 
cycle 95 °C for 20 seconds, annealing 52 °C for 30 seconds and amplification 
(extension step) at 72 °C for 1 minute. This was immediately followed with a 
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melting cycle of 95 °C for 15 seconds and 55 °C for 1 minute and of 95 °C for 
15 seconds. The PCR was run using an Applied Biosystems StepOne Plus 
real time PCR cycler equipped with StepOne software v2.1. 
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Table 4.1 Primers sequences (housekeeping and target genes) used for qRT-PCR reactions. 
 
Primer Primer sequence (5´…3´)  Product size (bp) Primer concentration (pmol) Accession No. 
mprF, F 5´-AGA CCA CCC GAT AAA AAC AAT C-3´ 114 10  HM140975.1 
mprF, R 5´-AGC GTC AAC AAT TAC ACC AC-3´                114 " " 
Pyk, F 5´-GCA TCT GTA CTC TTA CGT CC-3´ 90 " Theis et al. (2007) 
Pyk, R 5´-GGT GAC TCC AAG TGA AGA-3´ 90 " " 
dlt, F 5´-CAAG TGC GAC GAT TTA CA A C-3´ 129 " D86240.2 
dlt, R 5´-GTT GAA AGAC TAG GCG CAA-3´ 129 " " 
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4.2.4.5  Normalization of qRT - PCR data  
In most cases, the data were normalized using the instrument software with 
auto-normalization. However, the data were also normalized manually 
producing the relative quantification (RQ) values. The data was first 
normalized against the housekeeping gene (Pyk). This was achieved by 
subtracting the cycle threshold (CT) value of the housekeeping gene  from the 
CT value target genes (mprF and dlt) to produce the delta cycle threshold 
(ΔCT). The ΔΔCT values of each sample were then produced by subtracting 
the ΔCT of the control (vehicle control) from the ΔCT value for each treatment. 
The RQ of individual samples was then produced using the following 
equation: (RQ= 2−ΔΔCT). 
 
4.2.5  Statistical analysis 
Data were subjected to balanced analysis of variance (ANOVA) and post hoc 
LSD tests using Minitab v.16 and Statistical Package for the Social Sciences 
(SPSS). In addition, the numerical data for gene expression were analyzed 
using SPSS v.20 statistical software, using two-way ANOVA and univariate 
comparison post hoc tests (Fisher’s LSD). Data were shown as mean ± 
Standard Deviation (mean ± SD), and P < 0.05 was considered significant. 
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4.3  Results 
4.3.1  Results of hBD-2 alone, and hBD-2 mix with L. plantarum against 
some bacterial human skin pathogens 
Recombinant hBD-2 was observed to display a large amount of antimicrobial 
activity against the bacterial human skin pathogens used in the current study. 
Incubation with 10 μg / ml hBD-2 alone / with L. plantarum for 2 h was shown 
to kill a portion of the bacterial population. The percentage viabilities [(mean 
number of colonies/ number of colonies observed on non-treated control) x 
100)] with hBD-2 alone were as follows: S. aureus 4137 (26.33 ± 3.4%), 
aureus 3761 (23.87 ± 2.1%) and P. aeruginosa (23.28 ± 2.26%), as outlined 
in Figures 4.2 (A - C).  
With regards to the investigation of synergy between hBD-2 and L. plantarum, 
the percentage viabilities were demonstrated to be lower compared to hBD-2 
alone. The results were significantly different to those observed when only 
hBD-2 was used (P < 0.05), and were as follows: S. aureus 3761 (4.34 ± 
1.17%), S. aureus 4137 (9.46 ± 3.4%) P. aeruginosa 8626 (8.54 ± 2%), as 
outlined in Figures 4.2 (A - C). 
 
 
 
 
 
Chapter 4                 Antimicrobial activity of probiotic L. plantarum and hBD-2 
 
123 
 
 
 
 
Figure 4.2 Antimicrobial activity of different hBD-2 concentrations and L. plantarum 
against: (A) S. aureus 4137, (B) S. aureus 3761, and (C) P. aeruginosa 8626 when 
used without / with L. plantarum after 2 h. Values are presented as mean ± SD. 
Values with different superscript letters within experimental groups (i.e. with or 
without L. plantarum at each concentration) are significantly different, while mean 
values with different superscript numbers across different hBD-2 concentrations 
(either with/ without L. plantarum) are significantly different.  
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With regards to the investigation of hBD-2 (30 µg / ml; without L. plantarum) 
for 2 h, percentage viabilities of MRSA strains were as follows: MRSA 33591 
(35.53 ± 3.4%) and MRSA 12493 (39.56 ± 2.7%), as outlined in Figures 4.3 
(A - B).  
With regards to the investigation of synergy between hBD-2 and L. plantarum, 
the percentage viabilities were demonstrated to be significantly lower  
compared to hBD-2 alone (P < 0.05): MRSA 12493 (15.28 ± 1.9%) and 
MRSA 33591 (17.76 ± 3.4%), as outlined in Figures 4.3 (A - B). 
 
 
Figure 4.3 Antimicrobial activity of different hBD-2 concentrations and L. plantarum 
against: (A) MRSA 33591, MRSA and (B) 12493 when used without / with L. 
plantarum after 2 h. Values are presented as mean ± SD. Values with different 
superscript letters within experimental groups (i.e. with or without L. plantarum at 
each concentration) are significantly different, while mean values with different 
superscript numbers across different hBD-2 concentrations (either with / without L. 
plantarum) are significantly different. 
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Increasing the incubation period to 5 h incubation time (with / without L. 
plantarum) decreased the survival rate of the bacterial population. With 
regards to the investigation of hBD-2 (10 µg / ml; without L. plantarum) for 5 
h, percentage viabilities of S. aureus strains/ P. aeruginosa were as follows: 
S. aureus 3761 (8.37± 2.59%), S. aureus 4137 (11.4 ± 2.6%), P. aeruginosa 
(12.56± 3.53%) as outlined in Figures 4.4 (A - C).  
With regards to the investigation of synergy between hBD-2 and L. plantarum, 
the percentage viabilities were demonstrated to be significantly lower 
compared to hBD-2 alone (P < 0.05): S. aureus 3761 (1.28 ± 1%), P. 
aeruginosa (1.76 ± 0.8%), S. aureus 4137 (2.37 ± 0.74%), as outlined in 
Figures 4.4 (A - C). 
 
 
 
 
 
 
 
 
 
Chapter 4                 Antimicrobial activity of probiotic L. plantarum and hBD-2 
 
126 
 
 
 
 
Figure 4.4 Antimicrobial activity of different hBD-2 concentrations and L. plantarum 
against: (A) S. aureus 4137, (B) S. aureus 3761, and (C) P. aeruginosa 8626 when 
used without / with L. plantarum after 5 h. Values are presented as mean ± SD. 
Values with different superscript letters within experimental groups (i.e. with or 
without L. plantarum at each concentration) are significantly different, while mean 
values with different superscript numbers across different hBD-2 concentrations 
(either with / without L. plantarum) are significantly different. 
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With regards to the investigation of hBD-2 (30 µg / ml; without L. plantarum) 
for 5 h, percentage viabilities of MRSA were as follows: MRSA 33591 (16.16 
± 4.2%) and MRSA 12493 (13.66 ± 3.16%), as outlined in Figures 4.5 (A - B).  
With regards to the investigation of synergy between hBD-2 and L. plantarum, 
the percentage viabilities were demonstrated to be significantly lower 
compared to hBD-2 alone (P < 0.05): MRSA 12493 (2.84 ± 0.98%) and 
MRSA 33591 (4.79 ± 1.97%), as outlined in Figures 4.5 (A - B). 
 
 
Figure 4.5 Antimicrobial activity of different hBD-2 concentrations and L. plantarum 
against: (A) MRSA 33591, and (B) MRSA 12493 when used without / with L. 
plantarum after 5 h. Values are presented as mean ± SD. Values with different 
superscript letters within experimental groups (i.e. with or without L. plantarum at 
each concentration) are significantly different, while mean values with different 
superscript numbers across different hBD-2 concentrations (either with / without L. 
plantarum) are significantly different. 
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With regards to the investigation of hBD-2 (10 µg / ml maximum 
concentration) for 2 and 5 h, percentage viabilities of L. plantarum were as 
follows: 63.5 ± 4.37% and 52.87 ± 4% for 2 and 5 h, respectively, as outlined 
in Figures 4.6 (A - B). 
 
 
 
Figure 4.6 Antimicrobial activity of different hBD-2 concentrations against L. 
plantarum after (A) 2 h, and (B) 5 h. Values are presented as mean ± SD. Values 
with different superscript letters between hBD-2 concentrations are significantly 
different. 
 
The statistical analyses observed high significant differences (P < 0.05) with 
all pathogens, incubation periods (2 h and 5 h), and treatments (hBD-2 and 
L. plantarum). 
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4.3.2  Influence of different sodium chloride concentrations on the 
bacterial activity of hBD-2   
To investigate the influence of different sodium chloride concentrations on 
the bacterial activity of hBD-2, different strains of bacterial human skin 
pathogens were incubated with hBD-2 (5 μg / ml) for 2 h incubation times 
with different NaCl concentrations, increasing from 25 to 150 mM. It was 
found that the survival of bacteria (mean ± SD) (numbers of viable colonies) 
gradually increased (25 - 150 mM) significantly (P < 0.05), as follows: from 
13.14 - 90.73% with S. aureus 4137 and 9.32 - 83.6% with P. aeruginosa, as 
described in Figure 4.7. 
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Figure 4.7 Effect of NaCl concentrations on the antimicrobial activity (number of 
viable colonies) for hBD-2 (5 μg / ml) against pathogens; (A) S. aureus 4137, and 
(B) P. aeruginosa 8626. The data presented as mean ± SD from (three independent 
experiments). Mean values with the same superscript letters within each hBD-2 
concentrations are not significantly different.  
 
4.3.3  Influence of different sodium chloride concentrations on the 
bacterial activity of hBD-2 and L. plantarum  
The results of L. plantarum and hBD-2 with NaCl against pathogens were 
significant compared to the non-treated control samples (P < 0.05), and 
reduced the viable counts (mean ± SD) compared with the results when 
using hBD-2 alone. The numbers of viable colonies was gradually increased 
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(25 - 150 mM), as follows: from 25.68 - 62.84% with S. aureus 4137 and 
28.26 - 67.9% with P. aeruginosa, as described in Figure 4.8. 
 
 
 
 
Figure 4.8 Effect of NaCl concentrations on the antimicrobial activity (percentage of 
viable colonies) for hBD-2 (5 μg / ml) and L. plantarum against pathogens; (A) S. 
aureus 4137, and (B) P. aeruginosa 8626. The data presented as mean ± SD from 
(three independent experiments). Mean values with the same superscript letters 
within each the following: control, hBD-2, L. plantarum, hBD-2 and L. plantarum with 
different NaCl concentrations are not significantly different. 
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4.3.4  Measurement of mprF and dlt gene expression using qRT-PCR 
The results with mprF and dlt gene expression using qRT - PCR, hBD-2 
alone and hBD-2 with L. plantarum together showed an up-regulation of the 
expression of the mprF and dlt genes in MRSA. The RNA of MRSA was 
successfully extracted, as outlined in Figures 4.9 - 4.10 and Appendix 2: 
Figure 2.2. cDNA was synthesized using conventional PCR assay and qRT - 
PCR. The observed results were that the MRSA cultured in the presence of 
hBD-2 alone and hBD-2 with L. plantarum displayed significant differences of 
mprF and dlt gene expression compared to controls. 
 
Figure 4.9 Agarose gel electrophoresis of RNA samples and amplification cDNA. L: 
ladder, (C): control without treatment, T: treatment (hBD-2), Pyk: pyruvate kinase 
gene (housekeeping gene), and mprF: modified peptide resistant factor gene (target 
gene). 
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Figure 4.10 Gene expressions for MRSA with the mixture of hBD-2 and culture of L. 
plantarum with some genes, and as follows: (A): MprF, and (B): dlt gene expression 
of MRSA 33591 was demonstrated up-regulation with hBD-2, L. plantarum and 
mixture hBD-2 with L. plantarum. (C): control without treatments. The data are mean 
± SD from three independent experiments, mean value with same superscript letters 
within each gene are not significantly different. 
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4.4  Discussion                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   
Cationic AMPs are necessary compounds of the immune system. AMPs 
protect the host by exerting bactericidal activity, modulating the immune 
response, molecular signaling and facilitating the communication between 
innate and acquired immunity (Goytia et al., 2013). Currently, researchers 
have observed that there are interactions between host mucosal cells and 
extracellular proteins / antimicrobial peptides produced by various probiotic 
genera, e.g. Bifidobacterium, Lactobacillus and E. coli strain Nissle 1917 
(Sánchez et al., 2010). Scheel et al. (2008) reported that numerous 
Lactobacillus strains and other probiotic bacteria called VSL#3 stimulate the 
secretion of hBD-2 into the culture media. Recombinant hBD-2, in a way 
similar to that of all defensins, exhibits antimicrobial activities against Gram 
positive and Gram negative bacteria (Veldhuizen et al., 2008). 
In the current study, hBD-2 activity was tested against limited number of 
strains of S. aureus and P. aeruginosa. 
The present study observed that increasing incubation time from 2 h to 5 h 
with hBD-2 increased its effectiveness compared with 2 h incubation, 
especially with 10 μg / ml concentrations, while it was less effective at 2.5 
and 5 μg / ml concentrations. Incubation time at 5 h with 2.5 and 5 μg / ml 
hBD-2 was found to have a similar bactericidal effect as at 2 h incubation 
time with 5 μg / ml and 10 μg / ml concentration, respectively, for most 
species.  
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Interestingly, MRSA showed no effect with low hBD-2 concentrations, such 
as 2.5 and 5 µg / ml, but was affected when the concentration was increased 
to 10 - 30 μg / ml. Furthermore, the activity increased when L. plantarum was 
mixed with different hBD-2 concentrations, compared with the activity of hBD-
2 alone. The reason for the small effect may be due to some resistant factors 
in MRSA, such as altered cell surface charge, production of proteases or 
external trapping of AMPs and others (Nizet, 2006). Furthermore, the activity 
increased when L. plantarum was mixed with different hBD-2 concentrations, 
compared to the activity of hBD-2 alone.  
The current study revealed that S. aureus was sensitive to hBD-2. Pazgier et 
al. (2006) reported that the antimicrobial activity of recombinant hBD-2 is 
largely dependent on the type of microorganism. For example, in this study 
recombinant hBD-2 was more effective against S. aureus and P. aeruginosa 
than against MRSA strains. Several studies conducted to evaluate the 
effectiveness of recombinant hBD-2 against pathogens demonstrated 
susceptibility of these microorganisms and were compatible with the findings 
of the current study. Among these studies were those conducted by 
Midorikawa et al. (2003) and Harder et al. (2000), who described the 
susceptibility of S. aureus and mucoid P. aeruginosa to hBD-2. In addition, 
Iwase et al. (2010) and Sandiford and Upton (2012) observed that there were 
some AMPs produced from S. epidermidis, epidermicin biosynthesis serine 
protease (Esp), which were able to kill some Gram positive bacteria. On the 
other hand, some studies were not compatible with the current study, such as 
the study conducted by Peschel et al.(2001), which reported that the 
pathogen S. aureus is insensitive to defensins, and that the reason may be 
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due to mprF gene or others. MprF thus constitutes a novel virulence factor, 
which may be of general importance for pathogens and represents a 
potential new method of attacking different multidrug resistant bacteria. 
Moreover, this study showed that combining hBD-2 and L. plantarum was 
more effective compared to hBD-2 alone, particularly when the incubation 
time increased to 5 h. The reason may be due to fact that the mechanism of 
action for both on target the cell membrane.  
In addition, L. plantarum produces many substances, such as organic acids, 
which may have an impact on pathogens (Fu and Mathews, 1999) and may 
act together with hBD-2 and other substances against pathogens. Chen et al. 
(2005), demonstrated that there is synergistic effect of AMPs, such as hBDs 
1, 2 and 3 and acidic pH against S. aureus and E. coli. This effect was 
significantly better and enhanced in acidic conditions. 
AMPs strongly disturb the anionic lipid component of bacterial membranes in 
the presence of acidic pH (organic acids) and cause bacterial lysis. This 
opinion was supported by Mason et al. (2006). Alakomi et al. (2000) revealed 
that the mode of action for lactic acid has been observed to permeabilize the 
outer cell membrane of Gram negative bacteria by causing the release of 
important substances, e.g. LPS, leading to loss of viability. As a result of 
permeabilization, the action of LA may facilitate the activity of other 
antimicrobial factors. In addition, Sugiarto and Yu (2004) reported that the 
mode of action for hBD-2 represented changes of the electric potential. 
Peptides will pass across the cell membrane and consequently accumulate 
into dimers. Pore complex will be formed because of the breaking of the H+ 
bonds between the amino acids in the terminal end of the strands connecting 
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AMPs (e.g. defensins) monomers. Formation of pore complex will cause 
membrane depolarization and cell membrane lysis, followed by an efflux of 
cellular substances and the death of bacterial cells (van Dijk et al., 2008). 
In the current study, L. plantarum demonstrated significant resistance to 
hBD-2 compared to pathogens. Hugo et al. (2006) observed that some non-
pathogenic and potentially probiotic Lactobacillus species, such as L. 
delbrueckii subsp. Lactis, were also able to resist the inhibitory effect of 
antimicrobial peptides, for example hBD-2. Furthermore, Venkatesan et al. 
(2012) observed that probiotics had high antibiotic resistance activity, 
antimicrobial activity and antioxidant activity. This may be due to several 
causes, whether in vivo or in vitro, such as interference of the chosen 
probiotic microorganisms with the host's cells and the immune system 
response (Hugo et al., 2006), the type of microorganisms, the conditions of 
study and other factors. 
In relation to the effect of NaCl on hBD-2 activity, the current study 
demonstrated that NaCl decreased hBD-2 activity, especially with high NaCl 
concentrations (150 mM). Inactivation of hBD-2 may be due to the salt 
combining with protein, and causing precipitation. Kuehner et al. (1996) 
mentioned that a molecular thermodynamic model was developed for salt 
induced protein precipitation. Several studies are compatible with the current 
study, such as that conducted by Goldman et al. (1997), who mentioned that 
the antimicrobial activity of hBD-2 is reduced by using NaCl concentration, 
and reported that even 150 mM of NaCl was sufficient to reduce the bacterial 
effect of hBD-2 by at least 15 fold. 
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When L. plantarum and hBD-2 were mixed with NaCl, some antibacterial 
activity against pathogens remained; this may be due to  L. plantarum not 
being adversely affected by such conditions. Rao et al. (2004) reported that 
Lactobacillus species, such as L. plantarum possess the ability to grow at 
high NaCl concentration and different initial pH values. At the same time, 
Lactobacillus strains were able to ferment glucose in up to 8% NaCl and 
produce antimicrobial substances, e.g. LA and bacteriocins.  
L. plantarum was selected for the present study because of i ts ability to 
produce antimicrobial substances, for example LA, and to tolerate harsh 
conditions. L. plantarum performed better than other species of Lactobacillus, 
and has been shown to diminish the negative effect of pathogens (Leroy and 
De Vuyst, 2004; Anderson et al., 2010). 
The effect of hBD-2, L. plantarum and mixture L. plantarum on expression of 
the mprF and dlt genes were different. The expressions of mprF and dlt 
genes were increased compared with the negative control (i.e. no probiotic or 
hBD-2). The results showed that the expression of inducer mprF was strongly 
up-regulated; no significant differences were observed between expression 
of this gene and dlt gene when hBD-2 and L. plantarum were used 
synergistically. 
Interestingly, mprF and dlt gene expression were increased in level but 
without functioning. This may be due to the mode of action of hBD-2 and 
antimicrobial substances (produced by L. plantarum) in acidic pH, and play 
an important role by overlapping with cell wall syntheses (obstruction). Acidic 
pH is better and encourages peptides in function (Chen et al., 2005). The 
results in the current study are supported with a study conducted by Chen et 
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al. (2005), which demonstrated that there is synergistic effect of AMPs, such 
as hBD-1, 2 and 3 in acidic pH conditions against S. aureus and E. coli. This 
effect was significantly enhanced in acidic conditions (pH 4.6), as well as 
resembling normal skin pH. Seidenari and Giusti (1995) and Ring et al. (2000) 
reported that the significance of pH in the skin is that it acts as a defence 
mechanism against pathogens. In addition, the alteration of skin pH is one of 
the pathological factors involved in skin conditions such as eczema. However, 
in the present study was found that the antibacterial activity of hBD-2 could 
be to some extent enhanced in acidic conditions (organic acids, bacteriocin 
and others produce by L. plantarum).A study conducted by Lemaire et al. 
(2007) observed that low pH prevents the expression of some genes 
responsible for cell wall synthesis, such as those responsible for PBP2. In 
this case, non-functioning PBP2 is produced in conjunction with reduced 
recruitment of PBP2a in facilitating resistance. This may be due to the effect 
of acidic pH on genes such as mprF and dlt, as well as differences in 
expression to mprF and dlt genes. However, further investigations with a 
wide range of MRSA strains are required to explain this. 
As for dlt gene, D-alanine (cationic charge) may be no transfer to techoic 
acids (anionic charge) to reduce negative charge, and then increase affinity 
between hBD-2 and cell wall. This case is leading to increase affinity 
between MRSA cell wall and hBD-2 (Nizet, 2006), and other antimicrobial 
substances (organic acids, bacteriocins and others). On the other hand, 
Lehrer and Ganz, (2002) mentioned that in the case resistant bacteria, the dlt 
gene exists in other Gram positives, such as S. aureus and is involved in the 
transfer of D-alanine into TAs. Bacteria overexpressing the dlt gene may 
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possess large amounts of d-alanine esters in their TA, thus binding cationic 
peptides less well and as a result may be less sensitive to the effects of 
AMPs such as hBD-2. Moreover, Peschel and Vincent (2001) demonstrated 
that the mprF gene mutant was more sensitive to killing by defensins, and 
was found to lack a positively charged membrane phospholipid derivative 
enriched in the amino acid L-lysine. Furthermore, Peschel et al. (2001) 
observed that increase binding of AMPs with bacterial cell wall in the case of 
absence lysylphosphotidylglycerol. 
 
4.5  Conclusions 
The current study was observed that hBD-2 had a significant impact on 
different bacterial human skin pathogens, particularly with a long incubation 
period at 37 °C for 5 h. In addition, this study suggests that when hBD-2 is 
used in conjunction with L. plantarum, synergistic antimicrobial activities are 
observed, in particular against MRSA, which frequently colonizes the skin; 
this synergistic / additive effect is possibly influenced by acidic conditions 
caused by the growth of L. plantarum, which may have corresponded to 
normal skin pH although this was not confirmed with appropriate 
measurements during the study. Therefore, further study of the effect of pH is 
required. Moreover, although there was a negative impact on the 
effectiveness of hBD-2 in the presence of NaCl, especially at high 
concentrations (150 mM), there was a positive impact when hBD-2 and L. 
plantarum were used with NaCl against pathogens. Finally, there is the 
importance of hBD-2 in getting rid of bacterial infections through the results of 
Chapter 5               Antimicrobial activity of probiotic L. plantarum and hBD-2s           
141 
 
gene expression, which demonstrated up-regulation of the mprF and the dlt 
genes in MRSA. 
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aureus (MRSA) to beta-Lactam (β-lactam) 
antibiotics by probiotic Lactobacillus 
plantarum  
 
The results have been presented at V International Conference on 
Environmental, Industrial, and Applied Microbiology, Medicine College, 
Madrid University, Madrid, Spain, 2nd - 4th October 2013 and the abstract 
published in the conference proceedings. The results have also been 
published as paper (Restoration of the susceptibility of methicillin-resistant 
Staphylococcus aureus (MRSA) to β-Lactam antibiotics by probiotic 
Lactobacillus plantarum (L. plantarum). In: A. Méndez-Vilas, An Industrial, 
medical and environmental applications of microorganisms: current status 
and trends. Wageningen Academic Publishers, ISBN: 978-90-8686-243-6, 
ISBN E-book: 978-90-8686-795-0, pp. 585 - 589. 
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Chapter 5: Restoration of the susceptibility of methicillin-resistant 
Staphylococcus aureus (MRSA) to beta-Lactam (β-lactam) antibiotics 
by probiotic Lactobacillus plantarum  
 
5.1  Introduction 
S. aureus is an important bacterium amongst other bacterial pathogens in 
humans and animals, and it causes a broad spectrum of diseases, ranging 
from skin and soft tissue infection, bone / joint infection, myositis, 
endocarditis, pneumonia and bacteraemia, to life threatening infections like 
necrotizing fasciitis, septicaemia and toxic shock syndrome-1 (TSS-1) (Lowy, 
1998). Fluit et al. (2001) reported that some S. aureus infections represent a 
challenge to treatment, particularly those genera which contain MRSA and 
related beta-lactams. Currently, MRSA is spreading endemically and has 
been diagnosed in most hospitals around the world, accounting for 40 - 70% 
of global nosocomial S. aureus infections in intensive care units (Blomquist, 
2006). In the last decade, MRSA has become an increasing danger, not only 
in hospitals, but also in general society (Fridkin et al., 2005; Moran et al., 
2006). Infections caused by MRSA represent a serious threat to humans and 
animals and they are of major concern to health authorities. In addition, 
MRSA has been identified as the main nosocomial pathogen in several parts 
of the world (Simor et al., 2001; Graffunder and Venezia, 2002). Libert et al. 
(2008) reported that in addition to its influence on farm animals, MRSA 
infections in humans have been associated with increased mortality and 
morbidity and increased length of hospitalization. Roghmann and McGrail 
(2006) found that in the period 2000 - 2006 the prolonged therapeutic use of 
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antibiotics in humans and the administration of antibiotics as promoters of 
growth in the diet of farm animals have been associated with the 
development of antimicrobial-resistant bacteria. The majority of antimicrobials 
(antibiotics) are given to patients randomly and without previous consultation 
by physicians, and this has led to an emergence of methicillin resistance. 
One of the main strategies which has developed recently to solve this 
problem is the use of probiotic microorganisms (Tagg and Dierksen, 2003; 
Roghmann and McGrail, 2006). Alvarez-Olmos and Oberhelman (2001) 
observed that antibiotic resistance is almost always attributable to S. aureus 
infections where there has been chronic exposure to antibiotics. This has led 
to a renewed emphasis on environmental methods to prevent diseases, 
which makes probiotic microorganisms a very interesting area for more 
research. Probiotic bacteria, for example LAB, are promising because they 
generate antimicrobial substances, e.g. bacteriocins and some enzymes, that 
are able to prevent biofilm formation and the growth of pathogens. For 
example, Ammor et al. (2006) reported that some probiotic LAB are highly 
antagonistic to biofilm forming MRSA. Maragkoudakis et al. (2006) reported 
that useful effects were conferred by a probiotic of Lactobacillus species 
through the inhibition of Gram positive and Gram negative pathogenic 
bacteria. Charlier et al. (2008) demonstrated that even low acidifying strains 
of the probiotic Lactococcus lactis were able to exert inhibitory effects during 
the early stages of culture. 
Probiotic LAB were reported to exert a  highly inhibitory effect on S. aureus 
growth. Many reasons have been proposed for the inhibition of S. aureus by 
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probiotic LAB substances, such as the production of organic acids (Gilli land 
and Speck, 1977), bacteriocins, H2O2 and others (Velraeds et al., 1996). 
There are two types S. aureus, methicillin susceptible S. aureus (MSSA) and 
methicillin resistant S. aureus (MRSA). MSSA possesses the mecA gene, 
which encodes four types of PBP (1 - 4) (Ubukata et al., 1989). In MSSA 
strains, all PBPs are inactivated in the presence of β-lactam antibiotics, 
leading to cell wall death that is caused by the inhibition of the transpeptidase 
step reaction, one of the final steps in cell wall biosynthesis. In contrast, 
MRSA survives in the presence of β-lactams because of an extra PBP 
(PBP2a) that is specific to MRSA and has a low binding affinity to all β-
lactams. It retains its activity in the presence of β-lactams, allowing MRSA 
cell wall biosynthesis to continue. The MecR1-MecI system was identified as 
a regulatory factor for PBP2a expression (García-Castellanos et al., 2004). 
Furthermore, a genetic mobile element containing the mecA gene, called 
staphylococcal chromosome mec (SCCmec), is believed to be transferred 
between staphylococci (Hanssen and Ericson Sollid, 2006). Deurenberg and 
Stobberingh (2008) demonstrated that SCCmec is classified into seven 
groups, and SCCmec is suitable for epidemiological studies of MRSA. 
The aims of the current study were to evaluate the antimicrobial activity of 
some probiotic Lactobacillus species against MRSA and, in addition, to 
explore the role of probiotics in the modulation of methicillin resistance in 
MRSA, using culture supernatant of L. plantarum. 
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5.2  Material and methods 
Methicillin sodium sulphate (C17H20N2O6S) powder (1 mg / ml) was 
purchased from (Sigma-Aldrich Ltd., UK). Antibiotic discs were obtained from 
Oxoid, UK. Antibiotics include cefotaxime 30 μg (CTX), ampicillin 10 μg 
(AMN), tetracycline 30 μg (TET), ciprofloxacin 10 μg (CIP), azithromycin 15 
μg (AZM), lincomycin 2 μg (MY), streptomycin 10 μg (S), chloramphenicol 20 
μg (CHP), gentamicin 10 μg (GN) and sulpha trimethoprim 25 μg (SXT). In 
addition, MHB, MRSB and NB were used. Several acids were used in the 
current study: lactic acid (88%; LA), acetic acid (100%; AA), citric acid 
(99.5%; CA), and propionic acid (99%; PA), which were supplied by Sigma 
(Sigma-Aldrich Ltd., UK). Sodium lactate 71% was also used, and supplied 
by Merck - BDH, UK. Microtitre plates were obtained from Steri lin Ltd. (Stone, 
UK). PBS tablets and lysostaphin provided by Sigma, UK. All tests were 
replicated three times under the same identical experimental conditions. 
 
5.2.1  Lactobacillus species and methicillin resistant S. aureus 
used in this study 
The following Lactobacillus species were used in the current study: L. 
plantarum, L. casei and L. acidophilus (107 CFU / ml). These species were 
selected because they showed the greatest antimicrobial activity, 
aggregation, biofilm formation against bacterial human skin pathogens , as 
reported in Chapter 4. Three strains of MRSA (106 CFU / ml) were also used, 
as follows: MRSA 12493, MRSA 33591 and MRSA 25691, as outlined in 
Table 2.1.  
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5.2.2  Agar well diffusion and agar spot methods 
To assess the antimicrobial activity of selected probiotic Lactobacillus 
species, several Lactobacillus species and MRSA strains were used in this 
experiment. L. casei, L. acidophilus and L. plantarum were tested as the 
probiotics, as listed in Table 2.1. In addition, MRSA 33591 and MRSA 12493 
were used as the pathogens. Lactobacillus species were grown on MRSB 
and MRS agar, MRSA strains were grown on NB, as described in sections 
2.2.4 - 2.2.5. 
 
5.2.3  Effect of different organic acids on MRSA 
LA was used in different concentrations (v / v) (0.0312%, 0.0156% and 
0.0078%). Other acids (1.5%) (v / v) were also used, namely: AA (pH 4.15), 
CA (pH 6) and PA (pH 5.1). Organic acids were used with methicillin discs in 
different concentrations (10, 15 and 20 μg / ml) on MRSA, by incorporation 
into the growth medium. Acids in different concentrations were mixed with 10 
ml NA, which was then left to solidify. After that 100 µl of MRSA was spread 
onto the solid medium. Then different methicillin discs were fixed on the agar, 
and plates incubated at 37 °C for 24 h, as shown in Figure 5.1. After 
incubation, the diameter of the inhibition zone was measured (in mm) with 
Vernier callipers (Figure 2.1). A clear zone of 2 mm or more around a spot 
was considered as positive (Tahara et al., 1996). Aliquots of fresh NA without 
organic acids were used as controls. 
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5.2.4  Effect of L. plantarum supernatant on methicillin resistance and 
other antibiotics  
In order to assess the effect of probiotics on MRSA antibiotic resistance, the 
supernatant of L. plantarum was harvested. Different volumes of supernatant 
(200 and 400 µl) were mixed with NA (10 ml). The medium was then left to 
solidify, and afterwards 100 µl MRSA (106 CFU / ml) was spread on the agar 
surface. Next, antibiotic discs of methicillin and other antibiotics (CTX, CIP, 
AMN, TET, AZM, MY, S, C, GN and SXT) were fixed onto the agar, and were 
incubated at 37 °C for 24 h, as described in Figure 5.1. Inhibition zones were 
measured using Vernier callipers, as mentioned in section 5.2.3. Aliquot of 
fresh NA without supernatant of L. plantarum was used as a control. 
 
5.2.5  Effect of neutralised L. plantarum supernatant, MRSB and sodium 
lactate on methicillin resistance 
L. plantarum supernatant was neutralised (pH 7.0) by adding 1 M NaOH and 
applied against MRSA 33591 by incorporation into the medium. 200 and 400 
µl of neutralised supernatant L. plantarum, 200 µl 71% sodium lactate, 200 
and 400 µl MRSB were applied against MRSA 33591. The procedure was 
the same as that outlined in section 5.2.4. Then antibiotic discs were fixed on 
the agar, and plates incubated at 37 °C for 24 h, as shown in Figure 5.1. 
Inhibition zones were measured using Vernier callipers, as outlined in section 
5.2.3. Aliquot of fresh NA without neutralised supernatant of L. plantarum, 
sodium lactate or MRSB was used as a control. 
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Figure 5.1 Procedure to determine the effect neutralised / non-neutralised 
supernatant L. plantarum, organic acids and sodium lactate 71% with different 
concentrations methicillin, which are observed the antimicrobial activity of different 
treatments against MRSA. 
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5.2.6  Determination of the minimum inhibitory concentration of 
methicillin 
The minimum inhibitory concentration (MIC) of methicillin was determined 
using a microtitre method (American National Standards Institute 1991). The 
methicillin stock solution was prepared using methicillin sodium sulphate (1 
mg / ml) in sterile distilled water. Muller-Hinton broth (950 µl) and 50 µl of 
MRSA 33591 (107 CFU / ml) were mixed, and distributed into each well at 
optical density 0.5. Methicillin solution in different concentrations: 0.001, 
0.002, 0.004, 0.006,0.008, 0.01, 0.012, 0.014, 0.016, 0.02, 0.024, 0.028, 
0.032, 0.036, 0.04, 0.08, 0.150, 0.200, 0.25, 0.3, 0.35 and 0.4 μg / ml were 
put into microtitre plate wells, then incubated at 37 °C for 24 h. The growth 
density was determined using a Magellan Plate Reader (OD at 595 nm; 
Molecular devices, UK Ltd., UK). Aliquots of fresh MHB and MRSA without 
methicillin were used as control. 
 
5.2.7  Determination of MIC for methicillin against MRSA with 
supernatant of L. plantarum  
The MIC of methicillin was determined to be 0.042 µg / ml using a microtitre 
method, as described in section 5.2.6. Ten µl of bacterial suspension (107 
CFU / ml) was inoculated in each well at OD (0.5), along with 8.5 µl 
methicillin antibiotic solution (0.042 µg / ml). Different volumes (1, 2, 4, 6, 8, 
10 and 12 µl) of filtered supernatant of L. plantarum (pH 3.73) were added to 
MHB up to a total volume of 200 µl. In addition, aliquots of fresh MHB, with / 
without methicillin were used as controls. Plates were incubated at 37 °C for 
24 h. The growth density was determined, as described in section 5.2.6. 
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5.2.8  Modulation of methicillin resistance genes by probiotics  
5.2.8.1  RNA extraction from bacterial cells 
MRSA 33591 cells (107 CFU / ml) were cultured at 37 °C for 18 - 20 h in 20 
ml final volume, containing: 17.15 ml MHB, 850 µl methicillin (0.042 µg / ml), 
1 ml broth MRSA culture bacteria and 1 ml L. plantarum supernatant (pH 
3.73). MRSA cells were harvested by centrifuging at 2772 × g (Harrier 18 / 80, 
MSE, UK.) for 10 minutes, and washed twice using PBS. Pellets were re-
suspended in 1 ml PBS and the OD of the suspension was adjusted to 1.0 at 
595 nm by adding an appropriate volume of PBS. Total RNA was extracted 
using the Rneasy Protect Bacteria Mini Kit (Qiagen, UK) according to the 
manufacturer’s instructions . A control set was prepared and incubated at 
37 °C for 18 - 20 h. The cells were centrifuged at 13000 ᵡ  g (Heraeus Fresco 
21 Microcentrifuge, USA) for 3 minutes, and washed twice using PBS, as 
described in section 4.2.4.1. Finally, RNA concentration and quality were 
evaluated using a NanoDrop spectrophotometer, as outlined in Appendix 2 
(Figure 2.2). 
 
5.2.8.2  Agarose gel electrophoresis  
In order to determine the quality of RNA, agarose gel electrophoresis was 
used, as described in section 4.2.4.2. 
 
5.2.8.3  Reverse transcription and cDNA synthesis  
Reverse transcription (RTs) was performed to create cDNA. This was carried 
out using a High Capacity RNA-to-cDNA 50 ᵡ Kit (Fisher Scientific, UK Ltd.), 
according to the manufacturer’s instructions, as described in section 4.2.4.3. 
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5.2.8.4  Quantitative RT - PCR (qRT - PCR) 
qPCR was carried out to semi-quantitatively to analyse gene expression 
levels in the experiment relative to the reference gene (the control). PCR 
amplification was performed with primers, with pyruvate kinase (Pyk) as a 
housekeeping gene, and mecR1, mecA and PBP2 as target genes (Table 
5.1). The target primer’s genes was designed using the mRNA sequences, 
which were obtained from a primer blast in the NCBI (National Centre for 
Biotechnology Information), as described in section 4.2.4.4. 
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Table 5.1. Primers sequences (housekeeping and target genes) used for qRT-PCR reactions. 
 
Primer              Primer sequence (5´…3´)        Product size (bp) Primer concentration (pmol)      Reference 
mecR1, F 5´-GTC GTT CAT TAA GAT ATG ACG 3´ 310 10  Suzuki et al. (1993) 
mecR1, R 5´- GTC TCC ACG TTA ATT CCA TT 3´ 310 "                " 
mecA, F 5´ GGC AAT ATT ACC GCA CCT CA 3´ 214 " Mulvey et al. (2005) 
mecA, R 5´ GTC TGC CAC TTT CTC CTT GT 3´ 214 "                " 
PBP2, F 5´- TGT GAA GAG AAC GAT TAT TAA G 3´ 824 " Boyl Varva et al. (2003) 
PBP2, R 5´- ATG AAT TAT ACT CAG AAT CTT GAT 3´ 824 "                " 
Pyk, F 5´- GCA TCT GTA CTC TTA CGT CC 3´ 90 " Theis et al. (2007) 
Pyk, R 5´ GGT GAC TCC AAG TGA AGA 3´ 90 "                " 
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5.2.8.5  Normalisation of qRT - PCR data  
In most cases, the data were normalised using the instrument software with 
auto-normalisation. However, the data were also normalized manually, 
producing the relative quantification (RQ) values. The data was first 
normalized against the housekeeping gene (Pyk). This was achieved by 
subtracting the cycle threshold (CT) value of the housekeeping gene  from the 
CT value target genes (mecR1, mecA and PBP2) to produce the ΔCT, as 
outlined in section 4.2.4.5. 
 
5.2.9  Statistical analysis 
Databases were subjected to balanced analysis of variance (ANOVA) and 
post hoc LSD) tests using Minitab v.16 and SPSS, as described in section 
4.2.5. 
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5.3  Results 
5.3.1  Agar well diffusion method  
The antimicrobial activity of Lactobacillus species; L. casei, L. acidophilus 
and L. plantarum was tested against MRSA strains by measuring the 
inhibition zones generated around the MRSA growth. Overall, the BCB L. 
plantarum produced the greatest inhibition zones with MRSA 12493 (9.80 ± 
0.28 mm) and MRSA 33591 (9.70 ± 0.57 mm) compared to L. casei and L. 
acidophilus. Moreover, the CFS Lactobacillus species demonstrated lower 
inhibition compared to BCB, and L. plantarum was more effective (4.70 ± 
0.28 mm) against MRSA 12493 compared to other species, as outlined in 
Table 5.2. 
The statistical analysis showed high significant differences (P < 0.05) with 
pathogens, probiotics, and treatments (BCB and CFS). 
 
 
Table 5.2 Zones of inhibition (mm; mean ± SD) for MRSA strains with a broth 
culture (BCB) and cell free supernatant (CFS) of probiotic Lactobacillus species. 
 
 MRSA 33591 MRSA 12493 
Probiotics      BCB       CFS      BCB       CFS 
L. plantarum 9.70 ± 0.57a, 1 4.20 ± 0.28a, 1 9.80 ± 0.28a, 1 4.70 ± 0.28a, 1 
L. acidophilus 8.00 ± 1.00a, 1   3.50 ± 0.50a, b, 1 8.20 ± 0.28b, 1 4.00 ± 0.76a, 1 
L. casei 7.00 ± 0.57b, 1 3.70 ± 0.28b, 1 9.00 ± 0.57b, 2 4.20 ± 0.28a, 1 
 
Values with the same superscript letters in each column are not significantly 
different, while mean values with same superscript numbers within each row are not 
significantly different. 
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5.3.2  Agar spot method 
The inhibitory effect of BCB was also measured using the agar spot method. 
The Inhibition zones of MRSA strains using Lactobacillus broth growing in 
MRS 2% glucose were significant (P < 0.05) with L. plantarum (10.70 ± 0.57 
mm) against MRSA 12493 compared to other Lactobacillus species. 
However, the effect of Lactobacillus in MRS 0.2% glucose produced a minor 
effect on MRSA strains. L. plantarum was more effective (2.30 ± 0.28 mm), 
compared to other species, as outlined in Table 5.3. 
The statistical analyses observed high significant differences (P < 0.05) with 
pathogens, probiotics, and treatments (modified and unmodified MRS). 
 
Table 5.3 Zones of inhibition (mm; mean ± SD) on modified and unmodified 
MRS for probiotic Lactobacillus species against MRSA strains. 
 
 MRSA 33591 MRSA 12493 
Probiotics Unmodified Modified       Unmodified       Modified 
L. plantarum 9.50 ± 0.50a, 2 2.30 ± 0.28a, 1 10.70 ± 0.57a, 1 2.30 ± 0.28a, 1 
L. acidophilus 8.70 ± 0.28b, 2   1.70 ± 0.57a, b, 1 10.00 ± 0.50a, 1 2.00 ± 0.50a, 1 
L. casei 7.80 ± 0.76
b, 1 
0.80 ± 0.28
b, 1 
  8.00 ± 0.50
b, 1 
0.90 ± 0.52
b, 1 
 
Values with the same superscript letters in each column are not significantly 
different, while mean values with same superscript number within each row are not 
significantly different. 
  
 
5.3.3  Effect of L. plantarum supernatant with methicillin and different 
antibiotics on MRSA 33591 
The results varied depending on the type and dose of antibiotics and the 
amounts of supernatant of L. plantarum. The results were significant (P < 
0.05) with 400 µl supernatant of L. plantarum, as presented in Figure 5.2 (A - 
C). The results were as follows: cefotaxime (39.5 ± 0.5 mm), methicillin 20 μg 
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(24.33 ± 0.76 mm), ampicillin (22.16 ± 0.28 mm), methicillin 15 μg (20 .33 ± 
0.57 mm) and tetracycline (13 ± 0.5 mm), as outlined in Figure 5.2 (A - C), 
and Appendix 3 (Figures 3.3 - 3.4).  
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Figure 5.2 Zone of inhibition (mm; mean ± SD) for different antibiotics with different 
amounts supernatant of L. plantarum (200 and 400 µl) against MRSA 33591 (A) 
cefotaxime, ampicillin and tetracycline (B) different methicillin concentrations (10, 15 
and 20 µg / ml), and (C) ciprofloxacin, gentamicin, sulpha-trimethoprime and 
chloramphenicol. The statistical analyses showed significant differences with 
antibiotics, supernatant and overlap between antibiotic with supernatant of L. 
plantarum. The data are mean ± SD from three independent identical experiments. 
Values with the same subscript letters with different antibiotics are not significantly 
different, while values with the same subscript numbers in different amounts 
supernatant of L. plantarum are not significantly different. 
 
 
The results with some antibiotics demonstrated that they were less effective 
when the amount of supernatant of L. plantarum was increased to 400 μl, as 
follows: ciprofloxacin (22.16 - 28.5 mm), gentamicin (2.3 - 18.6 mm), 
chloramphenicol (1.83 - 8.33 mm) and sulphatrimethoprime (1.5 - 15.83 mm), 
as outlined in Figure 5.2 C. In addition, some results were not significant 
(resistance and no inhibition zone) with the following antibiotics: azithromycin, 
lincocin and streptomycin. 
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5.3.4  Effect of lactic acid and other organic acids on MRSA 
LA was used to assess its activity on MRSA growth; three different LA 
concentrations in combination with three concentrations of methicillin were 
applied. The greatest inhibition zones were observed with 20 µg / ml 
methicillin, when the medium contained 0.0312% LA (31 ± 1 mm), as 
presented in Figure 5.3 A and Appendix 3 (Figure 3.1). 
Moreover, organic acids such as AA, PA and CA were used against MRSA in 
order to evaluate the role of pH in diminishing methicillin resistance in MRSA. 
The MRSA was exposed to 1.5%, as a final concentration of each acid. The 
results demonstrated the strongest inhibition zones with methicillin discs (20 
µg / ml) against MRSA, especially with AA (38.5 ± 0.5 mm), whereas, 
methicillin discs used with CA (3.83 ± 0.28 mm) and displayed weak or no 
effect on MRSA growth. Furthermore, PA produced significant inhibition (28.5 
± 0.5 mm) of MRSA, as outlined in Figure 5.3 B and Appendix 3 (Figure 3.2). 
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Figure 5.3 Zone of inhibition (mm; mean ± SD) for different concentrations of 
methicillin on NA (A) different concentrations LA, and (B) different organic acids 
1.5% (AA, PA and CA) against MRSA. The statistical analyses found significant 
differences with methicillin, organic acids, and overlap between them. The data are 
mean ± SD from three independent identical experiments. Values with the same 
superscript letters with different amounts of organic acids are not significantly 
different, while value with the same superscript numbers in antibiotics are not 
significantly different. 
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5.3.5  Effect of neutralised supernatant of L. plantarum, sodium lactate, 
and MRSB, in conjunction with different concentrations of methicillin, 
against MRSA 33591 
A neutralised supernatant of L. plantarum, sodium lactate 71% and MRSB 
were applied to MRSA in order to appraise the role of antimicrobial 
substances in reducing methicillin resistance in MRSA. The results 
demonstrated that the strongest inhibition of MRSA growth was with sodium 
lactate, and 20 µg / ml of methicillin more than the neutralised supernatant of 
L. plantarum, at different volumes (200 and 400 µl), as outlined in Figure 5.4 
and Appendix 3 (Figure 3.5). No effect was detected using the MRSB with 
any concentration of methicillin, as outlined in Appendix 3 (Figure 3.6). 
 
Figure 5.4 Zone of inhibition (mm; mean ± SD) for different methicillin 
concentrations against MRSA. Different volumes of neutralised supernatant of L. 
plantarum  (200 and 400 µl) and sodium lactate 71% (200 µl) were mixed with 
media. Then methicillin discs fixed, and incubated at 37 ºC for 24 h. The statistical 
analyses observed significant differences between neutralised supernatant of L. 
plantarum, sodium lactate, and overlap between them. The data are mean ± SD 
from three independent identical experiments. Values with the same superscript 
letters in different amounts of neutralised supernatant of L .plantarum and sodium 
lactate are not significantly different, while mean values with the same superscript 
numbers in antibiotics are not significantly different. 
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5.3.6  MICs for methicillin and supernatant  of L. plantarum  
The MIC of methicillin MRSA was calculated in order to determine the sub-
lethal concentration, which can modulate genes mediating methicillin 
resistance, followed by assessment of the role of CFS on the expression of 
those genes. The observed results indicated that 0.32 μg / ml of methicillin 
was the lethal concentration. However, to determine the effect of the 
supernatant of L. plantarum, a concentration of methicillin below MIC was 
selected. This concentration was 0.04 μg / ml. This level was chosen 
because microorganisms grow at this concentration. The MIC was obtained 
by the combination of different methicillin concentrations, and different 
volumes the supernatant of L. plantarum to the final pH 3.73. The observed 
results showed that 12 μl supernatant of L. plantarum and 0.04 μg / ml 
methicillin was the lethal concentration. A concentration of supernatant of L. 
plantarum and methicillin below MIC was selected. This concentration was 
0.04 μg / ml and 10 μl the supernatant of L. plantarum. 
 
5.3.7  MecR1, mecA, and PBP2a gene expression using qRT-PCR 
In order to assess whether the CFS affected the expression of genes (mecR1, 
mecA and PBP2) mediating methicillin resistance in MRSA, the RNA of 
MRSA was successfully extracted, as outlined in Figure 5.5 and Appendix 2 
(Figure 2.2) and cDNA was synthesized, using conventional PCR assay and 
qRT - PCR. The results displayed MRSA growth in presence of supernatant 
of L. plantarum and methicillin and a significant inhibition of mecR1 gene 
expression compared to control samples, whereas, mecA and PBP2 were 
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strongly up-regulated after MRSA was treated with supernatant of L. 
plantarum and methicillin, as outlined in Figure 5.6 (A - C). 
 
 
 
Figure 5.5 Agarose gel electrophoresis of RNA samples and amplification of cDNA. 
L: ladder (1013 bp), C 1: control 1 (without treatment), C 2: control 2 (with 
methicillin), T: treatment (with methicillin and supernatant of L. plantarum), Pyk: 
pyruvate kinase gene (housekeeping gene) and mecA: mecA genes (target genes). 
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Figure 5.6 Gene expressions for MRSA with the mixture of methicillin and culture 
supernatant of L. plantarum, and as follows: (A) mecR1 (down-regulation), (B) mecA 
(up-regulation) and (C) PBP2 (up-regulation), control 1 (without treatment), control 2 
(with methicillin) and treatment (with methicillin and supernatant of L. plantarum). 
The statistical analyses observed significant differences. The data are mean ± SD 
from three independent experiments. Values with the same superscript letters are 
not significantly different. 
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5.4  Discussion 
Probiotic lactobacilli  are currently used to treat a range of microbiological 
diseases, to inhibit of growth of pathogenic microbes and for the modulation 
of the GIT immune system against harmful microorganisms (Fooks and 
Gibson, 2002). In the current study, three Lactobacillus species were used to 
study their effect on MRSA resistance to methicillin. The present study 
examined the antimicrobial activity of probiotic Lactobacillus species using 
both BCB and CFS.  
The results demonstrated an inhibitory effect of Lactobacillus species against 
MRSA strains. The majority of MRSA strains appeared to be more sensitive 
to BCB compared to CFS, but to varying degrees, and L. plantarum 
displayed the strongest inhibition zone compared to other species.  The 
antimicrobial activity of probiotics for different Lactobacillus species is 
represented by the production of numerous anti-bacterial substances, such 
as organic acids, bacteriocins, CO2, H2O2 or other substances as antibiotics 
(Vallor et al., 2001), as described in section 2.4. 
 As for different organic acids and supernatant L. plantarum results, the effect 
of LA was very effective and significant. This antagonism is believed to be 
due to the action of LA on the bacterial cytoplasmic membrane, which 
interferes with the maintenance of membrane potential and inhibits active 
transport (Sheu et al., 1972; Eklund, 1989; De Vuyst and Vandamme, 1994). 
Moreover, Cherrington et al. (1991) reported that the cause may be mediated 
both by dissociated and un-dissociated acid. As well as the pH effect, un-
dissociated LA collapses the electrochemical proton gradient, ca using 
bacteriostasis and finally the death of the target bacteria (Eklund, 1989). 
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Furthermore, LA has been shown to permeabilize the external membrane of 
Gram negative bacteria by the release of LPS, leading to loss of viability 
(Arqués et al., 2004). 
Several studies have observed the effect of organic acids on pathogens, e.g. 
the study conducted by Domenech et al. (1992), which showed that four S. 
aureus strains incubated at 37 °C for 24 h in broth progressively acidified 
with different organic acids (lactic, citric, propionic, pyruvic, and ascorbic 
acids), and survival in different rates. Another study, carried out by Nihei et al. 
(1993), reported that petroleum jelly containing 3% AA was sufficient to 
remove MRSA on cutaneous lesions. Several factors may explain the 
susceptibility S. aureus to antibiotics after treatment with acids. One of these 
explanations was revealed in a study conducted by Sabath et al. (1972), 
which reported that the growth of bacterial cells in medium at pH 5.2 before 
antibiotic susceptibility testing at pH 7.4 failed to suppress antibiotic 
resistance, and indicates (a) that the gene determining methicillin resistance 
was not eliminated during growth at acid pH and (b) that suppression of 
resistance is easily reversed. There is another opinion that the acid medium 
itself prevents methicillin resistant bacterial cells from growing, whether the 
antibiotic is present or absent. Recently, Lemaire et al. (2008) observed that 
the susceptibility of MRSA strains to β-lactams, especially methicillin can be 
restored by acidic pH (the relationship between pH and the function of PBP-
2a was examined). In addition, acidic pH has the following effects: (a) β-
lactam antibiotics interact with PBP-2a with high affinity, and (b) PBP-2a 
undergoes a conformational alteration in the presence of β-lactam antibiotics 
consistent with the opening of the active site from the closed conformation.  
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Remarkably, the results for non-neutralised L. plantarum supernatant (pH 
4.85) were the same as with different organic acids, and were highly 
significant. Several products in metabolism of Lactobacillus species, which 
contain mainly LA and AA (Thanh et al., 2009). In addition, many products in 
addition to organic acids are produced by L. plantarum strains, for example 
bacteriocin, which contributes to the microbial activity, and a broad spectrum 
of antimicrobial activity against pathogens has previously been observed 
(Van Thu et al., 2011; Sankar et al., 2012). Furthermore, Lee et al. (2013) 
revealed that bacteriocins KU24 produced by some LAB, such as 
Lactococcus lactis KU24, exhibited inhibitory effects against MRSA. 
Interestingly, Sabath et al. (1972) reported that the susceptibility of MRSA to 
traditional β-lactams can be almost fully restored if MRSA is grown at pH 5.5 
or lower. This fact was first described in the early 1970s in re lation to 
healthcare-associated MRSA (HA-MRSA) growing in broth and exposed to β-
lactams, e.g. penicillins or first generation cephalosporins. This has now 
proved to be the case with other β-lactams, including carbapenems, and also 
applies to CA-MRSA (Lemaire et al., 2007). Hartman and Tomasz (1984) and 
Lemaire et al. (2007) demonstrated that this influence of low pH is due to (1) 
reduced copy numbers of PBP-2a (reduced or even explicit absence of the 
expression of PBP-2a) and (2) a lack of transpeptidase activity of PBP-2a at 
acidic pH. Lemaire et al. (2007) mentioned that the first reason be can 
rejected, since the expression of mecA and the immunodetection of the 
encoded PBP-2a are both unaffected by low pH. Therefore, the second 
reason cannot be ruled out and is probably the most acceptable. In fact, the 
active site of this protein is protected under normal conditions, which is the 
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main reason for the lack of effective inhibition of the enzyme by traditional β-
lactams. 
In the current study, the results for ciprofloxacin, chloramphenicol, gentamicin 
and trimethoprim were different and MRSA became resistant rather than 
sensitive. This may be because there is overlap between supernatant and 
antibiotics, and then supernatant destroyed and disrupted role of antibiotics. 
In addition, some antibiotics, such as azithromycin, lincocin and streptomycin 
were still resistant without any changes with regardless of the amount of 
supernatant used. Many reasons may be behind this and further 
investigations are required to explain this. 
The results with neutralised (pH 7) L. plantarum  supernatant and sodium 
lactate 71% were significant. The activity of inhibitors in the supernatant of 
Lactobacillus species is due to substances produced by these species, such 
as organic acids, and also to other inhibitory substances, such as CO2, H2O2, 
bacteriocins and others (Ogunbanwo, 2005). Van Thu et al. (2011) and 
Sankar et al. (2012) reported that several products in addition to organic 
acids produced by various strains of L. plantarum, e.g. bacteriocin, 
participate in inhibitory activity, and have a broad spectrum of antimicrobial 
activity against pathogens. In the current study, no activity against MRSA 
was observed in MRS broth. The reasons may be due to the absence of 
probiotic L. plantarum (probiotic Lactobacillus species ferment sugar to 
organic acids and produce other substances), as mentioned previously. 
In the current study, the effects of non-neutralised supernatant of L. 
plantarum on the expression of genes contributing to methicillin resistance 
were studied. The results revealed that the expression of inducer gene 
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mecR1 was strongly downregulated after exposure to CFS and methicillin 
compared to controls, which potentially means weak expression of mecA was 
induced by mecR1. Moreover, increasing mecA gene expression in the 
control sample may have been due to unexplained factors, as has been 
previously observed (Chen et al., 2011). However, the gene expression data 
recorded a strong increase in both PBP2 and mecA genes. This is probably 
attributable to different regulatory pathways of mecA gene expression. 
Moreover, several studies report that there are several regulators for the 
mecA gene. One such study, carried out by Arede et al. (2012), observed 
that no correlation was found between the existence of functional mecR1-
mecI genes and the level of β-lactams resistance in a representative 
collection of epidemic MRSA, and display that the mecA gene regulatory 
locus consists. The mecR2 function is necessary for the full induction of 
mecA expression, which compensates for the incompetent induction of the 
mecA by the mecR1, and allows the best expression of β-lactams resistance 
in MRSA with functional mecR1-mecI regulatory genes (Figure 5.7). 
 
 
 
Figure 5.7 MecA regulation by mecR2 instead of mecR1-mecI and blaR1-blaI 
pathways, adapted from Arede et al. (2008). 
 
 
In addition, there are other regulators of mecA, as mentioned in other studies. 
Two studies carried out by Ryffel et al. (1992) and Hiramatsu (1995), 
reported that the blaR1-blaI complex (concerned with β-lactase production) is 
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able to regulate the expression of the mecA gene. MRSA that have a 
dysfunctional regulatory region can either express the mecA constitutively or 
they can use the β-lactamase regulatory genes to optimally express the  
mecA, due to blaR1 being a strong inducer of the mecA, and the blaI a weak 
repressor. Hiramatsu (1995) revealed that the mecR1 and mecI genes have 
a high degree of homology to the blaR1-blaI genes (Figure 5.8).  
 
 
Figure 5.8 Regulation of mecA by mecI-mecR1 and blaI-blaR1. MecI represses 
transcription of the mecA and mecRI-mecI operon. Upon binding of the β-lactam to 
the sensor domain of mecRI, the intracellular peptidase domain cleaves the mecI 
repressor, which triggers mecA and mecI transcription. An analogous system 
controls blaZ and blaRI-blaI expression. Despite blaI and mecI repressors being 
interchangeable and both recognizing mec and bla regulatory sequences, cleavage 
of the expression regulators by blaRI and mecRI is specific, adapted from Berger-
Bächi and Rohrer (2002). 
 
 
The current study is compatible with one carried out by Lemaire et al. (2007), 
which observed that low pH prevents PBP2 from functioning (PBP2 is 
produced, but does not function) in conjunction with the PBP2a, and / or 
difficulties its recruitment. At the same time, Lemaire et al. (2007) explained 
that further studies must be conducted and with the expansion of knowledge 
it may be found that there are reasons other than acid for this phenomenon 
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(synthetic organic acids). This means that substances secreted by L. 
plantarum, such as bacteriocins, may have an effect on methicillin resistance. 
The mecR1 gene was strongly down-regulated after exposure to CFS with 
methicillin compared to controls, but the mecA and PBP2 genes were 
observed to be up-regulated after exposure to CFS and methicillin. 
Generally, the signal transducing integral membrane protein, mecR1 helps 
initiate the expression of the antibiotic-resistant mecA gene, which encodes 
the PBP2a. Blocking the mecR1 regulatory pathway may be a novel strategy 
for combating MRSA. 
  
5.5  Conclusions 
The current study demonstrated that the probiotic L. plantarum has a 
significant antimicrobial effect against MRSA, as has been reported in 
previous chapters. Furthermore, the present study reveals that some organic 
acids have a significant effect on MRSA due to acidic pH. Interestingly, the 
restoration of MRSA antibiotic sensitivity after treatment with supernatant of L. 
plantarum remained until the removal of the impact of the acid pH, using 
neutralised supernatant of L. plantarum and sodium lactate. This means the 
effects were due not only to acidic pH, but also to other substances found 
within the supernatant of L. plantarum. The results indicated that the mecR1-
mecI-mecA-PBP2 signalling pathway was obstructed, using supernatant of L. 
plantarum and methicillin, and that the susceptibility of MRSA to some 
antibiotics, especially β-lactam antibiotics, can be restored. 
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Chapter 6: General discussion and recommended future work 
 
6.1  General discussion  
The skin is the principal barrier against different microbial infections, it 
interacts with the external environment, and is colonized with a numerous 
population of microorganisms. The vast majority of colonizing normal flora 
are represented by bacteria, whether Gram positive or Gram negative 
(Harder et al., 1997). Skin and soft tissue infections are often a problem 
confronted in clinical practice, which range from mild to serious life 
threatening infections (Hersh et al., 2008; Swartz, 2004). In the last six years, 
resistance to antibiotics has increased due to several reasons such as 
prolonged therapeutic use of antibiotics, drugs administered to patients 
randomly and without previous consultation by physicians (Roghmann and 
McGrail, 2006). As is well known, the importance of skin diseases has 
increased recently, most notably the resistance to conventional therapies and 
most antibiotics of skin pathogens such as MRSA. The lack of response to 
traditional treatments and increasing concerns over antibiotic resistance has 
led to the search for possible alternative solutions. 
One potential area of investigation to alleviate this problem is the use of 
probiotic microorganisms (Roghmann and McGrail, 2006; Tagg and Dierksen, 
2003) such as LAB, whose inhibitory activity is due to several mechanisms, 
including production of several substances, such as organic acids, H2O2, 
bacteriocins and others (Malago and Koninkx, 2011). 
Probiotics are defined as live microorganism food supplements or microbial 
components, which have been observed to have beneficial effects on health 
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(Salminen et al., 1998). Probiotic microorganisms have been widely used for 
the treatment/ or prevention of gut disorders, but a growing number of clinical 
studies suggest that probiotic approaches provoke a systemic effect which 
extends beyond the gut and may even affect selected functions of the skin 
(Ouwehand et al., 2002b). Other applications of probiotics are few, 
particularly regarding the UGT and the skin regions (Reid, 1999). Therefore, 
the aim of this study was to investigate the application of a wide range of 
probiotics on the skin pathogens, which is considered a novel approach to 
look at the role of probiotics. 
In this thesis, there were four lines of investigation to look for and identify a 
number of possible direct interactions between probiotic Lactobacillus 
species and bacterial human skin pathogens: Firstly, the evaluation of 
antimicrobial activity of eight probiotic Lactobacillus species against five 
bacterial human skin pathogens using agar well diffusion and agar spot 
methods. Secondly, the assessment of the ability of probiotics Lactobacillus 
species and pathogens to aggregate, form biofilms and adhere to keratin. 
Thirdly, the evaluation of probiotic L. plantarum and investigation of the 
synergism between L. plantarum and hBD‐2 against human bacterial skin 
pathogens. Finally, antimicrobial activity of probiotic Lactobacillus species 
against MRSA, and the role of probiotics in the modulation of methicillin 
resistance in MRSA was investigated.  
It was originally envisaged that at least one of these four lines of investigation 
would be successful and would subsequently constitute the chief line of 
research for the thesis. After initial studies, a decision was made to persist 
with each of the four lines of investigation. Moreover, many reports indicated 
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that the probiotic Lactobacillus species are antagonistic towards pathogens 
through a combination of mechanisms such as the production of antimicrobial 
substances and inhibition of adherence. 
In the first line of investigation, the results showed that the majority of strains 
of human skin pathogens used appeared sensitive to the probiotic 
Lactobacillus species used (L. casei, L. salivarius, acidophilus and L. 
plantarum), but to varying degrees. Lactobacillus species were able to inhibit 
the growth of pathogens. The agar spot method gave better results than the 
well diffusion method, in terms of the inhibitions zones observed and the 
subsequent clarity of results. The increased antimicrobial activity of the L. 
plantarum on unmodified MRS (2% glucose) suggested that the activity was 
due mainly to LA production. Probiotic Lactobacillus species may potentially 
provide solutions to antibiotic resistance in some human skin pathogens. The 
current study suggests that following further research, it may be possible to 
exploit the inhibitory mechanisms of the probiotic microorganisms studied, 
either alone or in combination with each other and/ or other antimicrobial 
compounds.  
The second line of investigation demonstrated that compounds secreted by 
probiotics may interfere with a pathogen’s ability to adhere to a surface and 
impede growth. Aggregation of bacteria to each other has been correlated 
with adhesion. Auto-aggregation and co-aggregation are considered a 
prerequisite for colonization and infection of the cutaneous region by 
numerous pathogens. In the current study, probiotic Lactobacillus species 
and pathogens revealed no significant co-aggregation or adhesion to keratins, 
but significantly interfered with biofilm formation. L. casei demonstrated the 
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highest aggregation, whether in auto-aggregation or co-aggregation. The 
majority of auto-aggregation may be attributed to adherence properties (Boris 
et al., 1997). Some reports observed that there are structures on the surface 
of some Lactobacillus species and pathogens for example S-layer proteins in 
Lactobacillus, which play an important role in aggregation, and these 
contribute to 15 - 20% of the total cellular protein content (Pouwels et al., 
1998; Sa´ra and Sleytr 2000).  
Overall, in the current study, there were interactions between probiotic 
Lactobacillus species and skin pathogens when mixed together. Probiotic 
Lactobacillus species (L. casei, L. salivarius, L. acidophilus and L. plantarum) 
exerted a higher effect than individual strains alone. The majority of 
Lactobacillus species displayed co-aggregation with human skin pathogens 
(e.g. S. aureus strains or P. aeruginosa) because may be have different 
structures on the surface of these bacteria. The reduction of pathogens can 
either be by competition for adhesion sites or other growth factors (Comelli et 
al., 2002). Furthermore, Lactobacillus species have revealed low adherence 
with keratin when compared to pathogens.  
Metabolites produced by some LAB include bio-surfactants (Heinemann et 
al., 2000). Bio-surfactants produced by various strains of lactobacilli are 
complex biological mixtures that have been shown to inhibit the adhesion of 
pathogens to both biomaterial and epithelial cell surfaces (Velraeds et al., 
1998). The mucoid exopolysaccharide matrix, pili, flagella and LPS on the 
surface of P. aeruginosa (adhesion factors) (Gupta et al., 1994) and 
glycocalyx polymer in Pr. acnes act as a protective exo-skeleton natural 
barrier (Burkhart and Burkhart, 2003). Moreover, these structures are 
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believed to play an important role in the adhesion, especially in the initial 
steps (Greene and Klaenhammer, 1994). It is likely that the lactobacilli  used 
in this study interfered with these adhesion processes. Furthermore, 
Tahmourespour and Kermanshahi (2011) demonstrated that L. acidophilus 
was able to interfere in the adhesion and biofilm formation of the 
Streptococcus mutans. 
The third line of study looked at interactions between pathogenic bacteria, 
antimicrobial peptides (hBD-2) and probiotic Lactobacillus species (L. 
plantarum). Probiotic bacteria play an important role in activating 
antimicrobial peptides and inducing their expression e.g. E. coli Nissle 1917 
and several LAB of different species activated expression of the hBD-2 
(Wehkamp et al., 2004). In the current study, hBD‐2 showed high 
antimicrobial activity (as a bactericide) and this was significantly increased in 
the presence of L. plantarum demonstrating a degree of synergism between 
them. Goytia et al. (2013) mentioned that antimicrobial peptides protect the 
host by exerting bactericidal activity, modulating the immune system 
response, molecular signaling, and facilitating the communication between 
native and acquired immunity. Interestingly, hBD-2 and L. plantarum were 
more effective compared to hBD-2 alone, especially with longer incubation 
periods of 5 h. The reason may be due to synergism between L. plantarum 
(acidic pH) and hBD-2, and all of them the mechanism of action on cell 
membrane. In addition, the acidic pH caused the production of organic acids  
may be creating a suitable environment for the work of peptides, whether 
hBD-2 or other substances produced by L. plantarum (Chen et al., 2005). 
The mode of action for organic acids (LA and AA) is observed to 
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permeabilize the outer bacterial cell membrane of Gram negative bacteria by 
releasing important substances, such as LPS, leading to loss of viability, and 
the action of LA may facilitate the activity of other antimicrobial factors 
(Alakomi et al., 2000). 
There is an important role for NaCl on hBD-2 activity, in that it has a negative 
effect on antimicrobial activity. The reason may be that NaCl ultimately 
inactivates or disrupts the action of antimicrobial peptides, such as hBD-2. 
The reason is probably due to the ability of NaCl to precipitate the peptide. 
Inactivation of hBD-2 may due to the salt combining with protein, and 
precipitating hBD-2.  
When L. plantarum and hBD-2 were mixed with NaCl there was some 
effectiveness against pathogens as L. plantarum was not affected by the 
presence of NaCl; indeed Lactobacillus strains were able to ferment glucose 
in up to 8% NaCl and produce antimicrobial activity. This means that whilst 
NaCl works to inactivate bacteriocins, hBD-2 and other peptides, other non-
protein antimicrobial substances are not affected. Therefore, the antimicrobial 
activity in this case was considered to be due to L. plantarum alone. 
Gene expression of mprF and dlt was highly upregulated when hBD-2 and L. 
plantarum were used together compared with controls or hBD-2 alone. This 
effect was enhanced in an acidic environment (pH 4.6), which resembles the 
normal pH of skin. The signiﬁcance of pH in skin has been considered in 
terms of its ability to defend against pathogens, and the alteration of skin pH 
is one of the pathological factors involved in skin infections (Eberlein-König et 
al., 2000). In addition, pH may affect the structure of hBD-2, causing the 
alteration of their antimicrobial efficacy (Johansson et al., 1998). 
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The fourth and final line of investigation searched for restoration of sensitivity 
of methicillin resistant Staphylococcus aureus to β-lactams by the 
supernatant of L. plantarum, which was selected because it had the highest 
anti-microbial activity in earlier investigations. 
Interestingly, sensitivity of MRSA to β-lactams was restored using non-pH 
neutralised supernatant of L. plantarum. This may be due to the final 
products of metabolism of Lactobacillus species, which contain mainly 
organic acids or bacteriocins (Thanh et al., 2009; Lee et al., 2013). These 
substances participate in inhibitory activity and they have a broad spectrum 
of antimicrobial activity against pathogens. The influence of acidic pH could 
be attributed to one of the following reasons; reduced copy numbers of the 
PBP2a or lack of transpeptidase activity of PBP2a, the gene is expressed but 
not translated into protein, or the low pH could interfere with translocation of 
the protein into the cell wall. The first reason can be discounted because of 
the expression of mecA (Lemaire et al., 2007). Although the current study 
cannot rule out any of the other possible mechanisms it is thought that 
interference with transpeptidase activity is the most likely.   
Numerous organic acids were applied to find out whether susceptibility of 
MRSA to methicillin could be restored. Cherrington et al. (1991) reported that 
the activity might be mediated both by dissociated and un-dissociated acid. 
As well as the pH effect, Eklund (1989) showed that un-dissociated LA 
collapses the electrochemical proton gradient, causing bacteriostasis and 
finally the death of the target bacteria.  
To avoid the effect of pH, MRSA was exposed to pH-neutralised CFS of L. 
plantarum and sodium lactate. Significant inhibition of methicillin resistance 
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was observed suggesting that the supernatant of L. plantarum consists of 
several compounds that can actively inhibit the methicillin resistance pathway. 
The effect of sodium lactate also strongly supported this hypothesis. Maas et 
al. (1989) demonstrated that there are two possible mechanisms for the 
activity of sodium lactate. Firstly, the presence of high levels of lactate ions 
may shift the pyruvate reduction-to-lactate reaction closer to its 
thermodynamic equilibrium, thus inhibiting a major anaerobic energy 
metabolism pathway that is essential for growth. Secondly, in pathogens, 
lactate efflux from the bacterial cell may be coupled to ATP generation from 
protein transfer across bacterial cell membranes. 
In the current study, mecR1 was strongly downregulated after exposure to 
the supernatant of L. plantarum and methicillin. Furthermore, Chen et al. 
(2011) observed that increase expression of control due to the mecA gene 
could be constitutive or inducible. In addition, expression of PBP2 was similar 
to mecA (upregulated). Furthermore, the PBP2 is encoded by mecA, and the 
pathway of expression of both genes is the same. MRSA cells became very 
sensitive to methicillin after exposure to CFS of L. plantarum, which can be 
attributed to PBP2 dysfunction because of the drastic change in pH caused 
by organic acids that are present in CFS. There is another opinion which 
states that organic acids may not be the only factor as some restoration of 
sensitivity to methicillin was observed when MRSA was exposed to pH-
neutralised CFS and sodium lactate. The results showed that there is 
significant inhibition in methicillin resistance, and suggest that the 
supernatant consists of compounds that can actively inhibit the methicillin 
resistance pathway, in addition to other compounds, such as bacteriocins 
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and/ or others; this requires future research. Generally, low pH prevents 
PBP2 from functioning in conjunction with PBP2a and/ or difficulties its 
recruitment (Lemaire et al., 2007). 
In conclusion, probiotics, especially L. plantarum may be considered a 
possible avenue for investigation into new treatments of pathogen diseases 
for skin and soft tissue. Probiotics can inhibit the growth of pathogens in 
several ways. Furthermore, probiotics can produce several antimicrobial 
substances, which inhibit or impede the growth of pathogens. In addition, its 
activation of tissue to stimulate and encourage the production of antimicrobial 
peptides such as hBD-2, which obstruct growth or kill pathogens enhance its 
antimicrobial properties.  
In certain cases there may be some reluctance to applying live bacteria to 
infected skin, even though they may be regarded as safe. Therefore, it is 
useful to note that many of the beneficial properties of the lactobacilli studies 
here were achieved using cell free supernatants. The use of metabolites from 
lactobacilli rather than the organisms themselves may be more acceptable in 
clinical situations, and this aspect needs more investigation.  
Remarkably, some lactobacilli  species (L. plantarum) restore sensitivity of 
pathogens, such as methicillin resistant S. aureus to β-lactam antibiotics, 
such as methicillin and others, using culture supernatant of L. plantarum. 
Probiotic Lactobacillus species can apply as successful solutions to bacterial 
antibiotic resistance.  
Finally, probiotics can apply to treat resistant bacteria for antibiotics, such as 
MRSA without any side effects, safety, available in everywhere and low cost, 
in compared to antibiotics. 
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6.2  Recommendations and ideas for future work 
The main areas to be highlighted are: 
1. There is some knowledge accumulated on the application of probiotic in 
the skin diseases but this is still limited and the research should continue. For 
example, little is known about the immunological response of the human skin 
to probiotics. Therefore, it would be of benefit to undertake immunological 
studies of the skin, including the effect of probiotics on the modulation of 
immunity via their impact on the innate and adaptive immune response. 
2. Test more than one genus of probiotic microorganisms against bacterial 
human skin pathogens to determine which is better in comparison to probiotic 
Lactobacillus species, possessing greater beneficial properties against 
pathogens. 
3. Test different types of keratin in vivo and in vitro (on cell lines and tissue 
models) to monitor the real action of bacterial adhesion. The majority of 
researchers have demonstrated that the results are better in vivo compared 
to results in vitro. 
4. Further types of the antimicrobial peptides (AMPs) should be developed 
and tested, which may have greater effectiveness compared to hBD-2 e.g. 
cathelicidins or others.  
5. Appraise the role secreted protein and cell lysates for probiotics on 
pathogens exclusion. 
6. Evaluate the role of antimicrobial substances that are produced by some 
Lactobacillus species on pathogens using the transcriptomic techniques such 
as a Microarray technique and/ or real time PCR.  
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7. Test a wide range of antibiotics against large numbers MRSA. In addition, 
use of a large number of genes in gene expression and observe the changes, 
either upregulation or downregulation. In addition, must be study the role of 
cell wall proteins, which played an important role in all changes that event in 
MRSA cell wall. 
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Appendix 1: 
Data relevant for chapter (5 and 6) bacterial human skin pathogens pathway 
modulation by microbial compounds 
 MecA gene: 
  1741 tctatagcgc attagaaaat aatggcaata ttaacgcacc tcacttatta aaagacacga 
  1801 aaaacaaagt ttggaagaaa aatattattt ccaaagaaaa tatcaatcta ttaaatgatg 
  1861 gtatgcaaca agtcgtaaat aaaacacata aagaagatat ttatagatct tatgcaaact 
  1921 taattggcaa atccggtact gcagaactca aaatgaaaca aggagaaagt ggcagacaaa 
 
Pyk gene:  
  1803121 gtttcaacag ctgttgcaac tgcattgttt aacaatgcat ctgtactctt acgtcctttt 
  1803181 ttaactacag gttgaactcc ccaaacaatt gaacattgac gtgcagtttc ttcacttgga 
  1803241 gtcacc 
     
 
PBP2 gene: 
     121 tcaaaaaaga atagaaa tgtgaagagaacg attattaag a ttattggctt catgattatt 
      181 gcattttttg ttgttctttt actaggtatc ttattgtttg cttattatgc ttggaaagca 
      241 cctgctttta ccgaagctaa attacaagat ccgattcctg caaagatata tgacaagaac 
      301 ggagaacttg ttaaaacatt agataatggc caaagacatg agcatgtaaa tttaaaagac 
      361 gtgccgaaat caatgaaaga cgcagtactt gcaactgaag acaatcgttt ctacgaacat 
      421 ggcgcacttg attataaacg tttattcggt gcaattggta agaacttgac tggtggattt 
      481 ggttctgaag gtgcctcaac attaacacaa caagttgtta aagatgcatt tttatcacaa 
      541 cataaatcta ttggacgtaa agctcaagaa gcttacttat catatcgttt agaacaagag 
      601 tatagtaaag atgatatctt ccaagtatat ctaaataaaa tttactattc tgatggcgta 
      661 acaggtatta aagctgctgc taagtattac tttaataaag atttaaaaga tttaaactta 
      721 gcggaagaag cttatttagc cggtttacct caggttccaa acaactataa tatttatgat 
      781 catccaaaag ctgctgaaga tcgtaaaaac actgttttat acttaatgca ttatcataaa 
      841 cgcattacag ataaacagtg ggaagatgct aagaaaatcg atttaaaagc gaacttagta 
      901 aatcgtactg ctgaagaacg tcaaaacatt gatacaa atc aagattctga gtataattca 
      961 t acgttaact ttgtaaaatc tgaattaatg aataataaag cattcaaaga tgaaaattta 
 
mecR1 gene 
 
     1261 ataactaatt gttatatgct ttttgtagaa ctgcatctta ctttgacata ctttaagtcg 
     1321 ttcattaaga tatgacgatt ccaatgacga acttttaata acatcaattt gtcggaatgc 
     1381 cttaatcata taaaataagc acaacaaact accaaatacc catatcaaaa gaatcatata      
     1441 cgttatattt gaggtctcaa actgattaac attaattgct aagtctttcg taacagatga 
     1501 ttgttgacca tctaacatat gactaaccga agaagtcgtg tcagatacat ttcgattcat 
     1561 catatctttt gaaaatgtaa aattcgatat tttgtaaaat ggtattaatg gaattaacgt 
     1621 ggagacgagc actaataacc aaatcttatg tgacataata ttttgagtat attttatata 
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mprF gene 
 
 541 atttattcaa tggttagacc acccgataaa aacaatcgtt ttgtaggatt gtactgcact 
 601 ttagtgtcgt gtgttgaatg gttagcagct gcagttgtat tatatttctg tggtgtaatt 
 661 gttgacgctc 
 
dltA gene for S. aureus: 
 
  781 tgtggtgaaa ttctacctca cagagcagca aaagcgttag tgagccgttt cccaagtgcg 
   841 acgatttaca acacatatgg tccaactgaa gctacggtag cagttacaag tattcaaatt 
   901 acacaagaaa tcttagatca atatccgaca ttacctgttg gcgttgaaag actaggcgca 
   961 agattatcta ctacagatga cggtgaactt gttattgaag gtcaaagtgt aagtttagga 
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Appendix 2: 
 
 
 
 
Figure 2.1 RNA purity and concentrations data, obtained following RNA extraction, for 
MRSA 33591 samples (A) control and (B) with hBD-2. The highlighted value number is the 
RNA concentration of the sample measured using a NanoDrop spectrophotometer. 
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Figure 2.2 RNA purity and concentrations data, obtained following RNA extraction, from 
MRSA 33591 samples: (A) control 1, (B) control 2, (C) treatment. The highlighted value is 
the RNA concentration in the sample measured using a NanoDrop spectrophotometer. 
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Appendix 3: 
 
Figure 3.1 Zones of Inhibition around different concentration methicillin (10, 15 and 20μg) 
with 0.0312% concentration of LA against MRSA 33591 
 
 
 
Figure 3.2 Zones of Inhibition around different concentration methicillin (10, 15 and 20μg) 
with 1.5% concentration of different acids against MRSA 3359. 
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Figure 3.3 Zones of Inhibition around different concentration methicillin (10, 15 and 20μg) 
with different amounts supernatant of L. plantarum (200 and 400 μl) against MRSA 33591. 
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Figure 3.4 Zones of Inhibition around different concentration methicillin (10, 15 and 20 μg) 
with different amounts supernatant of L. plantarum (200 and 400 μl) against MRSA 25691 
(human skin wound strain). 
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Figure 3.5 inhibition zones around different concentrations of methicillin (10, 15 and 20 μg) 
with 400 μl neutralised supernatant of L. plantarum (pH 7) and 200 μl sodium lactate 71% 
against MRSA 33591. 
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Figure 3.6 Inhibition zones were not observed around methicillin discs (10, 15 and 20 μg) 
within different amounts MRS broth (200 and 400 μl) against MRSA 33591. 
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Appendix 4: 
Posters: 
4.1 Chapter 2: Evaluation of antimicrobial activity of probiotic Lactobacillus  
species against bacterial human skin pathogens 
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4.2 Chapter 2: Evaluation of antimicrobial activity of probiotic Lactobacillus  
species against bacterial human skin pathogens.  
 
The results have been published online (Abstract) in XVth International Congress on 
Animal Hygiene 2011, 3th - 7th July 2011, Vienna, Austria. 
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4.3 Chapter 3: Assessment of aggregation, biofilm formation, and adhesion to keratin. 
 
 
The results have been published (Abstract) in NEMO Keele Conference, Keele 
University, Keele, UK. 
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4.4 Chapter 4: Antimicrobial activity of human β-defensin-2 (hBD-2) and probiotic 
Lactobacillus plantarum (L. plantarum) against bacterial human skin pathogens. 
 
 
The results have been published abstract and article in SFAM conference 1st - 4th 
July, Cardiff, UK, and publish (abstract) in V International Conference on 
Environmental, Industrial, and Applied Microbiology, Medicine College, Madrid 
University, Madrid, Spain, 2nd - 4th October 2013. 
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Appendix 5:  
Training courses, conferences and taught sessions attended 
 
5.1. Generic Skills Training completed 
 
1. Module Postgraduate Research Skills and Methods (BIO5124), 6 th - 14th 
December 2010. 
2. GAT course, 27th January 3rd , 10th , 17th , 24th February 3rd March 2011. 
3. ENV 5101 Demonstration,  29th October - 9th December 2010.  
4. PowerPoint - Creating a Presentation, 22th February 2011. 
5. PowerPoint - Creating a Presentation, 27th February 2011. 
6. Plagiarism, 9th March 2011. 
7. Word Using Master Documents, 28th March 2011. 
8. Developing Professional Writing Skills, 6th April 2011. 
9. Presentation for BIO5124, 27th April 2011 
10. Session about Olympus Microscope, 26th May 2011. 
11. The transformation of QPCR, 24th October 2011. 
12. Excel 2010 Essential Features, 02nd November 2011. 
13. The transformation of QPCR, Jams Hargreaves-NGOTSS team, 24th October 
2011, Roland Levinsky Building, Room: 206, 13:00 - 14:00. 
14. Life technologies Real time PCR training course, 23ed November 2011, Exeter 
trainer Chris Maddren. 
15. Excel 2010 Essential Features, Jaqcui Hunter, 02nd November 2011, 10:00 -
13:00, Babbage building, Room: 322. 
16. Conditional formatting and chart, 29th February 2012, 10:00-12:00 
17. Excel 2010 Essential Features, Jaqcui Hunter, Babbage building, Room: 322. 
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18. PP. enhancing your presentation, 15th March 2012, Thursday 10:00 - 13:00, 
Babbage, R: 322. 
19. Excel sorting filtering and pivot tables, 21st March 2012, Wednesday 13:30 -
15:30, Babbage, R: 322. 
20. Writing for Research Publication, 30th March 2012, 9:00 - 12:30, Rolle Building, 
R: 117. 
21. Word Master Documents, 3ed April 2012, 10:00-12:00, Babbage, R: 322. 
22. SPSS, 29th May 2012, 13:00-17:00, Babbage Building Room: 109. 
23. The CRTB Research Day, Wednesday 4th July, Portland Square, Attendance. 
24. Practical techniques in molecular biology workshop, 16th - 19th July 2012, 
Plymouth University. 
25. The pipette workshop, 3ed floor Room: 312, Davy building 
26. Mass spectrometry-based proteomics and its application in malaria research, 27 th 
November 2012, Plymouth University. 
 
5.2. Other Skills Training completed (e.g. UKGRAD School; English / Foreign 
Language) and / or conferences / meetings attended  
1. English Language Summer School (intensive course) / Academic writing,  
Cookworthy Refectory, 25th October 2010 - 25th January 2011. 
2. Supporting English Language Classes (tutorial lessons), Cookworthy Refectory, 
31st May 2011. 
3. Postgraduate English Language Summer, Cookworthy Refectory, June 2011 July 
2011. 
4. English Language Summer School (intensive course) / Academic writing, 
Cookworthy Refectory, 25th October 2010 - 25th January 2011. 
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5. English Language for international Students,  Cookworthy Refectory, 10th October 
2011. 
6. English language support for international students, Cookworthy Refectory, 3ed 
December 2012. 
 
 
5.3: Seminar / Conference / Performance presentations 
1. Marine conference, Plymouth University, 20th December 2010, Audience. 
2. The Postgraduate society conference series, University of Plymouth, Roland 
Levinesky, 17th March - 2011, Audience. 
3. Annual Research Day Conference, Plymouth University, 4th - 5th - March 2011, 
Audience. 
4. The antimicrobial effect of probiotics on human skin diseases, Postgraduate / 
Society Conference Roland Levinsky / Plymouth University, 17th March 2011, 
Published (Abstract). 
5. 2nd Marine Institute Research Conference, University of Plymouth, Sherwell 
Centre, 5th May 2011, Audience. 
6. The Postgraduate Society Conference Series, University of Plymouth, Rolle 
Building Lecture Theatre, Poster, 29th June 2011, Published (Abstract). 
7. The effect of probiotics on human skin staphylococcal diseases, XVth International 
Congress on Animal Hygiene / Vienna, Austria, Poster, 3ed July 2011, Published 
(Abstract). 
8. Ecotoxicology Research and Innovation Centre (ERIC) conference, Portland 
Square Building, Plymouth University, 13th July 2012, Audience. 
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9. Activity of human β-defensin-2 (hBD-2) and probiotic Lactobacillus plantarum 
against bacterial human skin pathogens, SFAM Conference / Cardiff, UK, Poster, 1st 
- 4th July  2012, Published (Abstract). 
10. The effect of Lactobacillus species on the biofilm formation by bacterial human 
skin pathogens, NEMO in Keele University Conference / Keele University, Oral and 
Poster, 9th November 2012, Published (Abstract). 
11. The postgraduate society conference series, Plymouth University, Rolle Building, 
12th  November 2012, Audience. 
12. The effect of Lactobacillus species on the biofilm formation by bacterial human 
skin pathogens, CARS Postgraduate Symposium / Plymouth University, Poster,  
10th  December  2012, Published (Abstract). 
13. Postgraduate society 2nd conference, Plymouth University, November 2013, 
Audience. restoration of susceptibility of methicillin-resistant S. aureus (MRSA) to β-
lactam antibiotics by probiotic L. plantarum, SoBBS Seminar Series / Babbage 006 / 
Plymouth University, Oral presentation, 15th May 2013. 
14. The annual conference, Plymouth University, 18th June 2013, Audience. 
15. Annual Conference, Plymouth University, Poster, 19th June 2013, Published 
(Abstract). 
16. Activity of human β-defensin-2 (hBD-2) and probiotic Lactobacillus plantarum 
against bacterial human, Madrid / Spain, Poster, 2nd - 4th October 2013, Published 
(Abstract). 
17. Restoration of susceptibility of methicillin-resistant S. aureus (MRSA) to β-lactam 
antibiotics by probiotic L. plantarum, Madrid / Spain, Oral presentation, 2nd - 4th 
October 2013, Published (Paper), ISBN: 978-90-8686-243-6, ISBN E-book: 978-90-
8686-795-0, pp. 585-589. 
